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ABSTRACT 
'This thesis examines the influence of moderate exercise, attainable by a large 
percentage of the population, on lipoprotein metabolism in the fasted and postprandial 
states in normolipidaemic subjects. 
A cross-sectional study in middle-aged men and women (endurance athletes, 
recreational exercisers and sedentary controls) revealed that the more favourable fasted 
blood lipid profiles found in athletes were also apparent in recreational exercisers, with 
higher high density lipoprotein (HDL) cholesterol concentrations in female (1.94 v 1.57 
mmol.1-1, p<O.05), but not male (1.50 v 1.34 mmol.1-1 NS), recreational exercisers 
than sedentary controls. HDLz cholesterol concentrations were higher in both male 
(26%, p<0.05) and female (42%, p<O.Ol) recreational exercisers than controls. 
The influence of exercise on blood lipids and lipoproteins may be revealed more 
clearly in the postprandial state. Thus, subsequent studies examined the influence of 
exercise on postprandial lipaemia, as assessed from the serum triacylglycerol (TAG) 
concentrations over a 6-hour period, following ingestion of a high-fat test meal (66% of 
energy from fat). The first involved the influence of 90 minutes of walking at 40% of 
maximal oxygen uptake (V02max) after ingestion of the test meal on postprandial 
lipaemia in young adults (n=12). The totallipaemic response was 24% lower in the 
exercise trial than in the control trial (3.2 v 4.5 mmol.1-1.h, p<0.05), attributable to a 
lower response during the recovery period rather than during the exercise. 
The next study therefore examined postprandial lipaemia during the recovery period 
following a single bout of walking (2 hours at 30% V02max). The walking resulted in 
a 33% reduction in the totallipaemic response to the test meal, consumed 15 hours after 
completion of the exercise in young adults (n=12), compared to the control condition 
(4.3 v 6.5 mmol.l·1.h, p<O.OI). 
Finally, to see whether brisk walking stimulates a long-lasting effect on 
postprandial lipaemia, a training study was conducted: previously sedentary middle-
aged women who followed a 12-week programme improved their endurance fitness 
(13%, p<O.OI; using V02 at a blood lactate concentration of 3 mmol.l-1 as an index) 
and decreased body fatness (7%, p<O.05) (compared with randomly assigned 
controls). Postprandial lipaemia was unchanged after training when this was 
determined 48 hours after the last exercise session. The postprandial insulin response 
was, however, clearly decreased (35%) by training (area under the insulin/time curve, 
pre-training 80.0±23.5 llU.ml-1.h v 56.6±13.0 llU.ml-l.h post-training, p<0.05). 
The results of these studies show that moderate exercise in the form of brisk 
walking can attenuate postprandial lipaemia, but suggests that it needs to be taken 
frequently, as this influence may be short-lived. 
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1 INTRODUCTION 
A sedentary lifestyle has been identified as an independent risk factor for coronary heart 
disease (CHD) (Fletcher et al. 1990), similar in magnitude to other risk factors for 
CHD, including hypertension, hypercholesterolaemia and smoking. Calculation of the 
relative risk for CHD based on risk attributes assigns hypertension a value of 2.1, 
hypercholesterolaemia 2.4, smoking 2.5 and physical activity 1.9 (Wenger 1994). 
Indeed, the 1993 Recommendations of the European Atherosclerosis Society emphasise 
the association of sedentary habits with an increased risk of CHD and advocate regular 
aerobic exercise as part of a healthy lifestyle (Wenger 1993). 
The evidence from epidemiological studies suggests that regular vigorous exercise is 
associated with reduced mortality from CHD (Berlin and Colditz 1990). Indeed, the 
results of two recently reported studies (paffenbarger et al. 1993, Sandvik et al. 1993) 
demonstrate not only a reduced mortality from CHD in men who participate in regular 
exercise during leisure time (Paffenbarger et al. 1993) and amongst men in the highest 
fitness quartile (Sandvik et a1. 1993), but also a reduced risk of such individuals 
experiencing a cardiovascular emergency. 
The potential of a particular risk factor to influence the incidence of CHD, however, 
depends not only on the relative increase in risk it confers but also on its prevalence. 
Data from the National Fitness Survey (1992) suggests that inactivity is widespread in 
the United Kingdom as 8 out of 10 women and 7 out of 10 men do not take enough 
exercise to benefit health. Therefore, an increase in the number of individuals taking 
regular exercise could have an important impact on the incidence of CHD in this 
country. An important question which remains to be addressed, however, is the nature 
and amount of exercise needed to confer a decreased risk of CHD.lndeed, physical 
activity has the potential to modify CHD risk in the population only if the prescribed 
exercise regimen is acceptable to the majority of individuals. 
Few people may be persuaded to take up vigorous exercise regimens and such 
programmes are frequently associated with a high drop-out rate and incidence of injury. 
In comparison, a number of reports describe greater adherence to regimens of low-to 
-moderate intensity then to those of vigorous intensity (Martin and Dubbert 1982, 
Harris et al. 1989). Such exercise may include brisk walking, which has been shown to 
be sufficient exercise to induce changes in endurance fitness in middle-aged men and 
women (porcari et al. 1989, Hardrnan et al. 1992). Indeed, Wannamethee and Shaper 
(1992), in a study of British men, have reported that "moderate levels of physical 
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activity, such as frequent regular walking plus recreational activity once a week, seem 
to be sufficient to produce a significant beneficial effect on cardiovascular disease risk 
in men". In addition, these researchers conclude that more vigorous activity does not 
seem to confer any further protection. 
Additionally, it has been observed that the greatest cardiovascular benefit occurs when 
very sedentary persons begin a regular programme of moderate intensity, endurance-
type exercise (HaskellI994). Thus, from a public health point of view it makes sense 
to promote activities, such as walking, that can be readily performed by the least active 
persons since they are at the greatest risk and appear to have the most benefit. 
The mechanism by which exercise might help to protect against CHD has been a topic 
of speculation but is thought by many to include an effect on lipoprotein metabolism. 
Endurance trained men and women exhibit blood lipid profiles which are con·sistent 
with a reduced risk ofCHD. More specifically, endurance athletes exhibit elevated high 
density lipoprotein cholesterol (HDL-C) concentrations and lower triacylglycerol 
(fAG) concentrations than their inactive peers (HaskellI984). However, it is not 
known whether the more favourable blood lipid profiles evident in endurance trained 
athletes are also evident in those who have a more modest commitment to exercise at a 
recreational level. Thus, the first study in this thesis compares the blood lipid profiles 
of endurance trained men and women with those who participate in recreational 
exercise, in the presence of a sedentary control group. 
HDL-C concentrations are inversely associated with CHD and are accepted as a strong 
independent risk factor for CHD (Rifkin 1990). The most popular hypothesis proposed 
to account for this relationship is that HDL has a key role in reverse cholesterol 
transport (Miller and Miller 1975). More recently, however, it has been proposed that 
the association of high HDL-C levels with reduced risk for CHD is not direct but rather 
reflects a dependence of HDL-C concentrations on the metabolism of TAG-rich 
lipoproteins (Patsch and Patsch 1984). This proposal suggests that the higher HDL-C 
concentrations reported in athletes may reflect an enhanced ability of those who 
participate in exercise to degrade TAG-rich lipoproteins as they continuously appear in 
the circulation after food ingestion. 
The critical role of TAG metabolism has not been generally appreciated until more 
recently (Bainton et al. 1992, Patsch et al. 1992). Indeed, the status offasting TAG 
concentrations as a risk factor for CHD has been considered weak as, in multivariate 
analysis including other lipid parameters, TAG tends to be eliminated, primarily due to 
2 
the inverse association of HDL·C with TAG. This elimination of TAG by HDL through 
statistical analysis constitutes a paradox because in reality the concentration of HDL-C 
is dependent on the metabolism of TAG-rich lipoproteins (Miesenbock and Patsch 
1992, Tall 1986). It has further been suggested that this close metabolic inverse 
relationship between TAG and HDL·C concentrations provides the likely link between 
exercise and lipoproteins (Thompson 1990). 
Traditionally, studies investigating the influence of exercise on lipoprotein metabolism 
have been conducted in the postabsorptive state with fasting plasma representing an 
equilibrated state of the lipid transport system in the circulation. However, fasting TAG 
concentrations, measuring the TAG present only in very low density lipoproteins 
(VLDL), do not necessarily provide accurate information on TAG metabolic capacity 
(patsch et al. 1983), which may be more clearly characterised in the postprandial state. 
Indeed, recently it has been suggested that raised non·fasting TAG concentrations are 
an independent risk factor for mortality from CHD (Stensvold et al. 1993). 
Furthermore, in a case·control study (Patsch et al. 1992) postprandial TAG 
concentrations were found to exhibit an association with CHD that was statistically 
independent and stronger than that of HDL-C . 
Therefore, to understand more fully the relationship between physical exercise, 
lipoprotein levels and CHD risk it is important to examine the effects of exercise on 
both fasting and postprandial lipoprotein levels. Indeed, the examination of 
postprandial lipoprotein metabolism may be particularly relevant as man spends the 
majority of his life in the postprandial state where TAG is circulating in chylomicrons 
as well as in VLDL. 
As all TAG·rich lipoproteins are degraded by a common pathway (Brunzell et al. 
1973), the most revealing way to characterise the metabolic capacity for TAG may be to 
determine the extent and duration of their elevation in serum following challenge with a 
fat load. The magnitude of the TAG or lipaemic response to a standard fatty meal 
differs substantially among apparently healthy individuals who are considered 
normolipidaemic on the basis of fasting blood lipid values (Mattock et al. 1981, Patsch 
et al. 1987). Indeed, otherwise subtle abnormalities of plasma lipoprotein metabolism 
may be highlighted in the postprandial state (Tall 1986). The postprandial phase may, 
therefore, provide a very sensitive model for examining TAG metabolic capacity. In 
addition, this great variability in postprandial TAG concentrations may be of 
pathophysiologic importance, since a significant lipaemia may persist throughout most 
of the day in normal adults consuming fat containing food over three meals. 
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The notion that the postprandial metabolism of TAG-rich lipoproteins might play an 
important role in the development of atherosclerosis was raised more than 10 years ago 
by ZiIversmit (1979) in a review article entitled "Atherogenesis - a postprandial 
phenomenon". Prior to this, the role of cholesterol-rich lipoproteins in atherogenesis 
had been studied by many investigators but much less attention had been paid to the 
possible atherogenic character of lipoproteins that were rich in TAG. This was due in 
part to the observation that atheromatous lesions in man and in experimental animals 
accumulate much cholesterol and its esters but little or no TAG. 
Subsequently, Zilversmit and co-workers performed several studies in cholesterol-fed 
rabbits showing that cholesteryl ester-rich remnants of TAG-rich lipoproteins may 
contribute to the deposition of lipid in the arterial wall (Stender and Zilversmit 1981, 
Stender and Zilversmit 1982). Indeed, Zilversmit (1973) suggested that degradation of 
TAG-rich particles, taking place on the endothelial surface of arterial walls by the action 
of lipoprotein lipase (LPL), may be an atherogenic process as their cholesterol becomes 
incorporated into the vessel wall where lesion formation may be stimulated. Other 
support for this view can be derived from the in vitro studies of Floren and colleagues 
(1981) who demonstrated that chylomicron remnants can induce an accumulation of 
cholesterol within human cultured arterial smooth muscle cells. These observations are 
concordant with case control studies reporting that postprandial lipaemia is elevated in 
men with known coronary artery disease (Simons et a1. 1987, Simpson et al. 1990, 
Groot et a1. 1991, Patsch et al. 1992). 
The increase in plasma TAG after a meal in humans is derived from exogenous (dietary 
chylomicrons) and endogenous (hepatic VLDL) sources, as indicated by increased 
levels of apolipoprotein (apo) B-48 and B-1OO respectively. Recently new biochemical 
techniques have been developed allowing differentiation of apo B-l00 and apo B-48. 
Schneeman and co-workers (1993) have thus shown that following ingestion of an 
ordinary meal the ensuing alimentary lipaemia is caused by an accumulation of VLDL 
of hepatic origin as well as chylomicron particles of intestinal origin. They further 
suggest that chylomicrons are cleared by LPL preferentially during postprandial 
lipaemia and that the accumulation of VLDL particles may be more relevant to the 
potential atherogenicity of postprandiallipoproteins. This interpretation is supported by 
the observations of Potts and co-workers (1991) who have reported that after a fat-rich 
meal the clearance of chylomicron-TAG into human subcutaneous tissue is enhanced 
whereas that of VLDL-TAG is reduced. 
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A rationale for an influence of exercise on postprandial lipaemia may be advanced 
because an increase in the activity of LPL, the enzyme which hydrolyses TAG-rich 
lipoproteins, is reported to occur after a single bout of vigorous exercise (Lithell et al. 
1984, Taskinen et al. 1980, Kantor et al. 1984) and, furthermore, is associated with 
endurance training (Peltonen et al. 1981, Svedenhag et al. 1983). Reports then that 
endurance trained runners exhibit a lower lipaemic response to an oral fat tolerance test 
than sedentary controls (Cohen et al. 1989, Merrill et al. 1989) tie in persuasively with 
the elevated LPL activity reported in such athletes (NikkiJa et al. 1978a) and the earlier 
observation that such individuals have higher HDL-C concentrations than their inactive 
peers (Wood et al. 1976). The low lipaemic response of physically active men to 
ingestion of dietary fat may, therefore, contribute to their reduced risk of coronary heart 
disease (Morris et al. 1990). An accelerated uptake of chylomicrons would decrease the 
time during which the arterial wall is exposed to these potentially atherogenic particles 
and might indeed delay the progression of atheroma. 
Few studies have examined the influence of exercise on postprandial lipaemia. Those 
that have been undertaken have been conducted in patient groups (Wirth et al. 1985, 
Zauner and Benson 1977) or have utilised vigorous exercise (Weintraub et al. 1989, 
Sady et al. 1986), unlikely to be taken up and adhered to by a large percentage of the 
population. Moreover, all the studies have been of men, despite the paucity of 
information concerning the influence of exercise on risk factors for coronary heart 
disease in women (Redmond 1991). 
The information available from these studies suggests that vigorous exercise may result 
in attenuation of postprandial lipaemia (Weintraub et al. 1989, Klein et al. 1992). It is 
unknown however, whether brisk walking, a moderate form of exercise that is socially 
acceptable, is sufficient to provoke changes in postprandiallipaeinia. Thus, two studies 
in this thesis were conducted to examine the influence of a single bout of walking on 
the lipaemic response to a mixed high fat meal. To the author's knowledge, no other 
studies have been previously conducted to examine the influence of walking on 
postprandial lipaemia. The fIrst of these studies in this thesis examines the influence on 
postprandial lipaemia of walking at 40% of maximal oxygen uptake (V02max) for 90 
minutes after consumption of a high fat meal. The second investigates postprandial 
lipaemia during the recovery period, having performed a single bout .of brisk walking 
the previous day. 
Finally, a randomly controlled study was conducted to examine the influence of a 12-
week programme of brisk walking on postprandial lipaemia in normolipidaemic, 
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previously sedentary middle-aged women in order to examine any possible long-lasting 
effects of exercise on postprandial lipaemia. 
The results of the National Fitness Survey (1992) demonstrate the sedentary nature of 
the British population. Further, Griffin (1993) has recently suggested that there are 
indications that "enhanced postprandiallipemia of a variable degree is a relatively 
common metabolic disorder in the general population". These two factors in 
combination indicate, therefore, that there is potential to modify CHD risk by a possible 
influence of attainable exercise on postprandial lipaemia. 
The purpose of the investigations in this thesis were then to examine the influence of 
brisk walking on postprandial lipaemia in normolipidaemic adults. By previously 
confming studies concerning the influence of exercise on lipoprotein metabolism to 
fasting plasma, the potency of exercise to influence risk factors for CHD may have 
been underestimated. If exercise does indeed help to reduce the time for which the 
arterial wall is exposed to potentially atherogenic particles, then the case for 
encouraging increased physical activity as part of a prevention strategy against CHD 
would be strengthened. 
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2 REVIEW OF LITERATURE 
2.1 Overview 
This review begins by explaining how lipid is transported in the blood in lipoproteins, 
both in the fasted and postprandial state, and includes a description of the enzymes 
involved in the metabolism of these particles. The next section examines various factors 
affecting postprandial lipoprotein metabolism including the action of insulin following 
food ingestion, the composition of the fatty meal and the size of the endogenous TAG 
pool. Following this, a section is included reviewing the possible relationship of 
different lipoproteins to the development of atherosclerosis. The influence of exercise, 
both a single bout of exercise and endurance training, on lipoprotein metabolism is then 
reviewed, both in the fasted and postprandial states, concentrating on exercise of 
moderate intensity. 
It has been proposed that a variety of other factors as well as exercise may influence 
postprandial lipaemia, and these are discussed in the next section. These include the 
apolipoprotein E phenotype, age, alcohol intake and obesity. Next, the different 
methods of assessing postprandialliapaemia are reviewed, including oral fat tolerance 
tests, intravenous fat tolerance tests and the use of retinyl esters as markers of intestinal 
lipoproteins. Finally, the use of measurements of blood lactate concentration in 
assessing improvements in endurance fitness is discussed, as well as the effectiveness 
of walking exercise as a means of enhancing endurance fitness. 
2.2 Lipoprotein and apolipoprotein classification 
Plasma lipoproteins are macromolecular complexes, containing various lipids 
(cholesterol, TAG and phospholipids) and apolipoproteins, that serve as the vehicles 
for the transport of lipids in soluble form in the blood. A1llipoproteins share a common 
basic structure consisting of a hydrophobic core of lipids (TAG and cholesterol esters) 
and a hydrophilic shell of polar lipids (phospholipids and free cholesterol) and 
apoproteins (Stryer 1988). Lipoproteins exist in a state of dynamic equilibrium with a 
continuous exchange of lipid and protein between macromolecules. However, they can 
be divided into five basic catagories according to density (determined by 
ultracentrifugation) (Brewer et al. 1988). 
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(1) Chylomicrons (density < 0.95 g.ml-1) are composed of 98-99.5% lipid and 
0.5-2% protein and are fonned in the intestinal mucosa, transporting exogenous 
(dietary) fat 
(2) Very low density lipoproteins (VLDL) (density < 1.006 g.ml- i ) are composed 
of 85-90% lipid andlO-15% protein and are fonned in the liver, transporting 
endogenous TAG. 
(3) Intennediate density lipoproteins (IDL) (density = 1.006 - 1.019 g.ml- i ) are 
metabolic products of the degradation of VLDL which then become precursors 
forLDL. 
(4) Low density lipoproteins (LDL) (density = 1.019 - 1.063 g .m1- i ) are 
composed of 75% lipid and 25% protein and are responsible for transporting 
the bulk of cholesterol in the blood. 
(5) High density lipoproteins (HDL) (density = 1.063 - 1.210 g.ml-1) are 
composed of approximately 50% lipid and 50% protein and are synthesized in 
the liver and intestine in nascent fonn but fully develop in the plasma on 
interaction with VLDL and chylomicrons. 
The protein components of lipoproteins have also been classified into groups, 
designated as apolipoprotein (apo) A, apo B, apo C, apo D, apo E and some additional 
minor proteins (Patsch and Patsch 1984). Aside from their major function of facilitating 
lipid transport in blood, apolipoproteins also act as recognition sites for cell membrane 
receptors and as co-factors for enzymes which are involved in plasma lipoprotein 
metabolism. The function of these apolipoprotein groups are highlighted below. 
(1) The two apo A proteins, apo AI and apo All, are the major components of HDL 
and are also found in newly secreted chylomicrons. One of the major roles of 
apo AI is as an activator of the enzyme lecithin: cholesterol acyltransferase 
(LCA,!). 
(2) There are two apo B proteins, apo B-48 and apo B-100. Apo B-48 is fonned in 
the intestine and is the major structural component of chylomicrons. Apo B-I00 
is synthesised in the liver and is present in VLDL and IDL. It is virtually the 
sole protein component of LDL. 
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(3) The apo C proteins consist of three low molecular weight peptides, apo C-I, 
apo C-Il and apo C-IlI, which exchange readily between TAG-rich lipoproteins 
and HDL. Apo C-II has an important function as the activator of lipoprotein 
lipase (Mahley 1991). 
(4) Apo D is found exclusively in HDL, and as yet the role of this apolipoprotein is 
undefined, but may involve the transfer of cholesterol ester from HDL to TAG-
rich lipoproteins (Ginsberg 1990). 
(5) Apo E, present in alllipoproteins, is thought to be essential for the recognition 
and removal of chylomicrons and/or chylomicron remnants by the hepatic apo E 
2 or remnant receptor. 
2.3 Enzymes involved in lipoprotein metabolism 
The three key enzymes involved in lipoprotein metabolism are lipoprotein lipase, 
hepatic lipase and lecithin: cholesterol acyltransferase. 
2.3.1 Lipoprotein lipase 
Lipoprotein lipase (LPL) is the enzyme responsible for the hydrolysis of plasma 
chylomicron and VLDL triacylglycerol (Durstine and Haskell 1994). It is found on the 
luminal surfaces of capillary endothelial cells of many tissues including adipose tissue 
and cardiac and skeletal muscle (EckeI1989), where the hydrolysis of lipoprotein TAG 
takes place. Through its action LPL makes the TAG fatty acids available to the 
extrahepatic tissues of the body for either oxidation in muscle or for storage in adipose 
tissue and muscle (Robinson and Speake 1989). 
This enzyme is synthesized within the parenchyma! cells of the extrahepatic tissues. 
LPL is then released from these cells and moves to binding sites at the the luminal side 
of the endothelial cells in adjacent capillaries (Olivecrona and Bengtsson-Olivecrona 
1990), as is shown in Figure 2.1. The route of the enzyme's transfer from from the site 
of synthesis to its functional site, however, is not well understood (Robinson and 
Speake 1989). 
The lipase then moves slowly along the endothelial surface from one binding site to the 
next, carried by the blood. When it enters larger vessels and the general circulation it 
can spread to binding sites in other tissues, including those which do not produce LPL. 
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This spreading is counteracted by an avid uptake of LPL by the liver. Hence the system 
is not in equilibrium but there is continuous supply of new LPL molecules from sites of 
synthesis, resulting in high concentration at these capillary segments. 
Figure 2.1 
Vessel 
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Circulating 
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," liver 
lipase--
producing 
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The transport of Lipoprotein Lipase (OIivecrona and Bengtsson-
Olivecrona 1990). 
The synthesis of LPL is thought to be under the control of several hormones. These 
include the control of insulin, by possibly enhancing messenger RNA translation, and 
catecholamines, which may inactivate enzyme molecules (Cryer 1981). Once secreted 
from the tissue cell the enzyme can be considered to be ouside the sphere of potential 
hormonal control. The presence of apo Cll also plays an important role in the activation 
of LPL (Wang et al. 1992). 
The LPL activity of particular extrahepatic tissues changes with alterations in 
physiological and pathophysiological state. For example, in adipose tissue LPL activity 
and TAG fatty acid uptake are both high in the fed state but fall on fasting. On the other 
hand, in skeletal muscle TAG fatty acid uptake and LPL activity are both increased in 
the fasting state in order to provide fatty acids for oxidation (EckeI1989). Such tissue 
specific changes in LPL activity strongly suggest that the enzyme not only facilitates but 
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also directs TAG fatty acid removal fron the blood so as to provide for the changing 
requirements of individual body tissues (Quinn et al. 1982). 
2.3.2 Hepatic lipase 
Hepatic lipase and LPL have different but complementary roles in lipoprotein 
metabolism. LPL hydrolyzes TAG in chylomicrons and VLDL, but has little or no 
action on HDL in the plasma. On the other hand HL hydrolyzes both TAG and 
phospholipids in HDL and is thought to be involved in the catabolism of these particles. 
There is thus a strong negative relationship between HL activity and HDL-C 
concentrations, particularly HD~-C (Olivecrona and Bengtsson-Olivecrona 1990). HL 
may also have a role in the conversion of small VLDL to IDL (Olivecrona and 
Bengtsson-Olivecrona 1990) and may be important in the fmal stages of chylomicron 
metabolism, converting chylomicron and VLDL remnants to LDL particles (Nozaki et 
al. 1986). In addition, HL works in conjunction with cholesteryl ester transfer protein 
(CETP) in the degradation of HD~ particles (Durstine and HaskellI994). 
It is thought that the enzyme originates in the liver and it is found bound to the liver 
endothelial capillary lining, in place for lipoprotein metabolism. HL is taken up from 
blood only by adrenals and ovaries, implying specialized binding sites (Olivecrona and 
Bengtsson-Olivecrona 1990). 
2.3.3 Lecithin: cholesterol acyItransferase 
Lecithin: cholesterol acyltransferase (LCAT) is synthesized by the liver, found in 
plasma and activated by apo AI (Durstine and Haskell 1994). This enzyme promotes 
the esterification of free cholesterol on the surface of HDL and the cholesterol esters 
formed in this reaction are then incorporated in to the hydrophobic core of HDL 
(Fielding 1991). LCAT then plays a crucial role inHDL metabolism since it is 
responsible for converting the nascent HDL particle formed in the liver and intestine 
into its complete form in the plasma. Any reduction in LCAT activity could theoretically 
reduce plasma HDL concentrations (Eisenberg 1990). 
During alimentary lipaemia there is an approximate 40% increase in LCAT, as revealed 
by incubation of lipaemic plasma (Tall 1986). It has been suggested that this is 
possibly due to the greater availability of substrate (cholesterol and phospholipids) or, 
alternatively, it is conceivable that LCAT binds directly to TAG-rich lipoproteins. 
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2.4 Lipoprotein metabolism in the fasted state 
Figure 2.2 illustrates an overall schematic representation of lipid transport by plasma 
lipoproteins, showing the metabolic pathway of both endogenous and exogenous TAG. 
It can be seen from this diagram that the catabolism of TAG-rich lipoproteins of 
endogenous (hepatic) origin is similar to that of exogenous (dietary) TAG-rich 
lipoproteins. The metabolism of endogenous TAG (VLDL) will be discussed here, 
followed by a section concerning lipid digestion, intestinal lipoprotein secretion and 
postprandial lipoprotein metabolism. 
Intestine Liver 
f + 
Exogenous TG Production Endogenous TG Production 
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A schematic representation of TAG-rich lipoprotein catabolism (Chen 
and Reaven 1991). 
Endogenously synthesized lipids are carried in VLDL produced by the liver. The fatty 
acids used for TAG synthesis in the liver are derived from two sources: dietary 
carbohydrates that are converted into fatty acids in the hepatocytes, and fatty acids that 
are removed from the plasma by the liver. The latter are derived from either free fatty 
acids that are released into the plasma by extrahepatic tissues, primarily adipocytes, or 
the TAG contained in plasma lipoproteins taken up by the liver (Chappell and Spector 
1991)_ 
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The initial step in the catabolism of VLDL particles is hydrolysis of their TAG by the 
action of the enzyme lipoprotein lipase. The half-life of VLDL-TAG in normal human 
blood is between two and four hours (Durstine and Haske1l1994). Thus VLDL 
particles are converted to particles having the density of IDL. The principal protein of 
this molecule is apo B 100. During the conversion of of VLDL to LDL, surface material 
(proteins, phospholipids and cholesterol) including the majority of the C-IT and E 
apolipoproteins, dissociate from VLDL remnants and IDL and associate with HDL 
particles. Within the HDL particle the excess cholesterol is esterified with fatty acids, 
via interaction with the enzyme LCAT, and transfered back to IDL. The net result of 
this conversion is the replacement of most of the TAG core of VLDL with cholesterol 
esters. It has been proposed that a second lipolytic enzyme, HL may be involved in the 
conversion ofIDL to LDL (Brewer et al. 1988). Some of these IDL particles may be 
removed from the plasma by the remnant and LDL receptors, but most of them escape 
removal from the circulation. 
Lipoprotein lipase then hydrolyzes the remainder of the TAG in IDL forming LDL 
particles. The LDL, which has an average life-span of two and a half days, delivers 
cholesterol to extrahepatic cells and the liver. LDL is removed from the circulation by a 
saturable pathway involving the binding of the particle to high affinity receptors located 
on the surface of hepatic cells and is then internalised by endocytosis, as described by 
Brown and Goldstein (1984). If saturation of this pathway occurs LDL are removed by 
'scavenger cells' (Goldstein and Brown 1983). However, if these scavenger cells are 
overloaded with cholesterol they become converted into 'foam cells', which are 
characteristic of early atherosclerotic lesions. 
2.5 Lipid digestion and postprandial lipoprotein metabolism 
This section includes a review of the process of digestion and absorption of dietary 
lipid and the subsequent secretion of intestinallipoproteins, followed by an outline of 
lipoprotein metabolism in the postprandial state. 
2.5.1 Lipid digestion and absorption 
Up to 90% of fat ingested with a meal consists of TAG, while the rest is made up of 
phospholipids, cholesterol, fatty acids and fat-soluble vitamins (Glickman 1983). 
Digestion oflipid begins in the stomach by mechanical means and by the action of 
salivary lipase (Caspary 1992), although this is not quantitatively important. 
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Emulsification of dietary fat continues as the chyme enters the duodenum where gastric 
acid triggers the release of secretin. This in turn leads to a stimulation of the flow of bile 
and pancreatic juice which mix with the coarse emulsion. Bile salts alone are relatively 
poor emulsifying agents but the addition of lecithin and monoacylglycerols produced in 
the early stages of digestion helps to continue emulsification (patsch 1987). The 
resulting fat globules are then hydrolysed into monoglycerides and free fatty acids by 
the action of pancreatic lipase and other enzymes. The products of this hydrolysis now 
aggregate into micelles, which are similar in structure to emulsion droplets but much 
smaller, and consist of bile salts, fatty acids, monoglycerides, cholesterol and 
phospholipids. They form an aqueous suspension in the intestinal lumen, which can 
readily be absorbed by the mucosal cells. 
Lipid absoxption in man occurs largely in the jejunum (Gurr and Harwood 1991). 
Within the intestinal epithelial cells fatty acids and mono glycerides are resynthesised 
into triacylglycerols, a process occurring in the endoplasmic reticulum by enzymatic 
action. These new triacylglycerols and cholesterol are reesterified and packed into a 
monolayer of phospholipids and apoproteins to form the largest lipoprotein species, the 
chylomicron. The efficiency of this process of fat absoxption is shown by the fact that 
under physiological conditions less than 5% of ingested lipids appear in the faeces 
(Caspray 1992). Additionally, in a recent review, Holt and Balint (1993) suggest that 
lipid digestion and absoxption are not affected by ageing. 
2.5.2 Intestinal lipoprotein secretion 
The chylomicron particles are secreted from the Golgi vacuoles into the intercellular 
spaces, where they reach the the intestinal lymph, pass into the thoracic duct and enter 
the general circulation through the subclavian vein to cause postprandial lipaemia. The 
major apolipoprotein of chylomicrons is apo B-48 and it is reported this apolipoprotein 
is synthesized in the rough endoplasmic reticulum, transferred to the smooth 
endoplasmic reticulum and then incoxporated into nascent chylomicrons, before their 
secretion (patsch 1987). 
Chylomicrons begin to appear in the plasma within 1 hour after ingestion of fat and 
upon entering plasma they acquire apo E and apo C, associated with an increase in 
protein content from 1 % to 3% of mass (Green and Glickman 1981). Chylomicron size 
is largely determined by the flux of TAG through the intestinal cell (Green and 
Glickman 1981). Thus, chylomicrons are small at the beginning and larger during the 
peak of lipid absoxption. However, the size and composition of chylomicrons also 
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depends on the fat content of the meal ingested. Chen and Reaven (1991) conclude that 
in general, the larger the intake of dietary fat, and the greater the proportion of 
unsaturated fatty acid in the meal, the larger the size of the chylomicrons synthesised. 
Chylomicrons are usually completely removed from the plasma compartment 5-8 hours 
after the last meal (patsch 1987). 
2.5.3 Lipoprotein metabolism in the postprandial state 
Chylomicron catabolism begins with the hydrolysis of TAG by the action of LPL on 
the endothelial surfaces of blood capillaries, primarily in adipose tissue (Gurr and 
Harwood 199). This process is dependent on the presence of apo C-II on the 
chylomicron, which binds and activates LPL. Indeed, LPL has a greater affmity for 
larger TAG-rich particles than for smaller chylomicrons, most likely related to their 
greater apo C-II content (Green and Glickman 1981). The hydrolysis of chylomicron 
TAG continues until approximately 70-90% of the TAG is removed, at which time it is 
designated as a chylomicron remnant These remnants are small and spherical, 
comprising approximately 4% of the original chylomicron mass. This hydrolysis and 
subsequent remnant formation is accomplished in only a few minutes, the half-life of 
chylomicrons in plasma being less than five minutes (Durstine and HaskellI994). 
As chylomicrons become depleted of their TAG content, they also shed other 
components i.e. cholesterol, phospholipids and apoproteins. Indeed approximately 
80% of the phospholipids and 40% of the apolipoproteins (apo A and C) are transferred 
to HDL during chylomicron catabolism (Chen and Reaven 1991). Apo B-48 however 
remains an integral part of the particle throughout the rapid modification of the 
chylomicron. Infact, only apo B-48, apo E and apo C-III do not dissociate from the 
parent chylomicron particle and remain with it throughout its catabolism to the remnant 
and subsequent removal by the liver (patsch 1987). 
In addition, there is an exchange of cholesterol esters and TAG between TAG-rich 
lipoproteins and HDL. This movement is facilitated by the activitY of cholesteryl ester 
transfer protein (CETP) and it has been estimated that one-fifth of the total HDL pool of 
cholesteryl ester each hour is transferred to TAG-rich lipoproteins in exchange for 
TAG, phospholipids and protein. Thus, the formation and clearance of chylomicron 
remnants simultaneously serve to remove cholesteryl ester from HDL, as well as 
contributing to the flow of cholesterol from peripheral tissue to the liver for ultimate 
excretion (Chen and Reaven 1991). 
15 
The chylomicron remnant circulates in the plasma until it is removed by specific 
receptors on the surface of hepatocytes which recognise and bind to the apo E 
component of the remnant The whole receptor-remnant complex then pinches off from 
the membrane and is internalized where it is degraded by lysosomal enzymes. 
2.6 Factors influencing postprandial lipoprotein metabolism 
2.6.1 The action of insulin 
Insulin may be seen to play a central role in the regulation of postprandial lipid 
metabolism and may be considered to have three integrating actions. Firstly, insulin 
acutely inhibits the hepatic secretion ofVLDL-TAG (Frayn 1993). This might be seen 
as part of the co-ordinated regulation of postprandial metabolism by insulin. It has been 
suggested that chylomicrons compete with VLDL particles for lipolysis by LPL, the so 
called "common removal pathway" (Brunzell et a1. 1973). Indeed, Potts and colleagues 
(1991) showed extraction of TAG from both chylomicrons and VLDL particles during 
passage through adipose tissue. Together with results from experiments demonstrating 
a seemingly preferential action of LPL on chylomicrons rather than VLDL particles 
(potts et al. 1991) this may help to explain the rise in VLDL-TAG concentrations 
observed in the postprandial period (Cohn et al. 1989, Schneeman et al. 1993). 
Insulin also suppresses the release of non-esterified fatty acids (NEFA) from adipose 
tissue. This is a marked effect in the postprandial period (Coppack et a1. 1990) and is 
mediated both through inhibition of honnone-sensitive lipase and by an increase in the 
re-esterification of fatty acids within adipose tissue (Coppack et al. 1992). Since the 
rate of supply of fatty acids to the liver is one factor controlling the rate ofVLDL-TAG 
secretion, the reduced delivery of NEFA to the liver, coupled with the direct 
suppressive effect of insulin, leads to a decreased postprandial VLDL-TAG secretion. 
At the same time, it has been suggested that insulin has opposing effects on LPL in 
adipose tissue and skeletal muscle. In adipose tissue insulin activates or stimulates LPL 
activity in humans (Sadur and EckeI1982), aiding the removal of TAG-rich 
lipoproteins from the circulation and stimulating storage of fat. It has been suggested 
that the adipose tissue LPL response to insulin could mainly result from an altered post-
translational processing (EckeI1989). However, insulin has also been shown to affect 
the transport of LPL from its intracellular inactive pool (endoplasmic reticulum) to its 
active pool (Golgi apparatus) (Lamarche et a1. 1993). The possible involvement of 
insulin in regulating muscle LPL activity has been investigated in studies in vivo that 
16 
have sought to establish a correlation between the plasma levels of this honnone and the 
activity of the enzyme. The rationale for these studies is based on observations that in 
adipose tissue and muscle LPL activity often change in opposite directions. Indeed, a 
study conducted by Kiens and colleagues (1989) demonstrated that physiological 
concentrations of insulin did decrease muscle LPL activity in proportion to the effect of 
insulin on muscle glucose uptake. 
2.6.2 The composition oC the Catty meal 
After ingestion of a fatty meal there is an increase in TAG concentrations due to the 
appearance of chylomicrons and their remnants in the plasma. The elevation of 
postprandial TAG concentrations however depends on both the amount and type of fat 
ingested in the meal (Norum 1992). This section reviews the effect on postprandial 
lipaemia of the fat composition of the test meal, as well as the presence of carbohydrate 
ingested in combination with fat 
In general, the more fat in a meal, the greater is the increase in postprandial lipaemia 
(Chen and Reaven 1991). This has been demonstrated in two studies (Cohen et al. 
1988, Demise et al. 1989), both which conclude that the serum TAG response is 
proportional to the meal fat content In the study by Cohen and associates (1988) 12 
subjects ingested meals containing 40, 80 and 120 g of fat and in that by Demise and 
colleagues (1989) 10 subjects ingested liquid meals containing 50 and 100 g of fat One 
of the reasons for this linear postprandial TAG response is that fat absorption is very 
efficient even after large fat meals. This was demonstrated by Patsch and co-workers 
(1983) who, following ingestion of a test meal comprising of 350 ml of cream, found 
only very small amounts of fat in the faeces during the 72 hours after the meal. It is also 
possible that the removal rate of serum TAG is increased by large fat loads. A previous 
study has indicated however that the major removal pathway for chylomicron TAG is 
not stimulated by acute fat feeding, when providing a meal containing fat alone 
(Nilsson-Ehle et al. 1975). 
The type of fat ingested in a test meal may also influence the magnitude of postprandial 
lipaemia. Norum (1992) reports that the duration of the postprandial rise in TAG is 
longer after an acute dietary load with saturated fat than with polyunsaturated fat. The 
reason for this may be the resulting size of chylomicron particles after ingestion of these 
different fatty acids. Unsaturated fatty acids tend to result in larger chylomicron 
particles than saturated fatty acids (Ockner et al. 1969, Ockner and Iones 1970). This 
may be expected to influence postprandial chylomciron clearance since large 
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chylomicron seem to be cleared faster than smaller ones. Indeed, Weintraub and 
colleagues (1988) report that an acute load of polyunsaturated (fish oil or safflower oil) 
fat is cleared more rapidly than saturated fat, probably because of an increased 
susceptibility of polyunsaturated chylomicrons to the action of LPL (Weintraub et al. 
1988). The results of a study by Zampelas and co-workers (1993) agrees with these 
previous fmdings as they found that postprandial lipaemia was lower and heparin 
releasable LPL activity higher after ingestion of a fish oil meal compared to a mixed oil 
meal or one containing corn oil. These researchers thus suggest that one of the 
mechanisms by which fish oil may decrease postprandial lipaemia is by increasing LPL 
activity, thereby increasing the clearance of dietary TAG. 
Studies of the effect of fish oil have also shown that chronic ingestion of dietary fat can 
also modulate postprandial lipaemia (Chen and Reaven 1991). There is substantial 
evidence that consumption of fish oil will lead to a decrease in both fasting TAG 
concentrations and postprandial lipaemia (Brown and Roberts 1991b, Weintraub et al. 
1988). The mechanism by which a diet high in fish oil decreases postprandial lipaemia 
is not clear but is thought that it is due to the enhanced removal of these TAG-rich 
particles from plasma by lipolysis, secondary to the decrease in hepatic VLDL-TAG 
synthesis. 
The addition of insulinogenic carbohydrate to a test meal may be of potential interest 
since such carbohydrate elicts an insulin response that can suppress VLDL secretion (as 
described in section 2.6.1). Cohen and Schall (1988) systematically quantified the 
effects of various carbohydrates on the postprandiallipaemic response to a standard fat 
load. Their results indicated that the addition of 50 g of sucrose or glucose to 40 g of fat 
had no effect on total or peak postprandial increment in TAG concentration. In contrast, 
addition of either 50 g of fructose or 100 g sucrose was associated with an approximate 
doubling of postprandial lipaemia. The same research group have, however, since this 
study published different results (Cohen and Berger 1990) reporting that glucose (100 
g) ingested with fat decreases postprandial lipaemia in a dose-dependent manner. The 
authors explain these results by suggesting that if low doses of glucose are used (50 g) 
then the reduction in postprandial lipaemia is small (about 20%), similar in size to the 
mean intra-individual variation in postprandial lipaemia. Thus, the true 
hypotriglyceridaemic effect of glucose may be concealed when small number of 
subjects are studied. The reduction of postprandial lipaemia by larger doses of glucose 
(100 g) is greater (40%) than the intra-subject variation in PPL, and thus attenuation of 
the lipaemic response is more likely to be recognised. 
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However, Chen and colleagues (1991) have recently demonstrated that the degree of 
postprandial lipaemia is similar following ingestion of meals containing 25% fat and 
60% carbohydrate, as compared with meals consisting of 45% fat and 40% 
carbohydrate. So, in this study, an approximate doubling of the fat load did not lead to 
a proportionate increase in the degree of postprandial lipaemia when the carbohydrate 
load was simultaneously decreased. More information is needed in order to understand 
the impact of dietary carbohydrate on postprandial lipaemia. 
The recent publication of two studies examining the contribution of endogenous and 
exogenous TAG-rich lipoproteins to postprandial lipaemia following meals containing 
both fat and carbohydrate (Schneeman et al. 1993, Karpe et al. 1993) are of some 
interest in this matter. In the study by Schneeman and co-workers (1993) it was 
determined that after ingestion of a meal consisting of 38% of energy from fat (46 g fat) 
and 46% from carbohydrate that postprandial TAG concentrations were due to an 
accumulation ofVLDL particles (apo B-1oo) as well as an increase in chylomicron 
particles (apo B-48). Karpe and colleagues (1993) also confmn that apo B-1oo 
containingparticles (VLDL) contribute to postprandial lipaemia after ingestion of a meal 
containing 100 g of fat and 100 g of glucose. These studies serve to demonstrate the 
importance of the accumulation of VLDL particles during alimentary lipaemia, which 
may be influenced by the amount and type of carbohydrate in a test meal, due to the 
action of insulin and the consequential suppression of hepatic VLDL secretion. 
2.6.3 The size of the endogenous TAG pool 
The most powerful regulator of the postprandial plasma TAG concentration appears to 
be the size of the endogenous TAG pool (O'Meara et al. 1992). Denborough (1963) 
demonstrated that the degree of postprandial lipaemia was closely correlated with the 
fasting plasma TAG concentration in patients with CHD. These observations were 
extended by Nestel (1964), who indicated that plasma TAG concentrations following a 
fat meal were significantly correlated with the fasting plasma TAG concentration in both 
normal subjects and individuals with CHD, and the higher the fasting plasma TAG 
concentration, the slower the rate of removal from plasma of injected radiolabeled 
chylomicrons. Furthermore, he was able to show that the increment in plasma TAG 
concentration following the fat meal was significantly related to the rate at which 
chylomicrons were removed, i.e. the slower the rate of chylomicron removal, the 
greater the increment in plasma TAG concentration. As a result of these and related 
observations (Brunzell et al. 1973, Grundy and Mok 1976) it is thought that TAG-rich 
particles of endogenous and exogenous origin compete for the same removal sites (as 
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described in section 2.4), and that the plasma TAG removal pathway is saturable. 
Thus, the larger the endogenous TAG pool, the less efficient will be the catabolism of 
newly absorbed TAG-rich lipoproteins of intestinal origin, and the greater the increment 
in postprandial TAG concentration. This has been demonstrated most clearly in studies 
showing an exaggerated postprandial lipaemia in hyperlipidaemic patients, with high 
fasting TAG concentrations, compared with the lipaemic response of normolipidaemic 
controls (Sharma et al. 1981, Dullaart et al. 1989, Weintraub et al. 1987a, Ooi et al. 
1992, Cohen and Grundy 1992). 
However, implicit in this formulation are two assumptions. The first is that essentially 
all dietary fat is absorbed, which appears to be the case in subjects without 
malabsorption syndrome (Patsch et al. 1983). The second is_that the increment in 
postprandial TAG response is entirely due to the synthesis and secretion of newly 
absorbed dietary fat. It has however been demonstrated that the concentration of apo B-
100 in TAG-rich lipoproteins increases during postprandial lipaemia (Cohn et al. 1989, 
Schneeman et al. 1993), raising the possibility that the increment in plasma TAG 
concentration after a fat meal may be at least partly due to hepatic secretion of TAG-rich 
particles. In conclusion, due to the important role of the fasting TAG concentration on 
postprandial lipaemia, evaluation of the effect of a specific variable on postprandial 
lipaemia should take into account the endogenous plasma TAG pool size. 
2.7 Atherosclerosis and lipoprotein metabolism 
This section reviews the role of different lipoprotein particles in the development of 
atherosclerosis and examines the possible mechanisms by which they may produce 
their particular atherogenic or anti-atherogenic effect 
2.7.1 Chylomicrons, chylomicron remnants and atherosclerosis 
The notion that chylomicrons and/or remnants might play an important role in the 
process of atherosclerosis was raised 15 years ago by Zilversmit (1979) in a review 
article entitled "Atherogenesis - a postprandial phenomenon". Subsequently, Zilversmit 
and co-workers performed several studes in cholesterol-fed rabbits which provided 
additional experimental support for this possibility (Stender and Zilversmit 1981, 
Stender and Zilversmit 1982). As emphasized by this research group, it is possible to 
view the atherogenic potential of cholesterol-containing chylomicrons in two ways. On 
the one hand, circulating chylomicrons could deposit their cholesterol directly into the 
arterial intima following their absorption onto the surface of the arterial wall and 
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subsequent degradation by LPL - the so-called "direct pathway". On the other hand, all 
of the chylomicron remnants formed by the action of LPL anywhere in the capillary 
network need not be removed by the liver, but could also be deposited in the arterial 
wall. This latter phenomenon was defined as the "indirect pathway". Observations in 
the cholesterol fed rabbit suggested that the arterial influx of cholesteryl ester from these 
alternative pathways might approximate the quantity derived from LDL (Stender and 
Zilversmit 1981). Further studies performed in hypercholesterolaemic rabbits supported 
the view that a considerable quantity of cholesteryl ester could be deposited in the 
arterial wall from non-LDL particles, but suggested that chylomicron remnants, not 
chylomicrons, were responsible for this phenomenon (Zilversmit 1984). Indeed the 
intact unhydrolysed chylomicron appears not to be atherogenic (Patsch 1987). In other 
words, in this particular experimental model, the indirect, not the direct pathway 
seemed to be most responsible for the accumulation of cholesteryl ester in the arterial 
wall. 
Other support of this view can be derived from the in vitro studies of Floren and 
colleagues (1981), who demonstrated that chylomicron remnants can induce an 
accumulation of c~olesterol within cultured human arterial smooth muscle cells. Indeed, 
both chylomicron and VLDL remnants have both been shown to be atherogenic because 
of their cytotoxic and foam-cell inducing properties (Chung et al. 1989). Foam cells are 
lipid-laden macrophages that form following macrophage uptake of oxidized 
lipoproteins that have filtered across the arterial surface into the intima and these foam 
cells may coalesce to form the initial atherosclerotic lesion, the fatty streak (Geurian et 
al. 1992). Atherogenic VLDL and chylomicron remnant formation appears to be 
exacerbated in individuals with elevated postprandial lipaemia leading to the current 
proposal that atherosclerosis may be a postprandial phenomenon (Brunzell 1989, Gotto 
et al. 1991). 
2.7.2 LDL particles and atherosclerosis 
It has been shown that atheromatous lesions in man and experimental animals 
accumulate much cholesterol and its esters, and thus LDL particles have been thought to 
play a causal role in the development of atherogenesis, as LDL is the principal carner of 
cholesterol in the human plasma (Zilversmit 1979). Indeed, the role of LDL particles in 
the development of accelerated atherosclerosis is dramatically illustrated by studies of 
patients with familial hypercholesterolaemia, as demonstrated by the classic studies of 
Brown and Goldstein (1984). It should be kept in mind however that these subjects 
also have abnormally high levels of VLDL remnants and IDL, which could also 
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contribute to the atherogenic process. However. a strong independent relationship 
between plasma concentrations of LDL and the risk of developing atherosclerotic heart 
disease has been revealed in many epidemiological trials (see Grundy 1990). Further. 
LDL-like lipoproteins have been extracted from atherosclerotic plaques (Getz 1990). 
although the demonstration of such lipoproteins in the artery wall does not establish a 
cause of atherosclerosis (Steinberg et al. 1989). 
2.7.3 HDL particles and atherosclerosis 
Several major prospective epidemiological studies have confmned the strong. inverse. 
and independent relationship between HDL cholesterol and CHD risk (Gordon et al. 
1989). Since the publication of a report by Miller and Miller (1975). the most popular 
hypothesis concerning the protective mechanism of HDL has been described as "the 
reverse cholesterol transport theory". In this model HDL particles are thought to trap 
excess cholesterol from cellular membranes by esterification and to transfer the 
cholesterol to TAG-rich lipoproteins which are subsequently removed by hepatic 
receptors. This reverse cholesterol transport from peripheral cells to the liver would 
counteract the deposition of cholesterol at sites where an excessive cholesterol load 
produces atherosclerosis. High HDL-C levels would then signify a high rate of reverse 
cholesterol transport However. direct in vivo demonstration and quantification of 
reverse cholesterol transport in either experimental animals or humans is still lacking 
(Steinberg et al. 1989). 
An alternative theory. proposed more recently by investigators such as Patsch and 
Patsch (1984) and Kashyap (1991) does not involve HDL in such a direct role. 
According to this "non-causal" model. HDL does not interfere directly with cholesterol 
deposition in the arterial wall but rather reflects the extent to which TAG-rich 
lipoproteins are converted to atherogenic remnants while passing through the lipolytic 
cascade (Lechleitner et al. 1990). A rapid clearance of TAG-rich lipoproteins promotes 
the formation of HD~ and low levels of TAG-rich lipoproteins reduces the transfer of 
HDL cholesteryl esters into these lipoproteins. This keeps the cholesterol-carrying 
capacity of HDL high and the net effect is anti-atherogenic. Delayed clearance and 
accumulation of TAG-rich lipoproteins prevents the formation of HD~ and leads to 
enhanced loss of cholesteryl esters from HDL into atherogenic lipoproteins. HDL-C is 
thus reduced and the net effect is atherogenic. Thus. HDL-C concentrations may be 
dependent on the rate of catabolism of TAG-rich lipoproteins. The influence of T AG-
rich lipoproteins on HDL may be particularly pronounced in the postprandial state with 
the entry of chylomicrons into the circulation. 
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2.7.4 Fasting triacylglycerol concentrations, postprandial lipaemia and 
atherosclerosis 
The connection between fasting TAG concentrations (VLDL-TAG) and atherosclerosis 
has, in the past, been elusive. There are two main reasons for this. Firstly, fasting TAG 
concentrations are fraught with 'noise' due to large intra-individual variability, and 
secondly, information about long-term TAG concentrations may be coded in the HDL2-
C concentration rather than plainly evident from a single fasting TAG measurement. 
Together, these intricacies seem to be responsible for the apparent underestimation of 
TAG concentrations as a vascular risk factor. The measurement of the TAG system 
under strain, postprandial lipaemia, may help to eliminate the noise inherent in a single 
TAG measurement and provide a clue to average long-term TAG levels (Miesenbock 
and Patsch 1992). 
Patsch (1987) suggests that postprandial lipaemia could be a major factor in 
atherogenesis particularly as the major part of a lifetime is spent in the postprandial 
state, Le the time period between food ingestion and 6-8 hours thereafter, with TAG-
rich lipoproteins of both hepatic and intestinal origin circUlating. Postprandial lipaemia 
could affect the atherosclerotic process directly through the appearance of 
postprandially occuring lipoproteins, or indirectly, via its demonstrated effects on other 
lipoproteins such as LDL and HDL. 
Recently it has been suggested that rather than considering chylomicron remnants in 
particular to be atherogenic a more comprehensive view of postprandial lipaemia can be 
taken whereby TAG transport in general is considered potentially atherogenic, with the 
postprandial state of challenge constituting a particularly critical and revealing phase 
(Miesenbock and Patsch 1992). This broader view vould be labelled the "triglyceride 
intolerance hypothesis". According to this hypothesis, a low TAG metabolic capacity 
per se constitutes a handicap that imparts atherogenic susceptability. In other words, the 
risk of developing atheroscleosis is not linked exclusively or mainly to accumulation 
and misdirection of chylomicron remnants in the postprandial state, but rather to a 
general impairment of TAG transport, irrespective of whether this impairment affects 
the metabolism of TAG-rich lipoproteins of intestinal or hepatic origin. 
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2.8 Exercise and lipoprotein metabolism 
Participation in a single exercise session and a regular programme of physical activity 
result in changes in lipid and lipoprotein concentrations. In this section studies 
examining these changes will be reviewed, focusing on those studies utilising moderate 
exercise, but with the inclusion of studies involving more vigorous exercise where no 
information for less intense exercise is available. Firstly, the changes in both fasting 
and postprandial lipoprotein metabolism resulting from a single bout of exercise will be 
reviewed. The effects of endurance training on these parameters will then be reviewed. 
The possible mechanisms responsible for these changes in lipoprotein metabolism will 
also be discussed. 
2.8.1 The influence of a single session of exercise on lipoprotein 
metabolism in the fasted state 
Considerable attention has been given to the effects of one physical activity session on 
plasma lipid and lipoprotein concentrations. Currently over 70 published journal 
manuscripts and abstracts are available regarding a single period of exercise completed 
by men and women, which encompass both short and prolonged periods of varying 
exercise modes and intensities (Durstine and Haskell 1994). Of these, however, 
relatively few have examined moderate exercise. 
Fasting TAG concentrations (VLDL-TAG) are not usually altered immediately 
following or in the days after an exercise period of short duration and Iow intensity 
(Angelopoulos et aI. 1993, Davis et al. 1992). However, a decrease in the plasma TAG 
concentration by about 50% has been reported to occur immediately after a prolonged 
bout of heavy exercise (Lithell 1986) and this concentration is regularly reduced 24 
hours after exercise to approximately equal degree (Kantor et aI. 1984, Enger et al. 
1980, Lithell et aI. 1981, Lithell et al. 1984, Thompson et aI. 1980, Cullinane et al. 
1982). In some studies these TAG values were found to be restored to normal on the 
second day (Enger et aI. 1980, Lithell et aI. 1984) but in others they were still 
decreased by about one-third after two (Kantor et al. 1984, Thompson et al. 1980) and 
three (Thompson et al. 1980) days after the exercise. Other studies of heavy exercise 
have however reported no change in TAG concentrations immediately following 
exercise but only in the recovery period (Durstine et al. 1983, Kantor et aI. 1987). 
When lower fasting TAG concentrations have been observed following an exercise 
period, they slowly return to pre-exercise levels during the succeeding days. Generally, 
if an exercise session is prolonged and has a large energy requirement TAG 
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concentations will be lower immediately afterwards and or during the days following 
the activity. 
Studies evaluating exercise periods of moderate intensity and short duration have 
reported no change in total cholesterol concentrations immediately after or in the days 
following a single exercise session for men (Angelopoulos et al. 1993, Davis et al. 
1992) and women (Lee et al. 1991). A variety of responses have been reported for 
changes in total cholesterol concentrations immediately after or in the days foil wing a 
prolonged exercise session, but no consistent effect is apparent. No change in total 
cholesterol concentrations were reported after 2 hours of walking at 30% V02max (Pay 
et al. 1992). In summary, if a single exercise session is to have an impact on total 
cholesterol concentrations, the exercise must be prolonged and require a large amount 
of energy expenditure. Even then any effect will most likely not be seen until 24 hours 
after the end of the exercise session (Durstine and Haskell 1994). 
Some studies using short-duration and moderate intensity exercise designs have 
reported increased HDL-C concentrations immediately after an exercise episode (Lee et 
al. 1991, Angelopoulos et al. 1993). Durstine and co-workers (1983) have evaluated 
the HDL-C reponse to low-intensity exhaustive walking (45% V02max) and found 
increased HDL-C concentrations after 2 hours of exercise that persisted through 
exhaustion (exhaustion reached at 4.5 hours) and into the postexercise period. In a less 
prolonged walking study Pay and colleagues (1992) also found increased HDL 
concentrations after 2 hours of walking at 30% V02max. On the other hand Davis and 
associates (1992) compared two exercise intensities, 50 and 75% of V02max (energy 
expenditure for the two activities was held constant at 950 kcal: exercise time was 60 
and 90 minutes respectively) and found no change in HDL-C concentrations or any of 
the subfractions immediately after or in the days following the exercise bout. 
It appears that prolonged exercise (more than 1.5 hours) will usually elevate HDL-C 
concentrations immediately after exercise in men (Enger et al. 1980, Griffin et al. 
1988, Thompson et al. 1980) and women (Skinner et al. 1987, Goodyear et al. 1990). 
Thus, it is suggested that there may be a threshold for the volume of work completed 
that is necessary to induce consistent increases in HDL-C. In addition, training state of 
the subjects must be considered. In some cases, trained and sedentary have not always 
responded in the same fashion to a single exercise session. Kantor and co-workers 
(1987) reported elevated HDL-C concentrations immediately following and in the days 
following an exercise session in trained subjects, whereas sedentary subjects did not 
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have elevated HDL-C concentrations immediately after an exercise period, but did have 
elevated HDL concentrations 24, 48 and 72 hours following the exercise session. 
State of training may also be an important consideration when evaluating the changes in 
HDL subfractions after an exercise bout. Indeed, in this study by Kantor and 
colleagues (1987) trained subjects had elevated HDLz-C and unchanged HDL3-C in the 
days following the exercise session, whereas, the sedentary subjects had no change in 
HDLz-C but elevated HDL3-C concentrations during the same follow-up period. 
Another important observation in this regard was made by Kiens and Lithell (1989) in 
subjects completing a single session of exercise after 8 weeks of one-leg training. They 
found that trained muscle developed more HDLz-C than nontrained muscle. 
Thus, it seems as if the degree and duration of the lipoprotein changes after a single 
bout of exercise are dependent upon such factors as the degree of exertion (Lithell et aI. 
1981), the time spent exercising (Kantoret aI. 1984) and the physical fitness of the 
subjects (Lithell et aI. 1979). 
2.8.2 The influence of a single session of exercise on lipoprotein 
metabolism in the postprandial state 
Very few studies have examined the influence of a single session of exercise on 
lipoprotein metabolism when subjects are in the postprandial state with TAG circulating 
in chylomicron particles. The earliest of these studies was conducted by Cohen and 
Goldberg in 1960. These researchers examined plasma turbidity following ingestion of 
a standard high fat meal, with and without conducting a 9.6 km walk, in 22 subjects 
aged 20-25 years. They discovered that alimentary lipaemia was decreased during the 
exercise trial and suggested that this was due to increased fat clearance. 
Since then a few other studies have investigated the influence of a single bout of 
exercise on TAG concentrations following ingestion of a fatty meal. Schlierf and co-
workers (1987) investigated the influence of cycling at 40% V02max for 90 minutes on 
postprandial lipoprotein metabolism. They found that postprandial lipaemia was 
attenuated by 34% in the exercise compared to the control condition. These researchers 
also noted an increase in HDLz and HDy cholesterol concentrations in the postprandial 
state. 
A couple of studies have demonstrated lower postprandial TAG concentrations in the 
recovery from a single session of exercise (Klein et aI. 1992, Aldred et aI. 1993). In 
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one study subjects exercised for just 30 minutes at 75% of peak V02, one hour after 
consumption of a fatty meal (Klein et al. 1992). Postprandial TAG concentrations 3, 5 
and 7 hours after completion of the exercise bout were approximately 26% lower than 
those in the control condition. In a study conducted in our laboratory (Aldred et al. 
1993) a lower lipaemic response (30%) to a fatty meal was noted 12-15 hours after 
completing a 2 hour session of moderate exercise (1 hour cycling, 1 hour 
jogging/walking) at 60% of predicted maximal heart rate. 
Together, the results of these studies suggest that a single bout of moderate exercise 
results in attenuation of postprandial lipaemia. Although this attenuation is frequently 
ascribed to an increased clearance of chylomicron TAG the results may also be 
dependent on a number of other factors. These include, the rate of output of TAG from 
the intestine i.e. the rate of appearance of TAG, the rate of secretion of TAG from the 
liver in the form of VLDL and the rate of uptake of TAG-containing lipoproteins by 
receptor and non-receptor-mediated processes (Cohn et al. 1988a). 
The use of the intravenous fat tolerance test, which eliminates TAG absorption as a 
confounding factor, has also been used to examine the effect of a single session of 
exercise on lipid metabolism (Annuzzi et al. 1987, Sady et al. 1986). Sady and co-
workers (1986) found that the clearance rate of exogenous fat increased 76%, 18 hours 
after having perfomed a marathon, along with a 46% increase in LPL activity and a 
19% increase in the HDLz-C subfraction. In the study by Annuzzi and colleagues 
(1987) subjects exercised at 77% of maximal heart rate for 1.5 hours in one trial and for 
3 hours in another. The removal rate of exogenous TAG was only increased 24 hours 
after the 3 hour exercise session, and thus these authors conclude that the increased rate 
of removal of TAG from the circulation is related to the duration of the exercise and that 
some time is required following the exercise before it is manifest. Collectively, the 
results from these studies utilising the oral and intravenous fat tolerance tests suggest 
that postpandiallipid metabolism may be affected most in the recovery from a single 
bout of exercise. 
2.8.3 Potential mechanisms involved in the changes in lipoprotein 
metabolism resulting from a single bout of exercise. 
The changes in lipid and lipoprotein metabolism observed after a single bout of exercise 
have most often been attributed to an exercise induced increase in LPL activity. Fatty 
acids are a major energy source during endurance exercise and much of this fat is 
derived from intramuscular TAG stores (Lithell et al. 1979). Oscai and co-workers 
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(1990) report that approximately 50% of the fat oxidised during exercise comes from 
intramuscular TAG stores and the other 50% from plasma free fatty acids. Thus, 
depletion of intramuscular TAG stores by endurance exercise may promote secretion 
and/or synthesis of LPL by muscle cells. Indeed, a single session of stationary cycling 
increased plasma postheparin LPL activity in trained and untrained men (Kantor et al. 
1987). A number of studies have demonstrated elevated muscle LPL activity after 
vigorous exercise (Lithell et al. 1979, Lithell et al. 1984, Taskinen et al. 1980), as well 
as higher adipose tissue LPL activity (Taskinen et al. 1980). No information is 
available concerning plasma or tissue LPL activity following more moderate intensity 
exercise. 
Although this increase in LPL activity may not be evident until 4-18 hours after exercise 
(Durstine and Haskell1994), augmented LPL activity results in increased chylomicron 
and VLDL hydrolysis and reductions in plasma TAG concentrations (Kantor et al. 
1987, Kiens and Lithe111989, Sady et al. 1984). Increased remnants are a consequence 
of increased catabolism of chylomicrons and VLDL. These remnants, in conjunction 
with HDy (as the primary substrate), may combine in a series of reactions that yield 
HD~ (Thompson 1990). This increased HD~ synthesis appears to be a major 
contributor to the higher HDL mass resulting from endurance exercise and may occur in 
the vascular compartment of muscle (Kiens and LithellI989). 
Studies examining the arterio-venous difference in lipoproteins across isolated muscle 
beds have demonstrated more directly an acute exercise effect during exercise (Kiens 
and Lithell1989, Ruys et al. 1989). In the study by Kiens and Lithell (1989) subjects 
complete 8 weeks of one-leg cycle training. At the conclusion of the training period the 
subjects performed two hours of knee extension exercise. A significant increase in 
arterio-venous HDL2-C concentrations across trained skeletal muscle, but not across 
the nontrained muscle from the same individual was observed. Further, estimates of 
total TAG degradation and total HDL formation from both trained and untrained legs 
were highly correlated (r=O.91). Although muscle biopsies taken at rest after 8 weeks 
of exercise training indicated differences in resting muscle LPL activity for trained and 
untrained muscle groups, two hours of exercise did not change LPL activity 
immediately postexercise in either muscle group. However, muscle LPL activity was 
higher four hours after exercise but only in trained muscle. These results suggest that 
changes in lipoprotein metabolism induced by a single bout of exercise are explained by 
adaptations of LPL activity in skeletal muscle. 
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Ruys and colleagues (1989) examined the peripheral production of HDL-C by 
measuring the arterio-venous blood flow across the forearm muscle at rest and after 20 
minutes of isometric exercise. Subjects were studied twice, once after a fast and once 
after a high fat meal. Exercise led to an increased production of HDL-C in both 
conditions but this was much more pronounced in the fed as compared to the fasted 
condition. By contrast, there was no peripheral production of HDL-C in two subjects 
with LPL deficiency. These fmdings support the theory that LPL activity in the muscle 
capillary bed is at least partly responsible for the exercise related increased in HDL-C 
and suggests that this mechanism may be accentuated in the fed state with additional 
substrate available in the form of chylomicron TAG. 
The mechanism by which muscular work leads to an increase in LPL activity of skeletal 
muscle and adipose tissue is not clear. Since both glucagon and catecholamines are 
known to increase during exercise and, also, to stimulate muscle LPL activity they 
could afford one possible explanation. Indeed, Lithell and co-workers (1981) observed 
a positive relationship between the 24-hour excretion of epinephrine in urine and 
muscle LPL activity following prolonged exercise. The increase in insulin sensitivity 
which regularly accompanies acute exercise could also be a possible mechanism 
resulting in an increase in LPL activity in muscle. Indeed, the activity of LPL in both 
adipose tissue and skeletal muscle appears to be insulin dependent (Farese et al. 1991). 
An increase in insulin sensitivity may result in a decrease in adipose tissue LPL and an 
increase of the activity of this enzyme in skeletal muscle. Therefore, the up-regUlation 
of LPL in skeletal muscle by exercise in human subjects could be explained by the 
increase in insulin sensitivity and in glucose transport during acute exercise. It has been 
reported that the change in LPL activity of adipose tissue with a single bout of exercise 
is quantitatively less remarkable that that occurring in the working muscle (Nikkila 
1987). 
A single session of endurance exercise does not appear to have any marked effect on 
HL (Kantoret al. 1987, Kantor et al. 1984) or LCAT activity (Griffin et al. 1988, 
Berger and Griffiths 1987). The exercise induced elevation in LPL activity could partly 
explain the typical lipoprotein profile found in well-trained individuals. However, it 
remains to be determined whether less intense and shorter bouts of exercise, repeated 2 
or 3 times a week, can maintain elevated LPL activity, thereby causing a decrease in 
VLDL and an increase in HDL. 
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2.8.4 The influence of endurance training on lipoprotein metabolism in 
the fasted state. 
Many cross sectional and longitudinal training studies have been conducted to examine 
the influence of vigorous endurance training on lipoprotein metabolism (for review 
articles see Haskell1986, Durstine and HaskellI994). This review of this topic will 
centre mainly on the results of those studies employing moderate intensity training 
regimens. It is important to note that most of these longitudinal and cross-sectional 
studies do not comment on the time interval between the last exercise session completed 
by the subjects and the time of phlebotomy. It is possible therefore that the influence of 
the last bout of exercise may effect the outcome of such studies, as a single session of 
exercise influences these plasma lipid and lipoprotein concentrations, as detailed in 
section 2.8.1. 
Generally, both cross·sectional (Moore et al. 1983, Williams et al. 1986) and 
longitudinal studies (Weintraub et al. 1989, Thompson et al. 1988) have reported lower 
fasting plasma TAG concentrations in endurance trained subjects as compared to 
sedentary controls. However, the results of studies utilising less intense exercise 
programmes have been conflicting in this regard. Duncan and co-workers (1991) report 
no change in fasting TAG concentrations for women who completed 24 weeks of 
walking training, in agreement with the results of a study in which 72 men completed a 
I-year progamme of brisk walking with no resulting change (Stensel et al. 1993). 
However, Whitehurst and Menendez (1991) did observe lower TAG concentrations in 
31 older women who undertook a programme of brisk walking for 8 weeks, albeit a 
small decrease (4%). Santiago and colleagues (1987) actually observed an increase in 
TAG concentrations in women who followed a programme of either walking or jogging 
for 20 weeks. It has been suggested that the changes in fasting TAG concentrations 
with endurance training may be related to the baseline concentrations of the subjects and 
the volume of training completed (Durstine and HaskellI994). Although, fasting TAG 
concentrations may be an insensitive method for examining the metabolic capacity for 
TAG. 
Most observational studies report no difference in the total cholesterol concentrations of 
endurance trained male (Thompson et al. 1983) and female athletes (Moore et al. 1983) 
compared with their inactive counterparts. Consequently, the consensus is that 
physically active individuals do not have significantly lower plasma total cholesterol 
concentrations than do inactive individuals (for review see HaskellI984). Results from 
moderate intensity endurance-training studies agree with these cross-sectional 
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observations as they have not produced significant reductions in total cholesterol 
concentrations (Hardman et aI. 1989, Stensel et al. 1993, Cauley et al. 1987). Some 
studies have reported reductions in plasma total cholesterol after exercise training, but 
these did not concurrently follow an inactive control group. Thus, in these 
investigations seasonal variations and/or interference from other vadables may 
confound interpretation of the results for both men (Tran and Weltman 1985) and 
women (Lokey and Tran 1989). 
There is strong evidence that endurance exercise training is associated with increased 
HDL-C concentrations. Wood and associates (1984) list the results of 14 observational 
running studies and 8 such studies examining activities other than running which have 
shown significantly higher HDL-C concentrations in active subjects as compared to 
inactive controls. Although these observational studies do not prove an effect of 
exercise on HDL-C concentrations, since they cannot discount the possibility that both 
exercise and HDL-C are associated with some secondary vadable e.g. leaness, they do 
provide evidence supporting an influence of physical activity on HDL-C concentration. 
The results from longitudinal studies have, however, not been so congruent. Some 
endurance training studies employing moderate intensity exercise programmes have 
reported increases in HDL-C concentrations (Hardman and Hudson 1991, Duncan et 
aI. 1991, Santiago et aI. 1987, Cook et aI. 1986), while others have not (Stensel et aI. 
1993, Frey et al. 1982. Boyden et al. 1987, Gaesser and Rich 1984). The reason for 
this discrepancy is not known, but it is likely related to several factors: the length of the 
training period, the volume of training completed, changes in body composition, 
dietary intake, weight loss and the pretraining HDL-C concentration (Durstine and 
HaskeII 1994) 
There is some evidence of a dose-response relationship between the amount of exercise 
performed and the change in HDL-C concentrations. For example, in a study that 
evaluated initially sedentary men before and after 1 year of endurance training, a 
positive correlation (r=O.45, p<O.05) was found between the total distance run and the 
change in HDL-C (Wood et al. 1988). A similar correlation has also reported in a 
study of female subjects (Moore et al. 1983). 
In an effort to elucidate more precisely the relationship between exercise, HDL-C and 
CHD risk some investigators have measured the principal subfractions ofHDL-C 
(HD~-C and HDL3-C). In particular, attention had been focussed on the HDL2-C 
subfraction since this is thought to be largely responsible for the protective effects of 
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HDL-C against CHD (Miller et al. 1981). The I-year training study by Wood and 
colleagues (1988), mentioned above, found elevated HDLz-C concentrations after 
training in these previously sedentary men. In another report, men with known CHD 
has an increase in HDLz mass after endurance training (BaIIantyne et al. 1982). 
However, few longitudinal studies utilising moderate intensity exercise programmes 
have examined the HDLz-C subfraction. 
The influence of moderate exercise on HDL-C concentrations remains controversial. 
Certainly there is inadequate information for prescription of an optimal training intensity 
or volume in this regard, but it is clear that both high and low intensity exercise can 
stimulate increases in HDL-C. 
2.8.5 The influence of endurance training on lipoprotein metabolism in 
the postprandial state. 
Most studies evaluating the effects of regular participation in physical activity on plasma 
lipoprotein metabolism measure these changes in a fasted condition. Since the 
postprandial half-life of chylomicron TAG is less than five minutes, few studies have 
been completed concerning the consequences of endurance exercise training on 
postprandial plasma lipid concentrations. However, it has been shown that highly 
trained endurance men (Ericsson et al. 1982, Sady et al. 1988) and women (Podl et al. 
1994) remove chylomicrons from plasma faster than inactive controls following an 
intravenous lipid load. In addition, athletes have been shown to have a lower lipaemic 
response following ingestion of a high fat meal than sedentary controls (Cohen et al. 
1989, Merrill et al. 1989) or sprint trained individuals (Lee et al. 1993). 
Results from studies examining the influence of endurance training on postprandial 
lipaemia have resulted in either no change (Zauner and Benson 1977, Vanes et al. 
1989) or a lower lipaemia following ingestion of a high fat load (Weintraub et al. 1989, 
Altekruse and Wilmore 1973, Wirth et al. 1985). Only two of these investigations have 
utilised normolipidaemic subjects (Weintraub et al. 1989, Altekruse and Wilmore 
1973), the others examining hypertriglyceridaemic (Zauner and Benson 1977, Wirth et 
al. 1985) or coronary artery diseased patients (Yanes et al. 1989). 
The 6 subjects in the study by Weintraub and co-workers (1989) completed 7-weeks of 
endurance running as training. After training plasma chylomicron concentrations 
following a fat load were reduced by 37% and were inversely related to LPL activity. 
This reduction was most likely due to an accelerated removal of TAG from the 
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circulation by increased LPL activity in adipose tissue and skeletal muscle (Durstine and 
Haskell 1994). These researchers did not however fmd any increase in HDL-C 
concentrations as a result of the training and they thus suggest that any exercise induced 
increase in HDL-C concentrations may require a longer training period to become 
apparent The other study examining normolipidaemic individuals also found a decrease 
in postprandial lipaemia following 10 weeks of training with subjects running an 
average distance of 50 miles per week (Altekruse and Wilmore 1973). Neither of these 
studies used a control group. 
Wirth and colleagues (1985) trained 10 male hypertriglyceridaemic subjects for 4 
months, 3 times per week for 1 hour on each ocassion, "jogging, playing ball games 
and callisthenics and short periods of relaxation". Lipaemia was reduced by 16% in 
these subjects, with a 26% reduction in fasting TAG concentrations and no change in 
HDL-C concentrations. At the outset of this study these subject group had elevated 
fasting TAG concentrations, probably associated with profound postprandial lipaemia 
(Cohn et al. 1988b), perhaps leading to a greater potential to demonstrate an influence 
of exercise training. 
All of these studies have left a time interval between the last exercise session and the 
administration of the oral fat tolerance test, which is essential if the "chronic" effects of 
training, rather than the effects of the last bout of exercise (see section 2.8.2) on 
postprandial lipaemia are to be determined. 
Thus, the results from studies that have examined the influence of endurance training 
on postprandiallipaema have been conflicting. Further, there has only been a small total 
number of subjects studies, many of who were patients, in the absence of control 
groups and the training regimens have been rather intense. No studies have been 
conducted to investigate the influence of moderate exercise on postprandial lipoprotein 
metabolism. 
2.8.6 Potential mechanisms involved in the changes in lipoprotein 
metabolism resulting from endurance training 
There is evidence therefore that routine participation in physical activity can alter 
lipoprotein metabolism and lipid transport Our understanding of the precise 
mechanisms responsible for these modifications is not complete, but exercise appears to 
have an impact on LPL action, TAG synthesis, and LCAT regulation. Currently, the 
meartS by which endurance training provokes changes in plasma lipoprotein metabolism 
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has centered on the enzyme LPL. It has been proposed that an exercise induced increase 
in LPL activity leads to enhanced catabolism of TAG-rich lipoproteins and thus 
augments HDL-C production via the provision of additional substrate for HDL 
formation (Katan 1990). 
Considerable evidence exists to support this theory. It has been demonstrated in cross-
sectional studies that endurance trained runners at rest have higher plasma 
concentrations of heparin releasable LPL than less active controls (Herbert et al. 1984, 
Thompson et al. 1991). This elevated LPL activity appears to be a consequence of both 
increased muscle (Nikkila et al. 1978a) and adipose tissue LPL activity (Mamiemi et 
al. 1980). In addition, increased LPL activity has been found after a programme of 
endurance training (Thompson et al. 1988, Peltonen et al. 1981). Although, Peltonen 
and co-workers (1981) observed that much of the increase in LPL activity was found 
after the first week of training and therefore suggested that this higher LPL activity after 
training was, in part, a response to a single session of exercise. Thus, it can be seen 
that the time interval between the last exercise bout and the measurement of LPL may be 
important in determination of a true "chronic" effect of exercise on this enzyme. 
Svedenhag and colleagues (1983) also noted a training induced elevation (47%) of 
muscle lipoprotein lipase activity. Further, this was accompanied by an increase (19%) 
in muscle capillary density. These authors suggest that this increase in muscle LPL 
activity may help to explain the down-regulation of TAG and the up-regulation of HDL 
concentrations observed with endurance training, resulting from the increased 
catabolism of TAG-rich lipoproteins. More direct evidence to support the above theory 
has been provided by a well-designed one-legged training study by Kiens and Lithell 
(1989). In this study the quadriceps femoris muscle group was isolated in six men and 
trained one leg by dynamic exercise while the other leg served as a control. After 
training the muscle LPL activity was increased by 70% as well as a significantly higher 
formation of HDL-C and HD~-C. There was also an increase in capillary density in 
the trained leg which correlated well with the increased LPL activity. The greater 
capillarization in the trained muscle would increase the number of binding sites 
available for LPL to cleave TAG from VLDL (or chylomicrons) and, the larger capillary 
density would imply a longer mean transit time of blood through the muscle thus 
increasing the potential for fatty acid oxidation as well as the contact time between 
VLDL and LPL (Kiens and LithellI989). 
Since increased LPL activity results in increased HDL synthesis, increased synthesis 
has received much of the credit for the elevated HDL mass associated with endurance 
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exercise. However, present knowledge indicates that exercise training may prolong the 
survival ofHDL apolipoproteins. Herbert and colleagues (1984), using radioiodinated 
autologousHDL, found that the synthesis rates of HDL proteins are alike in runners 
and sedentary subjects, with no change in HDL protein synthesis after endurance 
training ('Thompson et al. 1988). However, the survival time of HDL protein was 27% 
longer in the circulation of physically active men, compared with inactive men (Herbert 
et al. 1984) and endurance training increased the half-lives of apolipoproteins A-I and 
A-IT in formerly inactive men (Thompson et al. 1988). The mechanisms by which 
training might prolong HDL survival are unknown but they may relate to the lipid 
enrichment of HDL particles both during and after exercise which could theoretically 
increase the core to surface ratio and therefore retard HDL degradation ('Thompson 
1990). 
It has been suggested, from animal experiments, that exercise training results in 
reduced TAG synthesis (Simonelli and Eaton 1978). This has also been demonstrated 
in humans after training (Gorski et al. 1990). However, the mechanism responsible for 
this decreased TAG synthesis after training remains unclear. It also has been suggested 
that the enzyme LCAT may be affected by endurance training, contributing to an 
increased synthesis of HD~. Mamiemi and colleagues (1982) demonstrated an 
increased activity of this enzyme after a vigorous training programme in young men. 
Other studies, however, have failed to show any such increase in LCAT activity after 
endurance training (Williams et al. 1990, Thomas et al. 1985) and thus the role of 
LCAT activity in exercise induced changes in lipoprotein metabolism remains 
controversial. 
2.9 Other factors affecting postprandial lipaemia 
2.9.1 Apolipoprotein E phenotype 
As previously explained, apolipoprotein E (apo E) plays a central role in receptor 
mediated removal of intestinal and hepatic TAG-rich lipoproteins from plasma. 
Different forms of apo E have been recognised in humans due to genetic variation in the 
apo E gene resulting from three common alleles in the population, E4, E3 and E2 
(Assmann et al. 1991). These alleles produce gene products with different isoelectric 
points, designated from basic to acidic, E4, E3 and E2 respectively. These three alleles 
result in three homozygous phenotypes, E4/4, E3/3 and E2/2, and three heterozygous 
phenotypes E4/3, E3/2, and E4/2. The approximate frequencies of these phenotypes are 
listed below. 
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E4/4=2% 
E3/3 =56% 
E2I2= 1% 
E4/3 =23% 
E 3/2= 15% 
E4/2=3% 
Weintraub et al. (l987b) 
Gene frequencies do however vary in slightly in different populations. In Finland, for 
example the E2 gene is less frequent whereas the E4 gene is more frequent (Ehnholm et 
al. 1986). However, E3 is the most common form of the gene in every population 
(Davignon et al. 1988). 
Several studieS have examined how apo E phenotype affects dietary fat clearance in 
normolipidaemic subjects, however, most of these studies have used small numbers of 
subjects in each phenotypic group (n = 5-10). Most of the information from these 
studies involves the apo E2/2 phenotype, which has been associated with type III 
hyperlipoproteinemia, a disorder characterised by increased fasting TC and TAG 
concentrations (DaIlongeviIIe 1992). 
Indeed, Brenninkmeijer and colleagues (1987) found a delayed removal of 
chylomicrons and chylomicron remnants in normolipidaemic homozygous E2I2 (n=5) 
subjects following ingestion of a vitamin A fat load. No differences in postprandial 
TAG concentrations were found between phenotypic groups in this study, although the 
E2I2 individuals did tend to have higher concentrations. An elevated and prolonged 
postprandial hypertriglyceridaemic response after a high-fat meal has been 
demonstrated, however, in normolipidaemic subjects with the E2I2 phenotype (Gregg 
et al. 1983). 
Furthermore, Weintraub and co-workers (1987b) concluded that relative to a group of 
E3/3 individuals (n=lO) , heterozygosity for E2 (n=9) also delayed chylomicron 
remnant clearance following administration of a vitamin A containing oral fat load. 
They suggest that this documents a metabolic defect in postprandial fat metabolism in 
carriers of the defective allele E2, who compromise approximately 15% of the general 
population. However, Brenninkmeijer and colleagues (1987) report that a E3/2 
phenotype group did not have defective .chylomicron remnant removal. 
In addition, a defect in the lipolysis ofVLDL from subjects with the apo E 212 
phenotype has been observed. The catabolism of injected VLDL has also been shown 
to be slower in E2I2 (n=4) phenotypic individuals than E3 subjects (n=5) (Demant et 
al. 1991) and Stalenhoef and colleagues (1986) found that the catabolism of apo B-48-
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containing lipoprotein particles was markedly delayed in subjects with the Em 
phenotype. These results suggest that an alteration in the lipolytic process may 
contribute to the plasma TAG accumulation in seen subjects carrying the E2 allele 
(Dallongeville et al. 1992). In the light of recent evidence that hepatic VLDL may make 
a significant contribution to the magnitude of postprandial lipaemia (Schneeman et al. 
1993) the effect of apo E phenotype on the receptor-mediated clearance of VLDL may 
be important as well as that on chylomicrons and their remnants 
There is evidence that other apo E polyrnorphisms may influence postprandial lipaemia. 
For example, Weintraub and co-workers (1987) found that individuals with the E4/3 
(n=7) phenotype (25% of population) had accelerated postprandial clearance of 
chylomicron remnants, suggesting that they clear chylomicron remnants to the liver 
more rapidly than E3/3 individuals. However, these results do not seem to agree with 
the observations of Dallongeville and associates (1992) who found that subjects 
carrying the 4 E/3 genotype had higher TAG and lower HDL -C concentrations than the 
E3/3 subjects, suggesting a delayed catabolism of TAG-rich lipoproteins in this 
phenotype. 
Brown and Roberts (1991a) found that an apo E4 group (n=5) displayed a significantly 
greater response curve than the apo E3/2 or 3/3 groups for both plasma TAG and 
chylomicron retinyl ester concentrations after a high fat meal. However, in this study 
the E4 group tended to have a 40% higher fasting TAG than the other groups. After 
adjustment for fasting TAG concentrations, the E4 group had the lowest TAG response 
relative to the E3/3 group, demonstrating again the importance of fasting TAG 
concentrations in the determination of the magnitude of postprandial lipaemia. 
Population based studies have shown that apo E polymorphism is 'also associated with 
differences in plasma LDL-C levels. Apo E2 is associated with lower LDL-C levels, 
with E2 binding poorly to remnant receptors, delaying remnant clearance but facilitating 
LDL catabolism. Apo E4 conversly has increased affmity for remnant receptors, 
enhancing remnant clearance and down-regulating LDL receptors and thus is associated 
with elevated LDL-C and apo B (Brown and Roberts 1991a). 
The observed impact of genetic variation in apo E on plasma lipid and lipoprotein levels 
in humans has led to the hypothesis that the apo E poLymorphism plays a major role in 
detennining susceptibility to atherosclerosis in man (Assmann et al. 1991, Davignon et 
al. 1988). However, predisposition to a complex disease like CAD is detennined by 
multiple genetic and environmental factors, so it is unlikely that anyone genetic locus 
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will predict the entire subgroup of individuals who will be affected (Davignon et al. 
1988). Menzel and co-workers (1983) conclude that the E2/2 phenotype cannot be 
considered a biochemical indicator of an increased risk of coronary atherosclerosis. On 
the other hand, they conclude that apo E3/2 may have a protective effect on the early 
development of atherosclerosis. 
Overall, there seems to be good evidence that the apo E composition of TAG-rich 
lipoproteins plays an important role in regulating the catabolism of these lipoproteins 
(Chen and Reaven 1991). 
2.9.2 Age 
Several investigators have commented on the association between age and the 
magnitude of postprandial lipaemia (Weintraub et al. 1987b, Cohn et al. 1988b, 
Kransinski et al. 1990b). The results of these studies found that postprandial TAG 
concentrations were elevated in older (mean ages 29±2 v 66±2 years) subjects (Cohn et 
al. 1988b) and that older subjects had a greater increase in retinyl ester concentration 
when vitamin A was administered in conjunction with a fat-rich meal (Weintraub et al. 
1987b, Kransinski et al. 1990b). Indeed, Weintraub and colleagues (1987b) found that 
the peak retinyl ester concentration and the area under the retinyl ester/time curve was 
33% and 50% higher respectively in older subjects (mean age 50±13 years) than in 
younger (mean age 21±3 years) subjects. 
These investigators further suggest that the increased postprandial plasma retinyl ester 
concentrations observed in the older subjects was due to delayed plasma clearance of 
intestinal TAG-rich lipoproteins, compatible with the lower LPL activity measured in 
the older subjects (Weintraub et al. 1987b). 
A cautionary note however should be given in the interpretation of these results. There 
is a well reported relationship between the size of the endogenous VLDL-TAG pool and 
the magnitude of postprandial lipaemia (see section 2.6.3). In one of these studies 
mentioned above (Cohn et al. 1988b) fasting TAG concentrations were higher in the 
older subjects and the authors report a highly significant correlation between fasting and 
postprandial TAG concentrations. Thus the higher reported postprandial lipaemia in the 
older subjects in this study may have resulted as a consequence of their higher fasting 
TAG concentration rather than their age per se. 
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2.9.3 Alcohol intake 
Intake of alcohol has been reported to have a marked effect on the subsequent 
metabolism of dietary fat Several studies have demonstrated that consuming alcohol 
with a high fat meal significantly increases postprandial lipaemia (Wilson et al. 1970, 
Superko 1992) compared with consumption of the high fat meal alone. Superko (1992) 
reports that daily consumption of alcohol does not appear to increase the lipaemic 
response to a high fat meal in normotriglyceridemic adults, rather it is the consumption 
of alcohol along with dietary fat that results in elevated postprandial TAG 
concentrations. 
At the present time there is little data available to provide an explanation for the effect of 
ethanol on alimentary lipaemia. Tall (1986) suggests however that there is evidence 
from experiments in rats that there is both a greater secretion of hepatic VLDL and an 
impaired clearance of chylomicron remnants when a fatty meal is given to alcohol 
treated animals. With the development of new techniques allowing quantification of 
human apo B-48 and B-IOO these questions may be addressed more fully in the future. 
In the light of this evidence of an effect of alcohol consumption on postprandial 
lipaemia, alcohol intake was controlled during the studies in this thesis. 
2.9.4 Obesity 
There is a paucity of information concerning the effect of obesity and weight loss on 
postprandial TAG metabolism. However, Lewis and co-workers (1990) have shown 
that the cumulative increment in postprandial TAG concentrations was 3.4 times greater 
in normolipidaemic obese subjects as compared with non-obese individuals. Despite the 
fact that subjects were selected for normal fasting lipid concentrations, fasting TAG 
concentrations were also higher and HDL-C concentrations lower in these obese 
SUbjects. As the available evidence seems to suggest that obesity influences 
postprandial lipaemia, no obese subjects were included in the studies conducted in this 
thesis. 
2.10 Methods of assessing postprandial lipaemia 
Several methods have been used to assess the rate of clearance of diet-derived or 
exogenous TAG. In the early studies of Nestel and co-workers (1962) direct 
measurements of chylomicron TAG clearance were obtained by measuring the 
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disappearance of a bolus of intravenously injected chylomicrons. This method involved 
the homologous administration of endogenously labelled chylomicrons isolated from 
thoracic duct lymph. Its use therefore has been limited by ethical and practical 
considerations. In most studies chylomicron TAG clearance is assessed by indirect 
methods such as oral or intravenous fat tolerance tests, which do not provide a 
quantitative assessment of chylomicron TAG clearance, or by duodenal perfusion 
techniques. 
2.10.1 Oral fat tolerance tests 
The simplest, and perhaps one could argue the most lifelike, way to assess postprandial 
lipemia is to measure plasma TAG concentrations before and after meals. Indeed, a 
great deal of very useful information has been generated in this fashion (Chen and 
Reaven 1991). 
On the other hand, such an approach does not differentiate exogenous TAG· rich 
lipoproteins i.e. newly synthesized and secreted lipoproteins of intestinal origin from 
endogenous TAG-rich particles secreted from the liver. Additionally, this method of 
assessing postprandialliapemia is indirect and plasma TAG concentrations during such 
tests depend not only on the rate of disappearance of exogenous TAG from the blood 
but also on the rate of TAG absorption in the gastointestinal tract and subsequent influx 
into the circulation. Nevertheless, it has been found to yield similar results to those 
from an intravenous fat-tolerance test and duodenal perfusion methods (Cohen 1989). 
Tall (1986) has also noted that another of the difficulties of studying changes in the 
lipoproteins after an oral fat load is the variable time between the ingestion of fat and the 
peak response of the plasma lipoproteins, resulting primarily from differences in gastric 
emptying rates. 
2.10.2 Intravenous fat tolerance test 
The intravenous fat tolerance test was devised to eliminate TAG absorption as a 
confounding factor in the estimation of chylomicron TAG clearance. For this test an 
artificial emulsion (Intralipid) is used to model the intravenous decay kinetics of 
chylomicron TAGs. Hallberg (1965) reported that intravenous injections of Intralipid 
and chylomicrons TAGs showed similar kinetic behaviour and results from a study by 
Rossner (1974) showed that this test was highly reproducible when repeated in the 
same subjects with intervals of up to six months. However, in most studies of 
normolipidaemic men, the mean half life of intravenously injected Intralipid TAG is 
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approximately 15 minutes, whereas the half-life of chylomicron TAG determined under 
similar conditions is approximately 6 minutes (Cohen 1989). 
2.10.3 Duodenal infusion clearance tests 
Grundy and Mok (1976) developed a method whereby chylomicron TAG clearance can 
be calculated from steady state plasma chylomicron TAG concentrations. These 
conditions are achieved by perfusing the duodenum with TAGs at a constant rate. This 
method is based on two assumptions. First, the rate at which chylomicron-TAG enters 
the blood is considered to be equal to the rate of influx of perfusate TAG into the 
duodenum. Secondly, it is assumed that the chylomicron fraction isolated by 
ultracentrifugation contains all of the chylomicron TAG but none of the endogenous 
TAG of plasma. There are practical limitations for the use of this method of assessing 
postprandial lipaemia, particularly with regard to investigating the influence of exericise 
on postprandial lipaemia, as this involves an extended period of intubation with a 
nasogastric tube (5 hours minimum) and the use of x-ray guidance to position the tube 
in the small intestine (Tall 1986). 
2.10.4 Retinyl ester as a marker of intestinal Iipoproteins 
Retinyl esters have been used by many investigators to measure the intestinal 
contribution to human alimentary lipaemia by incorporating retinol or retinyl palmitate 
into a fat containing meal and following the appearance of retinyl ester in the plasma. It 
is known that following absorption, vitamin A (retinol) is esterified with long-chain 
fatty acids within the enterocyte. Thus, if vitamin A is administered with a fat meal, the 
newly synthesized and secreted chylomicrons should contain retinyl ester in their core. 
When these TAG-rich lipoproteins are eventually removed by the liver as chylomicron 
remnants, the vitamin A released during the catabolism of the chylomicron remnant can 
ouly leave the liver as a complex of retinol bound to a specific binding protein, and 
therefore cannot reappear in the plasma as a lipoprotein component. Consequently. by 
determining the retinyl ester concentration in plasma it is possible to trace the 
metabolism of newly synthesised and secreted lipoproteins of intestinal origin. 
Berr and Kern (1984) concluded that the plasma clearance of retinyl palmitate-labelled 
chylomicrons is probably a good estimate of chylomicron remnant plasma clearance in 
man. More recently, however, the accuracy of this method of estimating chylomicron 
remnant clearance from plasma has been questioned (Chen and Reaven 1991) due to 
evidence that the peaks in plasma retinyl ester concentration do not correspond with the 
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peak in TAG concentration and because of experimental evidence that retinyl esters are 
transferred from chylomicrons to other lipoprotein fractions (Kransinski 1990a, 
Demacker 1992). This transfer of retinyl esters then indicates that the presence of 
retinyl esters in plasma does not always reflect the presence of intestinally derived 
lipoproteins. 
2.10.5 Measuring apolipoprotein B·48 and B·I00 
Thus, methodological problems, especially the paucity of nonexchangeable markers of 
newly synthesized lipoproteins or apolipoproteins, have been a major factor limiting a 
detailed understanding of the genesis of changes noted in the postprandial plasma 
lipoprotein profile. The recognition however, that apo B-48 is a non·exchangeable 
marker for intestinally derived particles has great potential in allowing intestinally 
derived particles to be traced. This should serve to determine if accumulating particles 
after a fatty meal are intestinally derived or hepatogenous in origin; 
Recently Schneeman and colleagues (1993) have conducted just such a study, 
measuring apo B-48 and B-1 00 in plasma after a fat containing meal by a method 
involving the use of a monoclonal antibody technique to separate B-48 containing 
TAG-rich lipoproteins from apo B-l00 containing lipoproteins. The development and 
accuracy of biochemical techniques to differentiate between apo B-48 and B-lOO have 
been complicated however by the low concentration of apo B-48 in plasma and TAG· 
rich lipoproteins relative to the concentration of apo B-I00. 
2.11 Training adaptations to brisk walking 
Many studies have investigated the adaptations to intense forms of exercise. More 
recently, however, research has emerged identifying the adaptations to more moderate 
training programmes, attainable by a larger proportion of the population. 
The results of training studies involving brisk walking have been shown to provoke 
significant increases in V02max in middle-aged men (pollock et al. 1971, Seals et al. 
1984a) and women (Jette et al. 1988, Seals et al. 1984a, Santiago et al. 1987, Duncan 
et al. 1991) in the order of 16%. 
Walking training has also been shown to provoke beneficial changes in the responses to 
submaximal exercise in middle-aged subjects. For example, heart rates are reduced at a 
given absolute exercise intensity after training (Hudson et al. 1988, Jette et al. 1988). 
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Moreover, lower blood lactate concentrations have been demonstrated during 
submaximal treadmill walking after training progranunes of six months (Seals et al. 
1984b) and one year (Stensel et al.1994, Hardman et al. 1992). In contrast to these 
findings Jette and co-workers (1988) did not fmd any significant change in submaximal 
blood lactate concentration after 12 weeks of training despite a significant increase in 
V02max. 
The study conducted by Duncan and colleagues (1991) is of particular interest as this 
demonstrates for the first time an increase in maximal oxygen uptake with walking 
training in a dose-response manner. In this study subjects were randomly allocated to 
be controls, "strollers" (3 mph), "brisk walkers" (4 mph) or "aerobic walkers" (5 mph) 
for a six month period. The endurance fitness of all groups increased compared to the 
control group as determined by increases in V02max of 4%, 9% and 16% respectively. 
In summary, evidence exists to show that brisk walking is a sufficient stimulus to 
induce cardiovascular and metabolic adaptations which are similar to those elicited by 
training programmes utilising more traditionally viewed forms of vigorous exercise. In 
addition, walking may be more beneficial for health in the longer term, especially in the 
older population, because of its reduced potential to cause injury (pollock et al. 1991, 
Seals et al. 1984a). 
2.12 Blood lactate concentration as an indicator of adaptations to 
endurance training 
Traditionally, V02max has been the measurement tool used to assess changes in fitness 
in an individual after a period of training. However, a change in V02max will not 
reflect fully the adaptations which occur with endurance training. This has been 
demonstrated by Davies and colleagues (1981) who found only a 14% elevation in 
V02max, but a 100% increase in the mitochondrial content of muscle and a 403% 
increase in endurance capacity after a 10 week training progranune in rats. Studies 
examining human SUbjects have also found a disparity between changes in V02max and 
changes in endurance capacity after training (Hardman 1982, Williams and Nute 1982). 
The reason for these findings is that V~ max is to a large extent genetically 
predetermined (Klissouras et al. 1973) and thus can only be enhanced to a limited 
extent under normal circumstances. In contrast, however, skeletal muscle has a 
profound ability to adapt when additional stresses are place upon it and the resultant 
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metabolic changes which occur may have a significant impact on endurance 
performance without altering Y02max. 
The measurement of the concentration of blood lactate during submaximal exercise 
attempts to make a more complete assessment of the adaptations to endurance training. 
The rationale for this procedure is based on the belief that changes in blood lactate 
concentration after training are reflective of alterations in the oxidative capacity of 
skeletal muscle and in particular improvements in mitochondrial efficiency. Also, 
submaximal blood lactate concentration (or Y~ at a given blood lactate concentration) 
has been shown to correlate well with endurance performance (Sjodin and Jacobs 
1981, Williams and Nute 1983) and may provide a better indication of improvements in 
endurance capacity then Y02max per se (Williams and Nute 1986). 
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3 GENERAL METHODS 
This chapter reporting methodology is divided into two main sections. The first 
describes the procedures used throughout this th0sis, many being common to several 
studies. The second section reports on specific methodology concerning the 
examination of the reproducibility of two different oral fat tolerance tests. 
3.1 Informed consent 
Prior to the commencement of each study, all subjects were made fully aware of the 
equipment and testing procedures to be employed and of any potential risks which they 
might incur. Each subject was then asked to sign a statement of informed consent, an 
example of which is shown in Appendix 1. . 
3.2 Oxygen uptake and carbon dioxide production 
Oxygen uptake and carbon dioxide production during exercise were determined from 
samples of expired air collected in 150 litre capacity Douglas bags (Harvard Equipment 
Ltd.). During the collection subjects wore a nose clip and a snorkel-type mouthpiece 
(both Harvard Equipment Ltd.). The mouthpiece was fitted to a lightweight one-way 
respiratory valve (Jakeman and Davies, 1979) which in turn was attached to a 1.5 metre 
section of wide bore (30 mm diameter) lightweight tubing (Falconia: Baxter, 
Woodhouse and Taylor). The tubing terminated in a two-way tap (Harvard Equipment 
Ltd.) which was used to open and close the Douglas bags. 
The oxygen content (%) of expired air was measured using a paramagnetic oxygen 
analyser (Taylor-Servomex Model 570A) while carbon dioxide content (%) was 
determined using an infra-red carbon dioxide analyser (Lira: Mines Safety Appliances 
Ltd. Model 3030). Both analysers were calibrated before each exercise test using 
certified reference gases (CryoService Ltd. Worcester. U.K.). All reference gases were 
in turn calibrated against a "gold standard" reference gas (Cryoservice Ltd. Worcester. 
U. K-). This gold standard reference gas was used throughout all of the testing 
reported in this thesis to ensure consistency. The volume of expired air withdrawn for 
analysis was measured using a flow meter. 
Once the oxygen and carbon dioxide analysis had been completed, the volume of air 
remaining in each Douglas bag was determind by evacuation (Moulinex vacuum pump 
237) through a dry gas meter (Harvard instruments), which had been calibrated against 
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a 600 litre Tissot spirometer (Collins Ltd.). The air temperature was measured during 
evacuation by a thermistor thermometer (Edale: type 2984, Model C) placed in the air 
outlet pipe of the dry gas meter. 
Finally, the measured gas volumes were corrected to standard temperature and pressure 
for a dry gas (STPD) and the volume of inspired air (VI) was then derived using the 
Haldane transformation. After this the volume of oxygen consumed (vD2) and carbon 
dioxide produced (VC02) were calculated (Appendix 2). 
3.3 Exercise tests 
Several different exercise tests were employed in this thesis. All involved walking on a 
motorised treadmill (Quinton plc) which was calibrated before and after each study 
(Appendix 3). Each subject was familiarised with treadmill walking before any tests 
were undertaken. 
3.3.1 Walking maximal oxygen uptake test 
V02max was determined directly using a modification of the protocol devised by 
Taylor and colleagues (1955). This involved an incremental walking test which was 
divided into three-minute stages. The speed of the treadmill remained constant 
throughout this test at either 1.56 m.s- i , 1.79 m.s-1 or 2.01m.s-l (3.5,4.0 or 4.5 mph) 
depending on a preliminary assessment of the subject's ability. The treadmill incline 
was set at 5% or 7% for the first three minutes, increased by 5% for the second three 
minutes and subsequently elevated by 2.5% at the end of each three-minute period. 
Douglas bag samples of expired air were collected between minutes 1:45 and 2:45 of 
each stage of the test from which oxygen uptake and carbon dioxide production were 
measured. Heart rate was monitored continuously throughout the test and the subject's 
rate of perceived exertion (RPE) was measured at the end of each stage using the Borg 
scale (Borg, 1973). The test was open-ended and continued in the manner described 
above until the subject signalled that they could only manage one more minute. At this 
point a final collection of expired air was collected and the test terminated. 
3.3.2 Submaximal, incremental treadmill test 
The purpose of this test was to determine the relationship between oxygen uptake and 
work rate during submaximal exercise for each individual. The test was sixteen minutes 
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long and divided into four, four-minute exercise periods. The speed of the treadmill 
remained constant throughout the test while the incline was elevated at the end of each 
four-minute exercise period. The speed and incline used for the treadmill test were 
determined by a subjective assessment of each individual's capability. The exact speed 
and grade used in each study is found in the method section of each individual chapter. 
Douglas bag samples of expired air were collected for the last minute of each four-
minute exercise period and heart rate was monitored continuously. The subject's RPE 
was also measured at the end of each stage of the test 
The oxygen uptake attained during each stage of the test was used as the independent 
variable and matched against the corresponding treadmill incline (%) as the dependent 
variable to derive a simple linear regression equation for each individual. The oxygen 
uptake values which would be attained if the subject was working at 30%, 40%, 50% 
and 60% of V02max, for example, were then calculated (i.e. 0.5 x V02max = oxygen 
consumption at 50% of V02max etc.). The exact predictions of exercise intensity and 
their subsequent incorporation into each protocol are described in the methods section 
of each chapter. 
3.4 Heart rate monitoring 
Heart rate was monitored continuously during each exercise test via an 
electrocardiograph (Rigel Cardiac Monitor 302. Rigel Research, U.K. Ltd.) and three 
chest electrodes (3M U.K. Ltd. Type 2255). Where heart rate was measured outside 
the laboratory, a short-range telemetry system was used (PE 3000, Sports-tester, 
Finland). 
3.5 Anthropometry and body composition 
3.5.1 Body mass 
Body mass values were measured using a beam balance (Avery), for the computation 
of body composition and also before each exercise test to allow calculation of oxgen 
uptake per kilogram body mass. For this measurement subjects were lightly dressed 
with shoes removed. 
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3.5.2 Height 
A fixed wall stadiometer was used for measuring height with subjects required to stand 
with heels together against a metal back plate. Slight upward traction was applied to the 
mastoid process in order to align the lower left orbit with the upper margin of the 
external auditory meatus (the Frankfort plane) before height was measured. 
3.5.3 Skinfold measurements 
A standard technique for measurement of skinfold thickness using rectangular jawed 
calipers (Holtain Ltd) was used at each site. These calipers were calibrated at the 
beginning and end of each study to ensure the required pressure was exerted by the 
jaws of the calipers. The skinfold was isolated between thumb and forefmger and 
calipers then applied. The measurement was read two seconds after the full pressure of 
the caliper was applied. All measurements were made on the non-dominant side. 
Skinfolds were assessed at the following sites: 
a. Biceps. With the arm bent at the elbow a point mid-way between the tip of the 
acromion and olecranon process was marked. The arm was then allowed to hang down 
vertically and relaxed and the skinfold was measured over the belly of the muscle above 
the centre of the cubital fossa. 
b. Triceps. This site was determined at the same level as the site for biceps, but in 
direct line with the olecranon process. 
c. Subscapular. This skinfold was picked up at a site under the inferior angle of the 
scapular at an angle inclined downward and laterally. 
d. Supra-iliac. This site was marked as the position half-way between the last rib and 
the superior iliac crest 
These skinfolds were used to estimate body density and allow calculation of body fat 
percentage according to the method described by Durnin and Womersley (1974). 
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3.6 Blood sampling 
3.6.1 Capillary blood sampling 
Thumb prick samples of capillary blood were collected both at rest and during exercise 
for the measurement of lactate concentration. Before samples were taken at rest the 
hand was immersed in warm water to increase superficial blood flow and thus 
arterialise the capillary blood. The skin was punctured using an Auto-clix automatic 
lancet (Boehringer Mannheim, U.K. Ltd.) and two 20111 samples of blood were 
collected into micro-pipettes (Acupette Pipettes; Scientific Industries Ltd.). The samples 
were immediately deproteinised in 200 Jll of 2.5% perchloric acid and subsequently 
centrifuged (Eppendorf centrifuge: model 5414) at 12,000 rpm for 30 seconds before 
being placed in a freezer (-70°C) where they remained until analysed. 
3.6.2 Venous blood sampling by venepuncture and cannulation 
Venous blood samples were obtained either by venepuncture from an antecubital vein 
or by cannulation of a vein in the cubital fossa or forearm. Care was taken to ensure 
prolonged occlusion of the antecubital vein did not occur during the phlebotomy 
process. Prior to cannulation 1% lignocaine was introduced sub-dermally at the site of 
entry to ensure minimum discomfort for the subject After the cannulation procedure 
subjects rested quietly for 10 minutes before any samples were taken. The cannula was 
kept patent using a 0.9% saline solution. All samples were taken in the seated position. 
Samples were then dispensed into plastic tubes and left to clot for one hour before 
being centrifuged (Burkard Koolspin set at 4°C). Serum was then removed and divided 
into aliquots and immediately frozen at -70°C. A 1 ml aliquot of serum was not frozen 
but stored in the refrigerator for subsequent analysis ofHDL-C and HDLz-C within 
five days of collection. 
3.7 Blood biochemistry 
Full details of the blood biochemistry are included in the appendices while a brief 
overview is given here. All these procedures were performed in the biochemistry 
laboratory in the Department of Sports Science at Loughborough University unless 
otherwise stated. 
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3.7.1 Estimation of plasma volume 
Haemoglobin concentration (Appendix 4) was detennined photometrically 
(Eppendorf photometer 1101 M) by a cyanmethemoglobin method using a 
commercially available test kit (Boehringer Mannheim, V.K. Ltd.). Haematocrit 
was ascertained using a micro-haematocrit reader (Hawksley) (Appendix 5). 
Plasma volume was then estimated according to the method of Dill and Costill 
(1974). 
3.7.2 Fluorimetric assays 
Blood lactate was measured using a modification of the enzymatic fluorimetric 
method described by Maughan (1982) (Appendix 6). Free glycerol was measured 
using an enzymatic fluorimetric method modified from that of Laurell and Tibbling 
(1966) (Appendix 7). All fluorescence values were measured using a Locarte 
fluorimeter (London, Model 8-9). 
3.7.3 Photometric assays 
Serum total cholesterol concentration (Appendix 8) was detennined using an 
enzymatic kit (Boehringer Mannheim, V.K. Ltd.). HDL-C was isolated in fresh 
serum by manganese chloride/sodium heparin precipitation (Gidez et al. 1982) and 
HDL3-C by subsequent precipitation by dextran sulphate (Appendix 9). The serum 
HDL cholesterol concentration was detennined by the enzymatic method described 
in Appendix 10. The concentration of HDL2-C was calculated as HDL-C minus 
HDL3-C, Low density lipoprotein cholesterol and VLDL-C were estimated in 
chylomicron-free serum using the Friedewald fonnula (Friedewald et al. 1972) 
(Appendix 11). 
Measurements of serum TAG (Appendix 12) and serum glucose (Appendix 13) 
were made using enzymatic kits (Boehringer Mannheim, V.K. Ltd). Free fatty 
acids were detennined by an enzymatic colourimetric method (Wako) (Appendix 
14). 
All of these photometric assays were analysed on an automated centrifugal analyser 
(Cobas Bio, Roche VK Ltd.) throughout this thesis unless otherwise stated in the 
methods section of an individual chapter. 
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3.7.4 Immunoturbidimetric assays 
Serum apoIipoprotein AI and B concentrations were determined by an 
immunoturbidimetric method using commercially available kits (Roche, UK Ltd.) 
(Appendix 15). This analysis was performed on an automated centrifugal analyser 
(Cobas Bio, Roche UK Ltd.). 
3.7.5 Radioimmunoassay 
Serum concentrations of insulin were determined by a solid phase 
radioimmunoassay using a commercially available kit (Diagnostics Products 
Corporation, USA). This analysis was performed on an automated gamma counter 
(Appendix 16). 
3.7.6 Apolipoprotein E phenotyping 
Phenotyping of apolipoprotein E was performed by Dr SI Mastana in the 
Department of Human Sciences at Loughborough University by isoelectric 
focussing using Western blot techniques (Appendix 17). 
For each assay described here all samples from the same subject were analysed in a 
single batch, except the HDL and HDLz-C assay which was performed on fresh serum. 
The coefficient of variation for each assay is included in Appendix 18, both between 
batch and within-batch. To ensure accuracy and precision quality control sera were 
used throughout (Precinorm L, Boehringer Mannheim, U.K. Ltd and Lipid control 
serum, Roche). 
3.8 Dietary analysis 
The seven-day weighed food inventory technique was used to monitor subjects' diets. 
Food intake records were analysed by a computerised version (Salford Microdiet) of 
food composition tables (Paul and Southgate 1978). 
3.9 Statistical analysis 
The statistics used in this thesis are non-parametric, due to the non-normally distributed 
nature of the data and size of subject groups. The Wilcoxon matched pairs test was 
used to test for significance of differences when repeated measures were made on the 
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same group. The Mann Whitney U test was used to detect differences between two sets 
of scores originating from different groups. Relationships between variables were 
examined, using the Spearman rank correlation coefficient Most of the statistical 
procedures used in this thesis are outlined by Cohen and Holliday (1982). Specific 
descriptions of the statistics employed are presented in the relevant experimental 
chapters. 
Values in this thesis are reported as mean plus or minus the standard error of the mean 
(SEM) unless otherwise stated and the five per cent confidence level has been adopted 
throughout. 
52 
3.10 The reproducibility of postprandial serum triacylglycerol 
concentrations during an oral fat tolerance test. 
3.10.1 Introduction 
Various oral fat tolerance tests have been described. Little information is available, 
however, concerning the reproducibility of serum TAG concentrations during an oral 
fat tolerance test. The results of one research group conclude that the oral TAG fat 
loading test is highly reproducible (Patsch 1987, Patsch et al. 1983, Brown et al. 
1992). However, Cohen and co-workers (1988) report that the mean intra-subject 
variation in postprandial lipaemia using such a test was 19%, and Cohn and colleagues 
(1988b) report that an individual's TAG response to a fat-rich meal was sometimes, but 
not always, reproducible. Many studies examining postprandial lipaemia, including 
those used in the reproducibility studies mentioned above, have utilised a high fat test 
meal with cream as the single main fatty ingredient (Groot and Scheek 1984, 
Georgopoulos et a!. 1988, Cohn et a!. 1991). The purpose of this study was, therefore, 
to examine the reproducibility of indices of postprandial lipaemia following ingestion of 
a high fat cream meal, in order to allow subsequent examination of the influence of 
exercise on postprandial lipaemia. 
3.10.2 Methods 
Subjects: Six subjects (3 male. 3 female) volunteered to participate in this study. All 
were physically active. non-smokers and not taking any drugs known to affect 
lipoprotein metabolism. Their physical characteristics are shown in Table 3.1. 
Study design: Each subject ingested a high fat meal on two separate occasions, 2 
weeks apart. Subjects reported to the laboratory after a 12-hour fast and a 2 ml blood 
sample was obtained by venepuncture. Subjects then ingested the test meal within 5 
minutes and rested quietly for the following 5 hours. Further 2 ml blood samples were 
obtained hourly by venepuncture with subjects seated. No food or drink, other than 
water, was ingested during this time. Subjects were asked to abstain from alcohol and 
refrain from exercise for 24 hours before each trial. 
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Age Body mass Height BM! Fasting TAG 
(~ears) (kg) (m) (kg.m·2) (mmol.1·1) 
SI male 39.6 63.7 l.70 22.0 l.21 
S2 male 2l.6 54.2 l.65 19.9 l.29 
S3 male 25.9 66.0 l.75 2l.6 1.23 
S4 female 24.4 56.3 l.63 21.2 1.14 
S5 female 27.2 53.0 l.68 18.8 1.30 
S6 female 30.3 60.0 l.69 21.0 1.07 
Table 3.1 Physical characteristics and fasting serum triacylglycerol concentrations 
of subjects (n=6). 
Test meal: The test meal consisted of double cream, water and raspberry flavouring 
and was prescribed according to body mass (l.3 g fat/kg body mass). This test meal 
provided a mean of 76.5±2.8 g fat, 3.8±O.2 g protein, 2.7±0.1 g carbohydrate and 
2.97±O.13 MJ of energy. 
Analysis: Blood was separated and serum stored at -70°C prior to assaying for TAG. 
All samples from one subject were analysed in a single batch. This analysis was 
performed manually using a photometer (Eppendorf photometer llOlM) according to 
the method described in Appendix 12. 
Statistics: Two indices of postprandial lipaemia were adopted; 
(1) the peak TAG concentration obtained, 
(2) the area under the TAG/time curve normalised to the 0 hour concentration, 
calculated using the trapezoidal rule. 
Spearman rank correlation coefficients were used to examine the relationships between 
trials. 
3.10.3 Results 
The test meal was not tolerated well by all subjects, with some experiencing feelings of 
nausea after ingestion, particularly in the second trial. Figures 3.1 (a - f) show the TAG 
concentrations before and after ingestion of the high fat meal for each individual in the 
first and second trials. TAG concentrations increased after ingestion of the high fat meal 
in both trials, with peak TAG concentration obtained on average 4 hours after 
ingestion. There was no difference in the time to peak between trials. 
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4 4 
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(mmol.l·l) 3 3 
2 2 
1 1 
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0 1 2 3 4 5 0 1 2 3 4 5 
(c) 5 (d) 5 
TAG 4 4 
(mmoI.1-1) 3 3 
2 2 
1 1 
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0 1 2 3 4 5 0 1 2 3 4 5 
(e) 5 (f) 5 
4 4 
TAG 
(mmol.l-l ) 3 3 
2 2 
1 1 
0 0 
0 1 2 3 4 5 0 1 2 3 4 5 
Time (h) Time (h) 
Figure 3.1 Serum TAG concentrations before and after ingestion of the high fat 
meal for each subject in triall( 0--<> ) and tria12 ( • • ). 
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The peak TAG concentration and the totallipaemic response (area under TAG/time 
curve) are shown in Table 3.2 for each subject in trials land 2. Spearman rank 
correlation coefficients for these indices of postprandial lipaemia are reported along 
with the scatter diagrams shown in Figure 3.2. Both Figures 3.2 (a) and (b) are 
presented with the line of identity shown. 
SI 
S2 
S3 
S4 
S5 
S6 
Table 3.2 
Peak TAG (mmo1.l-I) TAG Area (mmol.l-I.h) 
Triall Trial 2 Trial I Trial 2 
male 1.55 2.44 0.98 4.97 
male 4.08 4.26 9.65 11.05 
male 1.86 1.61 1.94 1.57 
female 1.62 1.84 2.72 1.82 
female 1.45 1.95 1.63 1.81 
female 1.20 1.77 0.86 1.95 
Peak serum triacylglycerol concentration and area under the TAG/time 
curve for each subject in trial I and trial 2. 
There was no relationship between fasting TAG concentrations and the totallipaemic 
response in either trial (trial I rho = 0.03, trial 2 rho = 0.23). There were also no 
significant correlations between TAG concentrations obtained in trial I and tdal 2 at any 
time point during the postprandial observation pedod as shown in Table 3.3. 
Time (h) 
rho 
Table 3.3 
o I 2 3 4 5 
-0.78 -0.05 0.37 0.60 0.09 -0.03 
The Spearman rank correlation coefficients for TAG concentrations at 
sample times during the postprandial observation period. 
As shown in Table 3.3 fasting TAG concentrations between trials I and 2 were 
inversely related (p<0.05). Prior to ingestion of the test meal fasting TAG 
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(a) Peak TAG concentration 
• 
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rho = 0.26 
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4 
2 
0 
0 
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Peak TA G Trial 1 
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(b) Total Jipaemic response 
• 
2 4 6 8 
TAG area Trial 1 
(mmol.l-1.h) 
• 
Spearman correlation 
rho = 0.09 
10 12 
Figure 3.2 Scatter diagrams (n=6) showing the Spearman rank correlation 
coefficients for (a) peak postprandial TAG concentration and (b) the total 
lipaemic response, with the line of identity shown. 
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concentrations were 18.9±6.7% different between trial 1 and trial 2. Table 3.4 shows 
these fasting TAG concentrations for each subject 
Fasting TAG (mmol.l-1) 
Trial 1 Trial 2 
SI 1.28 1.29 
S2 1.31 LlO 
S3 1.37 1.09 
S4 0.89 1.70 
S5 1.03 1.10 
S6 1.00 1.28 
Table 3.4 Fasting serum TAG concentrations in trials 1 and 2 for each subject 
3.10.4 Discussion 
The major fmding of this study was that the TAG concentrations following ingestion of 
a fatty cream meal were not highly reproducible in this group of physically active 
adults. There was a mean intra-subject variation in the totallipaemic response of 
35±11 %, higher even than the 19% intra-subject variation reported by Cohen and 
colleagues (1988) after repeat oral fat tolerance testing (80 g fat) in 8 subjects. In order 
to determine whether subjects had a reproducible pattern of postprandial lipaemia, Cohn 
and co-workers (1988b) also fed 5 subjects a fatty cream meal (1.0 g fat/kg body mass) 
on two occasions. They suggest that an individual's response to a fat-rich meal was 
sometimes, but not always reproducible, in agreement with the findings of the present 
study (Figure 3.1). 
These fmdings are in contrast to those of another research group (patsch 1987, Patsch 
et al. 1983, Brown et al. 1992) who conclude that the TAG fat tolerance test performed 
for a period of 8 hours is highly reproducible. A closer examination of the results of 
these studies, however, reveal results not dissimilar to those in the present study. This 
research group used an oral fat tolerance test consisting of 350 ml of heavy whipping 
cream, 2 tablespoons of instant non-fat dry milk, 1 tablespoon of sugar and 2 
tablespoons of chocolate flavoured syrup providing 130 g fat (83% of energy from fat). 
Patsch and co-workers (1983) administered this test meal to just 3 subjects on two 
separate occasions 7 -12 months apart. For these 3 subjects the intra-subject variations 
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(calculated from the lipaemic response data given) were 32%, 4% and 5%, an average 
of 14%. With such a small group of subjects it-is difficult to derive any conclusions 
regarding the reproducibility of postprandial TAG concentrations. Indeed, in the 
present study 2 of the 6 subjects had a variation in total lipaemia of less than the 14% 
(Le. 10% and 13%) calculated from this study by Patsch and colleagues (1983). 
Brown and co-workers (1992) carried out an investigation studying the reproducibility 
of the lipaemic response of 10 subjects, utilising the same test meal as Patsch and 
colleagues (1983), on two occasions within 10 days. Postprandial blood samples were 
obtained 3.5 and 9 hours after ingestion of this test meal. Spearman rank correlation 
coefficients of 0.69 and 0.87 are reported for TAG concentrations obtained 3.5 and 9 
hours after ingestion respectively, between trials. These workers conclude that this oral 
fat tolerance test was therefore highly reproducible. As only two postprandial blood 
samples were obtained in the study, calculation of totallipaemic response was not 
performed. In the present study the relationship between trial 1 and trial 2 for TAG 
concentrations obtained 3 hours after ingestion (rho = 0.60) was similar to that obtained 
by Brown and co-workers (1992) 3.5 hours after ingestion. 
However, TAG-rich lipoprotein secretion by the intestine might not be constant after fat 
ingestion (Cohn et al. 1989) possibly caused by variation in gastric emptying (Tall 
1986), gastrointestinal motility or in the rate of fat digestion in the intestine (Cohn et al. 
1989). If the rate of appearance of TAG is not constant after dietary fat absorption, a 
more sensitive description of the metabolic capacity for TAG for an individual may be 
to examine TAG concentrations over time (Le. area under the TAG/time curve), as in 
the present study, rather than examining a single time point after ingestion. No 
relationship was found in the totallipaemic response between the 2 trials in the present 
study. 
Patsch (1987) reports that their cream test meal described above is generally tolerated 
well and nausea, vomiting or diarrhoea do not "usually" occur. In the present study 
several subjects felt nauseous after ingestion of the test meal, in agreement with the 
findings of Cohen and colleagues (1988) who have reported that most subjects felt 
slight, transient nausea after consuming a test meal of 300 ml cream (120 g fat). 
Indeed, Tall (1986) reports that some subjects experience nausea and diarrhoea after 
ingesting fat alone. It is possible that absorption or gastric emptying of the meal in the 
present study may have been impaired as the meal was not palatable. Indeed, Cohen 
and colleagues (1988) report that after an unpalatable meal (olive oil and skimmed milk) 
the increase in TAG concentrations were delayed. Given the unreproducible nature of 
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the TAG concentrations following ingestion of the fatty cream test meal in the present 
study and the nausea experienced by the subjects, it was difficult to consider the cream 
high fat test meal an appropriate research tool. 
There are several possible explanations, concerning both the content of the test meal 
and the experimental conditions, why postprandial TAG concentrations were not highly 
reproducible in this study. Tall (1986) reports that the prior metabolic state of the 
subject has an important influence on the response to a test meal. Indeed, he suggests 
that weight loss, alcohol intake, exercise and probably a variety of other variables may 
influence the individual's response to a fatty meal. In the present study the variation in 
fasting serum TAG concentrations between trials does suggest variability in the 
metabolic state of the subjects prior to ingestion of the test meal. To minimise this 
variation in the metabolic state prior to oral fat tolerance testing further measures could 
be implemented. These include standardizing food intake before the oral fat tolerance 
test (Cohen et al. 1988) and increasing the period of inactivity prior to testing from 24 
to 48 hours, particularly if subjects participate in regular exercise programmes. 
It is indeed challenging to show good agreement in the selected indices of postprandial 
lipaemia between trials in this study, in part, because of the low postprandial response 
of three of the six subjects, and because the scores for 5 of the 6 subjects were so 
similar (Figure 3.2). 
Blood samples in this study were obtained by venepuncture which not only restricted 
the length of time over which lipaemia could be followed but may also have caused 
discomfort for the subject This discomfort may have resulted in an increase in 
circulating catecholarnines which have been reported to affect LPL activity (Robinson 
and Speake 1989). Use of cannulation will allow lipaemia to be followed for longer 
with less discomfort and will help to eliminate any stress response. 
Given that subjects who were to participate in subsequent studies examining the 
influence of exercise on postprandial lipaemia were all to be volunteers, the test meal 
itself needed to be more palatable. Providing a mixed meal may help to achieve this and 
is also more lifelike than ingesting fat alone. 
These results illustrate the difficulty in obtaining reproducibility in quantifying 
alimentary lipaemia by an oral fat tolerance test utilising a fatty cream meal. 
Neither of the selected indices of postprandial lipaemia or the TAG concentrations 
following ingestion of this high fat cream test meal was highly reproducible. This oral 
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fat tolerance test was therefore not considered to be an appropriate research tool to 
investigate the influence of exercise on alimentary lipaemia. 
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3.11 The reproducibility of postprandial serum triacylglycerol 
concentrations to a high fat mixed meal. 
3.11.1 Introduction 
The results of the previous study showed that there was a large intra-subject variation in 
serum TAG concentrations following ingestion of a cream-based high fat test meal. 
Studies examining postprandial lipaemia have most commonly used cream based, high 
fat test meals. Other researchers, however, have chosen to use mixed high fat meals 
(Kashyap et a!. 1983, Schlierf et a!. 1987, Weintraub et al. 1989) more typical of 
normal food intake than fat alone, although once again little information is available 
concerning the reproducibility of subsequent postprandial serum TAG concentrations. 
The purpose of this study was therefore, to examine the reproducibility of indices of 
postprandial lipaemia following ingestion of a mixed high fat meal, and the palatability 
of such a meal, in order that the influence of brisk walking on postprandial lipaemia 
could be investigated. 
3.11.2 Methods 
Subjects: Eightsubjects, (7 male, 1 female) volunteered to take part in the study. The 
physical characteristics and fasting lipid concentrations of the subjects are shown in 
Table 3.5 and 3.6. It can be seen from Table 3.6 that one subject (S3) would not be 
considered norrnolipidaemic. This was not known until the end of the study when 
blood lipid analysis was perfomed. 
Study design: Each subject ingested the high fat meal on two separate occasions 2 
weeks apart. Subjects performed no physical exercise for 48 hours prior to each trial 
and no alcohol was consumed for 24 hours before each trial. Subjects were also asked 
to weigh and record their food intake for one day prior to each trial and replicate this 
diet for the day prior to the second trial. After an overnight fast subjects reported to the 
laboratory and a cannula was introduced to a forearm vein. A fasted blood sample was 
taken and subjects then rested for the following 6 hours. Further blood samples were 
obtained hourly after ingestion. No food or drink other than water was allowed during 
the 6-hour postprandial observation period. 
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Age Body mass Height BM! 
(years) (kg) (m) (kg.m-2) 
S 1 28.3 62.5 1.70 21.6 
S2 60.5 70.2 1.80 21.7 
S3 52.9 78.6 1.83 23.5 
S4 42.4 79.4 1.78 25.1 
S5 25.8 76.5 1.83 22.8 
S6 38.1 74.8 1.75 24.4 
S7 30.5 67.5 1.70 23.3 
S 8* 25.4 70.2 1.67 25.2 
Mean 38.0±4.6 72.5±2.1 1.76±0.02 23.5±0.5 
* female subject 
Table 3.5 Physical characteristics of subjects (n=8). 
Fasting TAG Fasting TC HDL-C HD~-C 
(mmol.l-1) (mmol.l-1) (mmol.l-1) (mmol.l-1) 
S 1 1.23 4.79 1.61 0.59 
S2 0.98 4.37 1.29 0.35 
S3 4.26 6.64 1.16 0.36 
S4 1.15 5.85 0.93 0.44 
S5 0.61 3.96 1.06 0.42 
S6 2.21 5.41 1.16 0.37 
S7 1.40 4.05 0.82 0.21 
S 8* 0.68 3.77 0.96 0.38 
Mean 1.57±0.42 4.86±0.36 1.12±0.09 0.39±0.04 
* female subject 
Table 3.6 Fasting serum lipid and HDL-C concentrations of subjects (n=8). 
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Test meal: The test meal consisted of cereal, fruit, nuts, chocolate and whipping 
cream and was prescribed according to body mass (1.2 g fat/kg body mass) and was 
developed from the information provided by Schlierf and co-workers (1987). This test 
meal provided 85.2 g fat, 16.5 g protein, 94.5 g carbohydrate and 4.97 MJ of energy 
for a 70 kg person. The quantities of each ingredient used in the meal for a 70 kg 
person are listed below. 
Whipping cream 189 g 
Bananas 84 g 
Dried sultanas 10 g 
Milk chocolate 10 g 
Oatmeal 75 g 
Apples 50 g 
Brazil nuts 10 g 
Dessicated coconut 5 g 
This high fat test meal provided 66% of energy from fat, 32% of energy from 
carbohydrate and 2% of energy from protein. 
Analysis: Blood was separated and serum stored at -70°C prior to assaying for TC in 
fasting samples and TAG in all samples. HDL-C and HD~-C concentrations were 
determined from fresh serum from fasting blood samples. These assays were 
performed manually according to the methods described in Appendices 8-12 using a 
photometer (Eppendorfphotometer 11 01 M) . 
Statistics: Two indices of postprandial lipaemia were adopted; 
(1) the peak TAG concentration obtained. 
(2) the total lipaemic response described by the area under the TAG/time curve, 
normalised to the 0 hour concentration, calculated using the trapezoidal rule. 
Spearrnan rank correlation coefficients were used to examine the relationships between 
trials. Mean differences between trials (a) and the 95% confidence intervals (Cl) for a, 
calculated by the method described by Bland and Altman (1986), are also presented for 
peak TAG concentration obtained and the total lipaemic response. 
3.11.3 Results 
The test meal was well tolerated by all subjects, none feeling any nausea. Figures 3.3 
(a-d) and 3.4 (e- h) show the TAG concentrations before and after ingestion of the high 
fat meal for each individual in the first and second trials. TAG concentrations increased 
after ingestion of the high fat meal in both trials, with peak TAG concentration obtained 
3 or 4 hours after ingestion. There was no difference in the time to peak between trials. 
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(a) 8 (b) 8 
7 7 
TAG 6 6 
(mmoI.l-l) 5 5 
4 4 
3 3 
2 2 
1 1 
0 0 
0 1 2 3 4 5 6 0 1 2 3 4 5 6 
(c) 8 (d) 8 
7 7 
TAG 6 6 
(mmoI.l-l) 5 5 
4 4 
3 3 
2 2 
1 1 
0 0 
0 1 2 3 4 5 6 0 1 2 3 4 5 6 
Time (h) Time (h) 
Figure 3.3 Serum TAG concentrations before and after ingestion of the high fat 
meal for four subjects (1-4) in trial I (0--0 ) and trial 2 ( • .). 
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(e) (f) 
8 8 
7 7 
TAG 6 
6 
(mmol.l-1) 5 5 
4 4 
3 3 
2 2 
1 1 
0 0 
0 1 2 3 4 5 6 0 1 2 3 4 5 6 
(g) 8 (b) 8 
7 7 
TAG 
6 6 
(mmol.l-1) 5 5 
4 4 
3 3 
2 2 
1 1 
0 0 
0 1 2 3 4 5 6 0 1 2 3 4 5 6 
Time (h) Time (b) 
Figure 3.4 Serum TAG concentrations before and after ingestion of the high fat 
meal for four subjects (5-8) in trial I (0---0) and trial 2 (. • ). 
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Table 3.7 shows the peak TAG concentration and the totallipaemic response for each 
subject in both trials. The Spearman rank correlation coefficients for these indices of 
postprandial lipaemia are reported on the scatter diagrams shown in Figure 3.5. The 
line of identity is shown on both Figure 3.5 (a) and (b). 
SI 
S2 
S3 
S4 
S5 
S6 
S7 
S8 
Mean±SEM 
Table 3.7 
Peak TAG (mmol.l·1) TAG area (mmol.1-1.h) 
Trial 1 Trial 2 Trial 1 Tria12 
4.56 3.67 13.56 10.33 
1.86 1.85 3.99 2.12 
6.82 5.95 10.61 4.29 
3.15 2.44 5.66 4.21 
1.72 1.93 5.01 5.12 
7.29 4.79 16.11 10.00 
3.73 3.28 8.28 8.38 
1.26 1.97 2.51 2.95 
3.80±0.81 3.24±0.53 8.22±1.71 5.93+1.13 
Peak serum TAG concentration and totallipaemic response for each 
subject in trial 1 and trial 2. 
There was a relationship between fasting TAG concentrations and the tota1lipaemic 
response in the first trial (rho = 0.75, p<0.05) but no such relationship in the second 
trial (rho = 0.45). The peak TAG concentration attained was also related to the fasting 
TAG concentration in both trials (trial! rho = 0.88, trial 2 rho = 0.86, both p<O.O!). 
The relationship between TAG concentrations obtained during the postprandial period 
in trials 1 and 2 are shown in Table 3.8. 
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Peak TAG Trial 2 
(mmol.l-1) 
TAG area Trial 2 
(mmol.l-1.h) 
8 
7 
6 
5 
4 
3 
2 
1 
0 
0 
18 
15 
12 
9 
6 
3 
(a) Peak TAG concentration 
• 
1 
• 
• 
Spearman correlation 
rho = 0.88 
2 3 4 5 678 
Peak TAG Trial 1 
(mmol.l·1) 
(b) Total Iipaemic response 
• 
• 
• 
Spearman correlation 
rho = 0.83 
O~--,---'----.---.---r---' 
'0 3 6 9 12 
TAG area Trial 1 
(mmol.I-1.h) 
15 18 
Figure 3.5 Scatter diagrams (n=8) showing the Spearman rank correlation 
coefficients for (a) peak postprandial TAG concentration and (b) the total 
lipaemic response, with the line of identity shown. 
68 
Time (h) 0 1 2 3 4 5 6 
rho 0.88* 0.79 0.91* 0.98** 0.93* 0.88* 0.93* 
significant relationships, *p<0.05, **p<O.01 
Table 3.8 Spearman rank correlation coefficients for TAG concentrations at time 
points throughout the postprandial observation period (n=8). 
There was no relationship between the total Iipaemic response and the fasting 
concentrations of HDL (trial 1 rho =0.36, trial 2 rho =0.26) or HD~-C (trial 1 rho = 
0.26 , trial 2 rho = -0.26). The fasting serum TAG concentrations for each subject are 
shown in Table 3.9 in trial 1 and trial 2. Table 3.1 0 shows the mean difference (a) and 
the 95% confidence intervals for a for both the peak concentration and the total Iipaemic 
response, in order to examine the degree of agreement in these indices between trials. 
Fasting TAG (mmol.l-1) 
Trial 1 Trial 2 
SI 1.26 1.19 
S2 0.80 1.15 
S3 3.98 4.53 
S4 1.33 0.96 
S5 0.57 0.64 
S6 2.46 1.96 
S7 1.63 1.17 
S8 0.60 0.75 
Mean±SEM 1.58+0.41 1.54+0.45 
Table 3.9 Fasting serum TAG concentrations in trials 1 and 2 for each subject. 
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a 
95% Cl 
Peak TAG (mmo1.1-1) 
0.79 
0.17 - 1.41 
TAG area (mmo1.1-1.h) 
2.45 
0.37 - 4.53 
Table 3.10 Mean difference (a) between trials and 95% confidence intervals (Cl) for 
peak TAG concentration and totallipaemic response. 
3.11.4 Discussion 
One main fmding of this study was that this mixed high fat test meal appeared to be 
palatable and was well tolerated. There were significant positive relationships between 
trials 1 and 2 for the selected indices of postprandial lipaemia (peak TAG concentration 
rho = 0.88 and tota11ipaemic response rho = 0.83) with a mean intra-subject variation 
in the tota1lipaemic response of 26±7%. 
Kashyap and colleagues (1983) also examined the reproducibility of the magnitude of 
postprandial lipaemia following ingestion of a high fat mixed meal (100 g fat, 63 g 
carbohydrate) consisting of a cheese sandwich and a milkshake in 11 subjects. From 
their data it can be calculated that the mean intra-subject variation in postprandial 
lipaemia was 23±5% and a correlation coefficient of rho = 0.85 was found in the total 
lipaemic response between trials, similar to the result found in the present study. 
The calculation of correlation coefficients in this study demonstrates that postprandial 
lipaemia in trial 1 and trial 2 are related. However, these correlation coefficients should 
be interpreted with caution. There is certainly a strong relationship between 
postprandial lipaemia in trial 1 and trial 2, but this does not necessarily mean that there 
is good agreement between the two trials. We would have perfect agreement between 
the two trials only if all the points in Figure 3.5 lie along the line of equality shown. A 
perfect correlation would be found if the points lay along any straight line. Table 3.10 
shows that the confidence intervals are wide, reflecting the small sample size and the 
great variation of the differences_ These results also suggest that it is difficult to obtain 
precision in measuring the metabolic capacity for TAG by oral fat tolerance testing. 
However, the use of confidence intervals presumes that the differences are normally 
distributed, unlikely in the present study given the small sample size. 
The test meal given in this study was a mixed meal consisting of solid foodstuffs. Since 
gastric emptying rates can be influenced by the consistency of ingested food, it is 
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possible meals given in a solid fonn may have a different effect than fat -rich meals in a 
liquid fonn (Cohn et al. 1989). It is also possible that when fat is given as part of a 
meal in the presence of carbohydrate or protein this may alter the subsequent 
metabolism of TAG (Tall 1986, Griffiths et al. 1994a). For example Cara and 
colleagues (1992) found that dietary fibre from cereals may reduce postprandial 
lipaemia in humans. 
Also, Cohen and Schall (1988) have quantified the influence of various carbohydrates 
on the postprandiallipaemic response to a standard fat load (40 g fat). Their results 
indicate that the addition of 50 g of either glucose or sucrose had no effect on total 
Iipaemic response or peak TAG. In contrast, addition of either 50 g of fructose or 100 g 
sucrose was associated with an approximate doubling of postprandial lipaemia. A 
similar effect of fructose has been reported by Nikkila and Pelkonen (1966). These 
authors propose that the influence of fructose on alimentary lipaemia was secondary to 
its ability to increase hepatic secretion ofVLDL-TAG. In this context, it should be 
remembered that fructose does not appear to stimulate insulin secretion, whereas 
glucose does (Chen and Reaven 1991). In a later study, Cohen and Berger (1990) 
found that starch had no discernible effect on postprandial lipaemia and that glucose 
ingestion diminished lipaemia. They suggest that this is not due to increased clearance 
of TAG from the circulation following glucose and fat ingestion, but rather reflects 
delayed gastric emptying and decreased hepatic secretion of TAG. 
Chen and co-workers (1991) have recently demonstrated that the degree of postprandial 
lipaemia is essentially similar following acute ingestion of meals containing 25% of 
energy from fat and 60% of energy from carbohydrate, as compared with meals 
containing 45% of energy from fat and 40% of energy from carbohydrate. Variability in 
test meals is of potential interest since carbohydrate in meals elicits an insulin response 
that can effect hepatic VLDL secretion (Schneeman et al. 1993). 
In conclusion, the test meal was palatable and well tolerated by all subjects, none 
reporting any nausea. This test meal is more lifelike than the cream only meal, 
containing substantial amounts of both fat and carbohydrate, as is generally found in 
the diets of Western man (Cohen and Schall 1988). Also, the correlation coefficients 
suggest that the reproducibility of indices of postprandial lipaemia and TAG 
concentrations after ingestion of this test high fat mixed meal were better than after 
ingestion of the cream fatty meal. The confidence intervals however indicate that there 
is some difficulty in obtaining precision with oral fat tolerance testing. Overall, it was 
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decided that the reproducibility of the indices of postprandial lipaemia following 
ingestion of this test meal were acceptable. 
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4 THE SERUM LIPID AND LIPOPROTEIN CONCENTRATIONS 
OF ENDURANCE RUNNERS, RECREATIONAL 
PARTICIPANTS IN SPORT AND INACTIVE CONTROLS AGED 
40-59 YEARS. 
4.1 Introduction 
Individuals who report regular, vigorous exercise have a lower risk of CHD than their 
sedentary peers (Morris et al. 1980, Paffenbarger et al. 1978). The mechanism by 
which exercise might help protect against CHD has been the topic of speculation which 
has often involved an effect on lipoprotein metabolism. Endurance trained men and 
women exhibit blood lipid profiles which are consistent with a reduced risk of CHD 
(for review see Haskell 1984). 
Although there is very little evidence that physical activity has an independent effect on 
plasma total cholesterol, plasma HDL-C concentrations are invariably higher in 
endurance trained men (Williams et al. 1986, Thompson et al. 1983) and women 
(Moore et al. 1983, Durstine et al. 1987) than their sedentary peers. This effect is still 
evident when covariables such as age, relative weight, serum total cholesterol and TAG 
concentrations are taken into account (Nakamura et al. 1983). The importance of HDL-
C as a risk factor for CHD is widely accepted but the critical role of TAG metabolism 
has not been generally appreciated until recently (Bainton et al. 1992, Patsch et al. 
1992), yet this function provides the likely link between exercise and lipoproteins 
(Thompson 1990). Indeed, the higher concentrations of HDL-C observed in athletes 
may be a consequence of enhanced peripheral catabolism of TAG-rich lipoproteins in 
such individuals (Patsch and Patsch 1984), and as such may confer a reduced risk of 
CHD. 
The results of longitudinal studies have, however, not always been consistent with 
cross-sectional studies, possibly because of the differences in the duration and nature of 
the training regimens employed (Wood et al. 1983, Peltonen et al. 1981, Nye et al. 
1981). Consequently, it remains to be determined whether the favourable blood lipid 
profiles demonstrated by endurance athletes can be conferred by an amount of exercise 
which a large proportion of the population may be persuaded to undertake. 
The purpose of this study was, therefore, to examine whether the more favourable 
blood lipid and lipoprotein profIles evident in male and female endurance athletes are 
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also apparent in those who have a more modest commitment to exercise at a recreational 
level. 
4.2 Methods 
4.2.1 Subjects 
Subjects (55 female, 28 male) were recruited by advertising locally and volunteers aged 
40·59 years were accepted provided that they met the following criteria: (i) non-
smoker, (ii) systemic arterial blood pressure ofless than 160/95 mm Hg, (iii) not 
diabetic, (iv) free from a clinical history of hyperlipidaemia, bleeding or coagulation 
disorders or physician-diagnosed cardiovascular disease and (v) not taking any drugs 
known to affect lipoprotein metabolism. 
In addition, for subjects to be included in an activity group, the following criteria were 
established: 
(1) Endurance runners - subjects (8 male, 13 female) ran a minimum of 30 miles per 
week on a regular basis and had been participating at this level for at least five years. 
(2) Recreational exercisers - subjects (8 male, 8 female) undertook "planned exercise", 
sporting or otherwise 3 or 4 times a week for 20-30 minutes on each occasion. 
(3) Inactive controls - subjects (12 male, 34 female) performed no planned exercise and 
had been sedentary for at least one year. 
Assessment of physical activity status was made using a questionnaire (Appendix 21). 
Confidential interviews prior to the study revealed that 22 female subjects were pre-
menopausal (6 endurance runners, 1 recreational exerciser and 15 inactive controls), 8 
were peri-menopausal (2 endurance runners, 1 recreational exerciser and 5 inactive 
controls) and 25 were post-menopausal (5 endurance runners, 6 recreational exercisers 
and 14 inactive controls). Approval was obtained from the University Ethical Advisory 
Committee prior to the commencement of the study and informed consent was obtained 
from each subject 
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4.2.2 Study design 
Body fat percentage was estimated for each individual using the method described by 
Durnin and Womersley (1974), measuring skinfold thickness at 4 sites (biceps, triceps, 
supraiJiac and subscapular). The circumference of the waist and hip were also 
measured. Subjects reported to the laboratory after a 12-hour overnight fast and a 20 ml 
blood sample was obtained. Subjects refrained from exercise for 24 hours before this 
blood sample was taken. All male subjects and a subset of female subjects (8 inactive 
controls, 8 recreational exercisers and 13 endurance runners) completed dietary 
records, weighing and recording all food and drink for seven consecutive days. 
4.2.3 Analysis 
Blood samples were separated and the serum stored at _700 C until analysed for TAG, 
TC and Apo AI and B. HDL and the subfraction HDL3 were determined in fresh serum 
according to the method described in Appendix 9. Dietary records were analysed using 
a computerised version of the food composition tables by Paul and South gate (1978). 
The concentration of LDL-C was estimated using the Friedewald formula (Friedewald 
et al. 1972) as shown in Appendix 11. 
4.2.4 Statistics 
Data for males and females was analysed separately using the Mann Whitney U test for 
comparisons between the 3 different groups. The Pearson Product Moment correlation 
coefficient was used to determine relationships between variables. 
4.3 Results 
These results are divided into two main sections, the first presents the results for the 
male subjects, and the second those for the female subjects. 
4.3.1 Results for male endurance runners, recreational exercisers and 
inactive controls. 
Table 4.1 shows the physical characteristics of the male endurance runners (n=8), 
recreational exercisers (n=8) and inactive controls (n=12). There were no differences in 
age or height between the three groups. The male endurance runners had a lower body 
mass than both the recreational exercisers (p<0.05) and the inactive controls (p<O.OI). 
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Inactive controls Recreational exercisers 
(n = 12) (n = 8) 
Age (years) 51.5±2.2 48.7±3.2 
Height (m) 1.77±0.02 1.77±0.03 
Body mass (kg) 80.7±1.5 77.6±2.7t 
L4 skinfolds (mm) 59.8±6.2 48.l±5.4 
Body fat % 27.2±1.3 23.8±1.9* 
Waist:Hip ratio 0.93±0.01 0.86+0.02** 
significantly different from inactive controls, *p<O.05, **p<O.OI 
significantly different from endurance runners, t p<0.05 
Endurance runners 
(n = 8) 
48.0±1.4 
1.76±0.03 
68.2±3.5** 
35.8±4.1 ** 
19.1±1.6** 
0.84+0.01 ** 
Table 4.1 Physical characteristics of male endurance runners, recreational 
exercisers and inactive controls. Mean±SEM. 
Inactive controls Recreational exercisers Endurance runners 
(n = 12) (n = 8) (n= 8) 
TAG (mmol.l-1) 1.49±0.15 1.28±0.16 1.08±0.16 
TC (mmol.l-1) 4.94±0.37 4.37±0.33 4.02±0.23* 
HDL-C (mmol.l-1) 1.34±0.08 1.50±0.12 1.56±0.1l 
HD~-C (mmol.l-1) 0.45±0.05 0.61±0.08* 0.53±0.05 
LDL (mmol.l-1) 2.32±0.22 2.30±0.33 2.02±0.24 
TC:HDL ratio 3.14±0.20 2.99±0.29 2.67±0.24 
Apo AI (g.l-l) 1.57±0.07 1.59±0.1O 1.60±0.05 
AEo B (g.l-l) 0.63±0.05 0.61±0.05 0.58±0.05 
* significantly different from inactive controls, p<0.05 
Table 4.2 Fasting serum lipid, lipoprotein and apolipoprotein concentrations of 
male endurance runners, recreational exercisers and inactive controls. 
Mean±SEM. 
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Additionally, the male endurance runners (p<O.Ol) and the recreational exercisers 
(p<0.05) were leaner than inactive controls, as determined by estimation of body fat 
percentage. The ratio of waisthip circumferences was lower in both the runners 
(p<O.01) and the recreational exercisers (p<O.Ol) when compared with the inactive 
controls. The scores from the physical activity questionnaire (maximum score 100) 
were significantly different (p<0.01) between each group with mean scores of 69±4, 
40±4 and 25±4 for the endurance runners, recreational exercisers and inactive controls 
respectively. 
The fasting serum lipid, lipoprotein and apolipoprotein concentrations in the male 
endurance runners, recreational exercisers and inactive controls are shown in Table 4.2. 
There were two significant differences between the groups in the parameters measured. 
Firstly, serum total cholesterol concentrations were lower (p<0.05) in the endurance 
runners than in the inactive controls. Secondly, serum HD~-C concentrations were. 
26% higher (p<0.05) in the recreational exercisers than in the inactive controls. 
There were no significant differences in the fasting concentrations of TAG, HDL, LDL, 
TC:HDL or apolipoprotein AI and B between the three groups of male subjects. 
Although not significant, the mean serum TAG concentration was 28% lower in the 
endurance runners and 14% lower in the recreational exercisers than in the inactive 
control group. 
Concentrations of HDL-C were somewhat higher, although not significantly, in both 
the endurance runners (14%) and the recreational exercisers (11 %) compared to 
sedentary controls. There was an inverse relationship between concentrations of TAG 
and HDL (r = -0.44, p<0.05) and between TAG and HD~-C (r = -0.51, p<O.Ol) in 
the male subjects. In addition, the mean LDL cholesterol concentration was 13% lower 
in endurance runners than in the controls. 
Figure 4.1 and Table 4.3 show information concerning the dietary intake of the male 
endurance runners, recreational exercisers and inactive controls. There were no 
significant differences in the three groups in the percentage of energy obtained from fat, 
carbohydrate, protein or alcohol, or in their energy intake. The information in Table 4.3 
concerns the fat intake of the male subjects in this study. Both the endurance runners 
and the recreational exercisers consumed a lower (p<O.05) percentage of their mean 
daily energy intake as saturated fat and monounsaturated fat than the inactive controls. 
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Male inactive controls 
Energy intake = 11.4±1.7 MJ 
Male recreational exercisers 
Energy intake = ll.4±o.3 MJ 
Male endurance runners 
Energy intake = 11.6±o.6 MJ 
42.3±2.3 
47.6±2.3 
47.2±O.6 
o %CHO 
o % Fat 
[!3 % Protein 
JEJ % Alcohol 
Figure 4.1 The mean daily energy intake and percentage of energy intake from fat. 
carbohydrate (CHO). protein and alcohol in male subjects. Mean±SEM 
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Inactive controls Recreational exercisers Endurance runners 
(n=12) (n=8) (n=8) 
Fat (g) l14.3±19.4 93.3±8.6 100.1±5.4 
P:S ratio 0.3l±0.O4 0.42±0.09 0.50±O.1O 
Saturated fat (g) 43.6±5.7 41.7±6.l 42.4±4.6 
% energy l5.9±1.7 l1.2±1.5* l1.5±O.9* 
Monounsaturated fat (g) 36.1±4.8 34.1±3.4 39.3±2.3 
% energy l2.9±1.1 9.6±0.7* l1.0±O.9* 
Polyunsaturated fat (g) l2.9±1.7 15.5±1.2 l8.5±2.3 
% ener!l~ 5.2±0.6 4.2±0.4 5.2+0.7 
significantly different from inactive controls *p<O.05 
Table 4.3 The mean daily dietary fat intake of male endurance runners, recreational 
exercisers and inactive controls. Mean±SEM. 
4.3.2 Results for female endurance runners, recreational exercisers and 
inactive controls 
The physical characteristics of the female endurance runners (n=13), recreational 
exercisers (n=8) and inactive controls (n=34) are shown in Table 4.4. There were no 
differences in height or the ratio of waisthip circumferences between the three groups. 
The recreational exercisers were significantly older than the runners. Both the inactive 
controls (p<O.Ol) and the recreational exercisers were heavier (p<0.05) than the 
endurance runners. The female endurance runners were also leaner than both the 
controls and the recreational exercisers. However, the recreational exercisers were also 
leaner than the inactive controls (p<0.05). 
The scores from the physical activity questionnaire were significantly different 
(p<O.Ol) between each group with mean scores of 59±4, 40±5 and 22±2 for the 
endurance runners, recreational exercisers and inactive controls respectively. 
Table 4.5 shows the fasting serum lipid, lipoprotein and apolipoprotein concentrations 
in the female endurance runners, recreational exercisers and inactive controls. There 
were no differences in the concentrations of TC between the three groups. Fasting TAG 
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Inactive controls Recreational exercisers Endurance runners 
(n = 34) (n = 8) 
Age (years) 49.5±0.9 53.9±1.1tt 
Height (m) 1.62±0.01 1.67±0.02 
Body mass (kg) 68.5±1.9 68.2±2.4t 
lA skinfolds (mm) 89.7±5.3 59.3±5.1 *tt 
Body fat % 39.0±1.0 34.5±1.2*tt 
Waist HiE ratio 0.77±0.01 0.79+0.02 
significantly different from inactive controls * p<0.05, **p<O.OI 
significantly different from endurance runners t p<0.05, tt p<O.OI 
(n = 13) 
45.7±1.5 
1.64±0.02 
58.3±2.2** 
40.9±2.8** 
28.8±1.0** 
0.76+0.02 
Table 4.4 Physical characteristics of female endurance runners, recreational 
exercisers and inactive controls. Mean±SEM. 
Inactive controls Recreational exercisers Endurance runners 
(n = 34) (n = 8) (n = 13) 
TAG (mmol.l-1) 1.06±0.11 1.28±O.09tt 0.75±0.1O* 
TC (mmol.l-1) 5. 11±0.13 5.4o±O.26 4.70±0.23 
HDL-C (mmol.l-1) 1.57±0.05 1.94±0_16* 1.84±0.12* 
HDLz-C (mmol.l-1) 0.56±0.04 0.96±0.13** 0.82±0.1O* 
LDL (mmol.l-1) 3.03±0.13 2.92±0.33 2.52±0.21 
TC:HDL ratio 3.32±0.15 2.93±0.29 2.68±o.20** 
Apo A1 (g.l-l) 1.4o±O.05 1. 89±0. 11 * 1.97±0.14* 
AEo B (g.l-l) 0.86±0.03 0.71±O.04*tt 0.38±o.02** 
significantly different from inactive controls *p<0.05, **p<O.OI 
significantly different from endurance runnersttp<O.01 
Table 4.5 Fasting serum lipid, lipoprotein and apolipoprotein concentrations of 
female endurance runners, recreational exercisers and inactive controls. 
Mean±SEM. 
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concentrations, however, were lower in runners than in recreational exercisers 
(p<O.OI) or in inactive controls (p<0.05) by 41 % and 29% respectively. 
The concentrations of HDL and HD~-C were higher in both the endurance runners 
and the recreational exercisers than in the inactive control group. HDL-C and HD~.C 
concentrations were higher in runners by 15% and 32% respectively compared to 
inactive controls, and higher by 19% and 42% respectively in recreational exercisers. 
Although there was no significant difference in LDL cholesterol concentrations between 
the three groups, endurance runners had a LDL-C concentration 17% lower than the 
inactive controls. The ratio of TC:HDL was 19% lower in runners (p<O.OI) and 12% 
lower in recreational exercisers than in" inactive controls. 
Concentrations of Apo AI were significantly higher in runners (29%, p<O.05) and 
recreational exercisers (26%, p<0.05) than in inactive controls. Conversely, Apo B 
concentrations were significantly lower in runners (56%, p<O.OI) and recreational 
exercisers (20%, p<0.05) than in the inactive control group. Apo B concentrations 
were also significantly lower in runners than in recreational exercisers (46%, p<O.OI). 
Figure 4.2 and Table 4.6 show information concerning the dietary intake of the female 
endurance runners, recreational exercisers and inactive controls. There was no 
difference between the three groups in the mean daily energy intake. However, the 
runners obtained a lower percentage of their energy intake from fat and a higher 
percentage of their energy intake from carbohydrate compared to the inactive controls. 
The recreational exercisers obtained a higher percentage of their mean daily energy 
intake from protein than the endurance runners. 
The information in Table 4.6 concerns the fat intake of the female subjects in this study. 
The mean daily fat intake (g) of the endurance runners was 26% lower (p<O.O 1) than 
that of the inactive control group, with the difference attributable to a lower ingestion of 
both saturated and monounsaturated fat in the runners. 
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Female inactive controls 
Energy intake = 8.28±O.38 MJ 
4.3±1.6 
41.S±2.3 
Female recreational exercisers 
Energy intake = 7.64±O.74 MJ 
1.9±O.S 
46.1±3.7 
Female endurance runners 
Energy intake = 7.70±1.47 MJ 
2.3±O.7 
51.5±2.0** 
significantly different from inactive controls, *p<0.05, **0<0.01 
significantly different from recreational exercisers, tp<0.05. 
o %CHO 
Cl %Fat 
IEI % Protein 
11 % Alcohol 
Figure 4.2 The mean daily energy intake and percentage of energy intake from fat, 
carbohydrate, protein and alcohol in female subjects. Mean± SEM. 
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Inactive controls Recreational exercisers Endurance runners 
(n=8) (n=8) (n=13) 
Fat (g) 84.0±5.8 71.3±1O.5 61.9±4.0** 
P:S ratio 0.35±0.07 0.46±o.08 0.4l±0.02 
Saturated fat (g) 38.2±3.5 30.5±5.l 28.l±2.4** 
% energy l4.0±1.3 1 2.4± 1.7 13.5±0.9 
Monounsaturated fat (g) 33.6±2.8 28.0±4.2 23.4±1.3** 
% energy l2.l±0.7 l1.4±1.3 l1.4±0.6 
Polyunsaturated fat (g) l2.l±1.7 l2.9±2.5 10.3±0.9 
% energ~ 4.4±0.5 5.2±0.7 5.0±0.4 
significantly different from inactive controls, **p<O.Ol 
Table 4.6 The mean daily dietary fat intake of female endurance runners, 
recreational exercisers and inactive controls. Mean±SEM. 
4.4 Discussion 
The results of this study demonstrate that the higher HDL-C and HDLz-C 
concentrations found in male and female endurance runners are also evident in those 
who have a more modest commitment to exercise at a recreational level. 
Before discussing the differences in lipid and lipoprotein concentrations between the 
three groups in this study it is worth noting the blood lipid values obtained in this study 
with those reported for the British population of the same age. For example, the mean 
fasting TC concentration of the male. inactive controls in the present study was 4.9 
mmol.l-1. This is lower than the value for TC of 6.0 mmol.l-1 reported by Bainton and 
colleagues (1992) from the Caerphilly and Speedwell collaborative heart disease studies 
for asymptomatic men aged 45-59 years, and that reported by Mann and co-workers 
(1988) of 6.1 mmol.l-1 for men aged 40-55 years. Similarly, the inactive men in this 
study had lower fasting TAG concentrations (1.5 mmol.l-1) than those reported by 
other researchers (Bainton et al. 1992 1.7 mmol.l-1, Mann et al. 1988 1.9 mmol.l-1) for 
age matched asymptomatic males. In addition, the mean HDL-C concentration in 
83 
inactive males of this study was 1.34 mmol.l-1, higher than the value of 1.12 mmol.l-1 
reported by Bainton and co-workers (1992) in similar aged men. Overall, the male 
inactive subjects in this study had blood lipid profiles which were more favourable than 
those reported for British males of the same age. 
There is less data available detailing blood lipid concentrations of samples of females in 
the British population. However, the information which is available from the study by 
Mann and colleagues (1988) suggests that the female inactive controls in this study had 
lower fasting TAG (1.1 v 1.4 mmol.l-1) and TC (5.1 v 5.9 mmol.l-1) concentrations 
than those found more typically in women of the same age in Britain. 
Typically, cross-sectional studies have indicated ~o significant differences in TC 
concentrations between individuals reporting routine vigorous activity and less active 
individuals (Hartung and Squires 1980, Moore et al. 1983), as was found in the 
females of the present study. Where exercisers do show lower TC values than inactive 
controls, as evident in the male runners of this study, the difference is only modest (for 
review see Haskell 1984). 
The HDL-C concentrations in this study were 14% higher in male runners and 15% 
higher in female runners than in the respective inactive control groups. These results are 
in agreement with previous research finding HDL-C concentrations to be invariably 
higher in endurance trained men (Thompson et al. 1983, Herbert et al. 1984, Williams 
et al. 1986, Frey et al. 1990) and women (Moore et al. 1983, Durstine et al. 1987) than 
in their inactive peers. Thompson (1990) reports that well-trained male athletes have 
average HDL-C concentrations 40 - 50% higher than those of sedentary men, although 
Haskell (1986) reports a more conservative average 20 - 35% difference for both men 
and women. 
Additionally, HDL-C concentrations were 11 % higher in the male and 19% higher in 
the female recreational exercisers in this study than in their inactive peers. Higher HDL-
C concentrations compared to sedentary controls have indeed been previously reported 
in men (Nagao et al. 1988, Hartung and Squires 1980) and women (Durstine et al. 
1987, Hudson 1991, Haskell et al. 1980, Frandin et al. 1991) who undertake more 
moderate exercise. Concordant with these results, concentrations of apolipoprotein Al, 
essential for the function of HDL (Nagao et al. 1988), were elevated in female runners 
and recreational exercisers compared to inactive controls. In the male subjects, where 
differences in HDL-C concentrations between groups of varying activity status were 
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less pronounced, there were no significant differences in the concentrations of 
apolipoprotein AI. 
The HDLz-C concentrations in this study were markedly different between groups, 
with both the male and female recreational exercisers and endurance runners having 
higher concentrations than their sedentary peers. Indeed, it has been previously 
reported that the higher HDL-C concentrations found in those who participate in 
physical exercise appears to be mainly attributable to an increase in the HDLz-C 
subfraction (Eisenberg 1984). 
The mechanism by which exercise influences the serum HDL-C concentration has not 
been fully clarified. It is known, however, that HDLz is derived from HDL3 during the 
lipolysis ofTAG-rich lipoproteins by the activity ofLPL (patsch et al. 1978). Indeed, 
increased muscle LPL activity has been reported in endurance trained men and women 
compared to sedentary controls (Nikkila et al. 1978a). The higher HDLz-C 
concentrations observed in those who participate in exercise may, therefore, be a 
consequence of increased catabolism of TAG-rich lipoproteins (Sady et al. 1988). 
Since the degradation of TAG-rich particles is largely dependent upon the LPL activity 
in peripheral tissues (Cryer 1981), a training induced increase in muscle LPL activity is 
expected to result in transference of an increased amount of surface material to HDL in 
the plasma compartment (Kiens and Lithell 1989). 
In agreement with the postulation of a close metabolic relationship between HDL-C and 
TAG concentrations (Miesenbock and Patsch 1992), a modest inverse relationship was 
observed between these parameters in the present study (r = -0.39, p<O.Ol) and 
between TAG and HDLz-C concentrations (r = -0.32, p<O.Ol). Fasting TAG 
concentrations were lower in the male and female runners in this study by 28% and 
29% respectively, than in inactive controls. This agrees with the observation of 
Thompson (1990) that fasting TAG concentrations are on average 20% lower in 
athletes than sedentary individuals. However, although serum TAG concentrations 
decreased with increasing physical activity, at least in the male subjects in this study, 
the difference between the groups was not significant. Fasting TAG concentrations 
may, however, be an insensitive method for examining the metabolic capacity for TAG, 
particularly as TAG measurements are fraught with "npise" due to large intra-individual 
variability (Miesenbock and Patsch 1992). Information about long-term serum TAG 
concentrations or the metabolic capacity for TAG, the truly relevant parameter, may be 
more accurately described by a measure of the TAG removal system under strain : 
postprandial lipaemia. 
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The body fatness of the inactive subjects in this study (males = 27%, females = 39%) 
were similar to those reported for adults of the same age in the National Fitness Survey 
(1992) with average values of approximately 28% and 36% for males and females 
respectively. It has been suggested that exercise may influence lipid and lipoprotein 
metabolism by modifying body fatness (Wood et al. 1988). In the present study male 
and female recreational exercisers and endurance runners were leaner than the inactive 
controls. An inverse relationship has been previously reported between body fatness 
and HDL-C concentrations (Manson et al. 1990) and was evident in the present study 
(males rho = -0.39 p<0.05, females rho = -0.35 p<0.05). A lower body fatness may, 
therefore, be in part responsible for the lipid and lipoprotein differences in groups of 
differing levels of habitual physical activity. However, local adaptations in skeletal 
muscle also play a part as HDL-C has been reported to increase with increased physical 
activity, even in the absence of changes in adiposity (Hardman et al. 1992, Kiens et al. 
1980, Thompson et al. 1988, Miller 1987). Moore and co-workers (1983), comparing 
the lipid profiles of runners, joggers and sedentary women, also found that when 
results were adjusted for differences in body fatness there was still a significant 
difference in HDL-C concentrations between groups. 
Measurement of the ratio of the circumference at the hip and waist attempts to estimate 
differences in the distribution of body fat between the three groups in the present study. 
The W:H ratio values obtained in this study for the inactive controls were similar to 
those reported by the National Fitness Survey (1992) for similar aged men (0.93) and 
women (0.77). There were no differences in W:H ratio between the three groups of 
females in this study. The sedentary men, however, had a higher W:H ratio than both 
the recreational exercisers and the endurance runners. A strong independent relationship 
between the magnitude of the ratio of the circumference at the hip and waist and 
cardiovascular disease has been reported (Lapidus et al. 1984, Despres et al. 1990) and 
thus those men who did not participate in any regular physical exercise in this study 
could be considered at an increased risk of cardiovascular disease in this regard. 
Yet another part of the observed difference between lipid and lipoprotein patterns of 
physically active and sedentary men may be attributed to the acute effects of muscular 
work. The interval from the last exercise session to phlebotomy may influence the 
outcome of a cross-sectional study as acute effects of exercise on both HDL-C . 
concentrations (Sady et al. 1986) and TAG concentrations (Cullinane et al. 1982) have 
been reported. Indeed, many cross-sectional studies in the literature do not report any 
methodology controlling for the acute effect of the last bout of exercise (Herbert et al. 
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1984, Hartung and Squires 1980, Williams et al. 1986, Frey et al. 1990). In the 
present study all subjects abstained from exercise for 24 hours before blood sampling 
took place, in an attempt to minimize this effect The acute effects of a single bout of 
heavy exercise, particularly on TAG concentrations, have, however, been reported to 
last for up to 42 hours (Kantor et al. 1984). Thus it is a possibility that a proportion of 
the differences between the groups in this study are due to the acute effects of a 
previous bout of exercise, although this effect is probably not large as subjects did not 
exercise for a minimum of 24 hours before phlebotomy. 
Another factor which may influence the effect of exercise on lipoprotein concentrations 
is habitual diet. Surprisingly, energy intake did not differ between male and female 
endurance runners, recreational exercisers and inactive controls in this study. An 
increased energy intake might be anticipated in those expending more energy through 
participation in physical activity. The average daily energy intake of the female runners 
was, infact, less than that of the inactive controls (7.7 MJ versus 8.3 MJ), in agreement 
with the findings of Moore and colleagues (1983), although the difference was not 
significant. This may be accounted for either by the lower body mass of the athletes or 
by the desire of female runners to maintain or achieve a low body mass (Walker 1987). 
The only difference in the nutritional intake of the three groups of male subjects, as 
estimated from 7 -day weighed food intake records, was that the runners consumed a 
lower proportion of their daily energy intake from both saturated fat and 
monounsaturated fat than. inactive controls. It has been suggested that a diet lower in 
saturated fat and a higher P;S ratio will decrease TC and LDL in men (Johnson and 
Greenland 1990) by suppressing LDL receptor activity (Stone 1990). Male runners did 
have lower TC concentrations than inactive controls in the present study and, although 
there were no significant differences in LDL concentrations between the three groups, 
this concentration was 13% lower in the runners than in the inactive controls, agreeing 
with the observation of Thompson (1990) that differences between such groups are 
generally between 5 and 10%. In the female subjects there were no differences in TC 
concentrations between the 3 groups, despite the fact that runners consumed a lower 
absolute quantity of saturated fat than sedentary controls. However, LDL 
concentrations were 17% lower in runners compared to inactive controls. 
It has also been suggested that high dietary intakes of carbohydrates can lead to a 
depression in HDL-C concentrations (Julius and Hanefeld 1990). Katan (1984) reports 
that substituting carbohydrate energy for fat energy decreases HDL-C concentrations by 
0.05-0.15 mmol.l-1, if 10% of energy as fat is replaced by an equivalent amount of 
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carbohydrate. The difference in HDL-C concentrations in the present study between the 
inactive controls and the recreational exercisers (male = 0.16 mrno1.1·1, female = 0.37 
rnrno1.1-1) and endurance runners (male = 0.22 mrno1.1-1, female = 0.27 mmo1.1-1) is 
thus greater than could be explained by modest dietary differences between the groups. 
Indeed, the higher percentage of energy intake from carbohydrate of the female runners 
. in this study and their higher HDL-C concentrations when compared to the inactive 
controls, illustrates that high levels of dietary CHO do not depress HDL levels in lean 
individuals engaged in exercise training, in agreement with the findings of Thompson 
and colleagues (1983). 
Previous cross-sectional studies have also reported minor differences in habitual diet 
beween groups of individuals with varying physical activity levels (Thompson et al. 
1983, Moore et al. 1983). Most conclude, by regression analysis, that the large 
differences in lipid and lipoproteins between the groups are primarily the result of 
physical activity not dietary factors (Hartung et al. 1980, Moore et al. 1983). Indeed, 
Hagan and co-workers (1983) found that weekly dietary intake was a less important 
predictor of lipoprotein levels than were body mass index or distance run. 
Menopausal status or advancing age is yet another variable affecting lipid and 
lipoprotein concentrations in women. It appears that the menopause may be associated 
with a more adverse lipoprotein profile (Bush et al. 1988). In the present study the 
recreational exercisers were older than the endurance runners. However, HDL-C 
concentrations were not lower in the recreational exercisers or total cholesterol 
concentrations significantly higher in this group compared to the female runners. 
Cauley and colleagues (1982 and1986) conducted two cross-sectional studies with 
post-menopausal women and found a positive association between physical fitness and 
HDL-C concentrations, results similar to those studies performed with pre-menopausal 
women. The available evidence from cross-sectional studies suggests that regular 
physical exercise is associated with higher levels of HDL-C in women of all ages 
(l'aylor and Ward 1993). 
Cross-sectional comparisions of exercisers and sedentary individuals usually cannot 
distinguish the physiologic consequences of training from differences arising from self-
selection into exercise. Indeed, Williams and co-workers (1982) have reported a 
tendency for men who choose to take up running as a sport to have significantly higher 
plasma HDL-C and lower plasma TAG concentrations prior to participation in the 
sport. Although it is very unlikely that this self-selection bias invalidates the principal 
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conclusion of this cross-sectional study demonstrating a positive association between 
physical activity and HDL-C concentrations, this bias should be considered. 
The results of this study suggest that the more favourable lipid and lipoprotein 
concentrations found in endurance runners are also evident in those who have a more 
modest commitment to sport at a recreational level. This agrees with the conclusion of 
Wannamethee and Shaper (1992) that moderate levels of physical activity, such as 
frequent regular walking and recreational sporting activity, seem to be sufficient to 
produce a significant beneficial effect on cardiovascular disease risk. 
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5 THE INFLUENCE OF A SINGLE BOUT OF LOW INTENSITY 
EXERCISE ON POSTPRANDIAL LIPAEMIA. 
5.1 Introduction 
The previous Chapter of this thesis demonstrated that the higher fasting HDL-C 
concentrations consistently reported in endurance athletes when compared to their 
sedentary counterparts (Williams et al. 1986, Thompson et al. 1983, Herbert et al. 
1984) are also evident in those who participate in less vigorous exercise regimens. It 
has been suggested that the concentration of HDL-C is dependent on the metabolism of 
TAG-rich lipoproteins (Miesenbock and Patsch 1992, Tall 1986). Thus, the elevated 
HDL-C concentrations seen in those who participate in exercise may reflect an 
enhanced ability of such individuals to degrade these lipoproteins. 
Most studies examining the effect of exercise on lipid and lipoprotein metabolism have 
been carried out in the postabsorptive state. Fasting TAG concentrations, however, do 
not necessarily provide accurate information on TAG metabolic capacity (patsch et al. 
1983), which may be more clearly characterised in the postprandial state. Indeed, the 
magnitude of postprandial lipaemia is reported to differ substantially among individuals 
considered normolipidaemic on the basis of fasting blood lipid values (Demise et al. 
1989, Patsch et al. 1987, Mattock et al. 1981). Therefore, the postprandial phase may 
provide a very sensitive model for examining TAG metabolic capacity. Indeed, during a 
typical 24-hour day, 80% of the time is spent in a postprandial state that involves 
elevations in postprandial TAG-rich lipoproteins that may contribute to atherosclerosis 
(Superko 1992). 
Previous studies have demonstrated that endurance athletes show a lower lipaemic 
response to a standard fatty meal than sedentary controls (Cohen et al. 1989, Merri11 et 
al. 1989, Sady et al. 1988). In addition, some investigations have been conducted to 
examine the influence of a single bout of exercise on postprandial lipaemia (Cohen and 
Goldberg 1960, Nikkila and Konttinen 1962, Maruhama et al. 1977, Welle 1984, 8ady 
et al. 1986, Schlierf et al. 1987, Klein et al. 1992). Compared to control conditions, 
alimentary lipaemia was attenuated by exercise in five of these seven studies. Thus 
conflicting results have been found, most of the exercise bouts have been rather intense 
and the total number of subjects studied is small. The purpose of the present study was 
to examine the effect of a single bout of walking at 40% Y02max, a form of exercise 
attainable by a large percentage of the population, on postprandial lipaemia following a 
high fat mixed meal during exercise and in the recovery period. 
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5.2 Methods 
5.2.1 Subjects 
Twelve (6 male, 6 female) nonnolipidaemic young adults volunteered to participate in 
the study. All took part in regular physical activity, were non-smokers and not taking 
any drugs known to affect lipoprotein metabolism. The physical characteristics and 
fasting lipid concentrations of the subjects are shown in Table 5.1 and 5.2. Maximum 
oxygen uptake (V02max) was detennined during an incremental uphill walking test for 
each subject, as previously described in Chapter 3 (3.3.1). 
5.2.2 Study design 
Each subject undertook two separate trials, an exercise trial and a control trial, 
approximately 7 days apart in a balanced crossover design. In both trials subjects 
reported to the laboratory after an overnight fast and a cannula was introduced into a 
forearm vein. A blood sample was taken and the high fat test meal then ingested. 
Further blood samples were obtained I, 1.5,2, 3,4,5, and 6 hours after consumption 
of the test meal. 
Subjects perfonned no physical exercise for 2 days prior to each trial and food intake 
was weighed and recorded for the 2 days prior to the fIrst trial and replicated for the 2 
days prior to the second trial. In addition, no alcohol was consumed for 24 hours 
before each trial. 
Exercise trial: In the exercise trial subjects rested for 1.5 hours after ingestion of the 
test meal and then walked for 90 minutes at approximately 40% V02max on a treadmill. 
Subjects then rested for the remaining 3 hours. 
The speed of walking and the incline of the treadmill required to elicit 40% V02max for 
each individual was detennined by previously conducting a 16-rninute incremental 
submaximal walking test as described in Chapter 3 (3.3.2). For this test subjects 
walked on the treadmill at a speed and grade estimated to elicit 30, 40, 50 and 60 % 
approximately ofV02max for 4 minutes each. From this test the speed and grade 
eliciting approximately 40% of V02max could be detennined. The mean walking speed 
for the 90 rninutes was 1.8±O.02 m.s-1 (4.0±0.1 mph), with a range from 1.6 - 2.0 
ms-1 (3.5 -4.5 mph) and the mean incline was 5.3±O.7% (range 0.3 - 8.7%). 
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Age Body mass Height BM! V02max 
(years) (kg) (m) (kg.m-2) ml.kg-1.min-1 
Females 24.7±1.4 63.7±3.8 1.63±O.O2* 23.8±1.l 41.8±3.8* 
(n=6) 
Males 27.2±1.6 74.7±3.9 1.76±O.11 24.1±1.l 54.6±3.0 
(n=6) 
All 25.9±1.1 69.2±3.1 1.70±O.O2 24.0±O.7 48.2±3.0 
(n=12) 
* significantly lower than males, p<O.05 
Table 5.1 
Females 
(n=6) 
Males 
(n=6) 
All 
(n=12) 
Table 5.2 
Physical characteristics of female and male subjects. Mean±SEM. 
Triacylglycerol Total cholesterol HDL-C HDLz-C 
(mmol.l-1) (mmol.l-1) (mmol.l-1) (mmol.l-1) 
O.78±O.11 4.07±O.28 l.O9±O.O4 O.44±O.O6 
O.87±O.15 3.76±O.34 1.17±O.O9 O.4l±O.O7 
O.82±O.O9 3.92±O.22 1.13±O.O5 O.42±O.O4 
Fasting serum lipid and lipoprotein concentrations of female and male 
subjects. Mean±SEM. 
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Expired air samples were collected into Douglas bags every 15 minutes for 
measurement of oxygen uptake and carbon dioxide production. Heart rate was recorded 
at the same intervals from three chest leads. Immediately prior to the exercise bout and 
every 30 minutes throughout the test, duplicate 20 III capillary blood samples were 
taken from the thumb. 
Colltrol trial: In the control trial subjects rested quietly throughout the 6-hour 
observation period after consumption of the test meal. 
5.2.3 Test meal 
The high fat test meal was prescribed according to body mass (1.2 g fatJkg body mass) 
and consisted of cereal, fruit, nuts, chocolate and cream as described in Chapter 3 
(3.11.2). The test meal provided a mean of 16.3±o.7 g protein, 93.6±4.2 g 
carbohydrate, 84.4±3.7 g fat and 4.93±o.23 MJ energy. The meal was well tolerated 
by all subjects, none showing any signs of nausea. 
5.2.4 Analysis 
Capillary blood samples taken from the thumb during the exercise bout were 
immediately deproteinised and stored at -70°C prior to assaying for lactate. During each 
trial aliquots of blood were removed at 0 and 6 hours after ingestion to measure 
haemoglobin concentration and haematocrit for estimation of changes in plasma volume 
(Appendix 5). The remaining blood was separated and the serum stored at -70°C. 
Serum was analysed for TAG, corrected for free glycerol, TC, HDL-C and HDL2-C, 
FFA, glucose and Apo AI and B in all blood samples. Serum insulin concentration was 
measured in samples taken at 0, 1.5, 3 and 6 hours after ingestion. The phenotype of 
apolipoprotein E was determined from serum for each individual. The method of 
analysis for each assay is described in detail in Appendices 7-17. 
5.2.5 Statistics 
Three indices of postprandiailipaemia were adopted; 
(i) peak TAG concentration observed 
(ii) totailipaemic response, as described by the area under the T AGltime curve, 
normalised to the 0 hour level and calculated using the trapezoidal rule. 
(iii) the lipaemic response for specified time intervals, i.e. pre-exercise (0 - 1.5 hours), 
exercise (1.5 - 3 hours) and recovery (3 - 6 hours). 
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Comparisons between trials were made using the Wilcoxon matched pairs signed rank 
test. Spearman rank correlation coefficients were calculated to examine the relationships 
between variables. 
5.3 Results 
All subjects completed the 90 minutes of walking, eliciting an average relative exercise 
intensity of 40.1±1.1 % V02max. The average heart rate during the walk: was 125±1 
beat.min-I . Figure 5.1 shows the mean heart rate and the respiratory exchange ratio (R) 
during the 90-minute walk. There was no change in the R value until the measurement 
taken during the last minute of walking (p<0.05). Substrate contribution to energy 
provision was estimated by indirect calorimetry as 13.o±4.5% of energy provision 
from fat at the start of exercise compared to 20.3±5.1 at the end of the 90-minute period 
(p<0.05). 
Heart rate 
(beat.min-I ) 
160 1.00 
150 0.95 
140 
0.90 R 
130 
0.85 
120 
0.80 
110 
100 
--0- Heart rate 0.75 
• R 
90 +---,---,---r---r--..,.----,r--t-0.70 
o 15 30 45 60 75 90 105 
Time (minutes) 
Figure 5.1 Heart rate and the respiratory exchange ratio during the 90 minutes of 
walking. Mean±SEM. 
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Calculations from indirect calorimetry (Appendix 20) also revealed that a mean of 
8.8±2.5 g of fat were utilized during the exercise and 131.2±14.0 g of carbohydrate. 
There was no relationship between the amount of fat utilized during the exercise bout 
and the change in postprandial lipaemia. The estimated energy expended during the 
walking was 2.50±0.20 MJ, with no relationship between the energy expended and the 
change in postprandial lipaemia. Changes in blood lactate concentration during the walk 
are shown in Figure 5.2 with an increase above the pre-exercise value of 0.65±O.07 
mmol.l-1 to 1.83±O.33 mmol.l-1 (p<0.05) after 30 minutes of walking, reaching a 
concentration of 1.97±0.40 mmol.l-1 by the end ofthe 90 minutes. 
Lactate 
(mmol.l-') 
Figure 5.2 
3 
2.5 
2 
1.5 
1 
0.5 
0 
0 30 60 90 
Time (mins) 
Blood lactate concentrations during the 90 minutes of walking. 
Mean±SEM. 
Figure 5.3 shows the TAG concentrations throughout each trial. Prior to ingestion of 
the test meal fasting TAG concentrations were not different between the control and 
exercise trials, as shown in Table 5.3. Serum TAG concentration was significantly 
elevated (p<O.01) 1 hour after ingestion of the test meal in both trials, remaining 
elevated (p<O.OI) at 6 hours after ingestion in the control trial, but not in the exercise 
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Figure 5.3 Serum triacylglycerol concentrations during the control and exercise trials. Mean±SEM_ 
**significantIy different than control trial, p<O.Ol. 
trial. In both trials peak TAG concentration was attained 3 hours after ingestion, there 
being no difference in the time to peak between trials. Table 5.3 shows that there was 
no difference between trials in the peak TAG concentration attained. However, the total 
lipaemic response (area under the TAGltime curve) was 23.5±11.3% lower in the 
exercise trial than in the control trial (Table 5.3). There was considerable inter-
individual variation in the totallipaemic response to the high fat meal, as demonstrated 
by the range shown in Table 5.3. For 11 of the 12 subjects the totallipaemic response 
was lower in the exercise trial than in the control trial. 
Fasting TAG Peak TAG TAG area 
(mmol.l·1) (mmol.l-1) (mmol.l-1.h) 
Control 0.82±0.09 2.03±O.23 4.48±0.62 
(range) (0.56 - 1.59) (1.35 - 3.69) (1.62 - 8.22) 
Exercise 0.90±0.1O 2.23±O.28 3.22±O.48* 
(range) (0.50 - 1.49) (1.29 - 4.45) (1.05 - 6.19) 
* significantly lower than control trial p<O.05 
Table 5.3 Fasting and peak serum TAG concentrations and totallipaemic response 
in the control and exercise trials. Mean±SEM and range. 
There was no relationship between the fasting TAG concentration and the totallipaemic 
response in either the control (rho = 0.31) or the exercise trial (rho = 0.35). Also, no 
relationship was found between the totallipaemic response and fasting HDL-C (control 
rho = -0.13, exercise rho = -0.19) or HDLz-C (control rho = 0.13, exercise rho = 
0.02) concentrations. 
The difference in the totallipaemic response between the two trials was attributable to a 
lower lipaemic response during the recovery period, i.e. 3 to 6 hours after ingestion of 
the test meal, as is demonstrated in Figure 5.4 and Table 5.4. 
Of the 12 subjects in this study, 9 (5 female, 4 male) exhibited the homozygous 
apolipoprotein E phenotype E3 allele, with the remaining 3 subjects being 
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TAG area 
(mmol.l·l.h) 
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Figure 5.4 The lipaemic response for specified time intervals during the control and exercise trials. Mean±SEM. 
** significantly different than control trial, p<O.Ol. 
heterozygous E3-2. The effect of exercise on the lipaemic response to the test meal was 
not significantly different between males and females. 
Control 
Exercise 
0-6h 
4.48±O.62 
3.22±0.48* 
Lipaemic response (mmol.1-1.h) 
o - 1.5 h I.S - 3 h 
O.62±O.06 
0.48±O.06 
1.4S±O.18 
l.30±O.21 
3 -6 h 
2.42±O.44 
l.3S±O.32** 
significantly lower than control trial, *p<O.OS, **p<O.OI 
Table 5.4 The lipaemic response for specified time intervals in the control and 
exercise trials. Mean±SEM. 
Following an initial fall (p<O.OI) in serum free fatty acid (FFA) concentrations after 
ingestion of the high fat test meal, these started to rise by a similar amount in both trials 
up to the commencement of walking in the exercise trial, as shown in Figure 5.S. In the 
control trial there was a gradual rise in FFA concentrations, significantly higher than 
fasting concentrations 5 and 6 hours after ingestion of the meal. In the exercise trial 
FFA concentrations were significantly higher compared to the control trial during the 90 
minutes of brisk walking, and remained higher in the recovery period. 
Marked differences can be seen with regard to serum glycerol concentrations with and 
without exercise (Figure S.6). While glycerol concentrations, similar to FFA 
concentrations, fell slightly following ingestion of the meal, there was a sharp increase 
with exercise. In the control trial glycerol concentrations rose throughout the 
postprandial observation period and were significantly higher (p<O.OS) than fasting by 
5 and 6 hours after ingestion. In the exercise trial glycerol concentrations were not 
significantly different from the control condition after cessation of exercise, in contrast 
to the FF A response. 
Serum total cholesterol concentration rose significantly (p<O.OI) after ingestion of the 
test meal in both trials and remained elevated (p<O.OS) throughout the postprandial 
observation period in both trials. There were no differences in total cholesterol 
concentrations between the exercise and control trials. These data are presented in Table 
5.S. Similarly, there were no significant differences in either serum HDL-C or HD~-C 
concentrations between the two trials. HDL-C concentrations remained unchanged 
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Serum free fatty acid concentrations during the control and exercise trials. Mean±SEM. 
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Serum glycerol concentrations during the control and exercise trials. Mean±SEM. 
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Glucose 
(mmol.1-1) 
TC 
(mmol.l-I ) 
HDL-C 
(mmol.l-I ) 
HDLz-C 
(mmol.1-1) 
Table S.S 
o 1 I.S 2 3 4 S 6 
Control 4.36±O.OS 3.93±O.2S 4.22±O.20 4.29±O.lS 4.63±O.OS 4.41±O.lS 4.4S±O.21 4.4S±O.14 
Exercise 4.29±O.OS 4.10±O.24 4. 13±O.26 4.S2±O.07 4.S4±O.1O 4.42±O.23 4.39±O.06 4.3S±O.OS 
Control 3.S2±O.2S 4.0S±O.27 4.07±O.27 4.01±O.27 4.03±O.27 4.00±O.2S 4.0S±O.26 4.09±O.29 
Exercise 3.7S±O.31 4.01±O.32 4.01±O.32 4.00±O.31 4.06±O.30 3.90±O.30 3.93±O.30 3.97±O.30 
Control 1.12±O.OS 1.17±O.O6 1.18±O.O6 1.1S±O.06 1.14±O.OS 1.14±O.O6 1.17±O.O6 1.21±O.O6 
Exercise 1.13±O.OS 1.1S±O.OS 1.19±O.O8 1.1S±O.OS 1.16±O.OS 1.17±O.OS 1.17±O.O9 1.20±O.O9 
Control 0.41±O.OS O.4S±O.OS 0.46±O.OS O.4S±O.OS 0.44±O.OS 0.44±O.OS O.4S±O.OS 0.47±O.OS 
Exercise 0.41±O.OS 0.41±O.08 0.40±O.OS O.39±O.09 O.38±O.09 0.41±O.OS 0.42±O.OS 0.42±O.09 
Serum glucose, total cholesterol and lipoprotein concentrations before and after the high fat meal in the control and exercise 
trials. Mean±SEM. No significant differences between trials. 
throughout the postprandial period in both trials and were only significantly elevated 6 
hours after ingestion (p<O.OS). There were no changes in HD~-C concentrations in 
either trial. 
Figures 5.7 and 5.8 show the apolipoprotein AI and B concentrations during each trial. 
Concentrations of apo AI were significantly elevated I hour after ingestion of the test 
meal in both trials compared to fasting concentrations. In the control trial apo AI 
remained elevated throughout the postprandial period observed. In the exercise trial apo 
AI concentrations were significantly higher only until the end of the 90-minute period 
of brisk walking. Concentrations of apo AI were different between the two trials only at 
2 hours after ingestion. There were no differences between trials in the apo B 
concentration throughout the study. Postprandially the concentration of apo B was 
elevated above fasting concentrations in both trials I hour after ingestion and remained 
higher throughout the control trial .. 
Table 5.5 also shows the serum glucose concentrations during each trial, demonstrating 
that homeostasis was maintained in both the control and exercise trials with no 
significant differences between trials. After ingestion of the high fat test meal, serum 
insulin concentrations increased in both the control and exercise trials (Figure 5.9). In 
the control trial insulin concentrations were still elevated 3 hours after ingestion of the 
meal and then fell towards fasting concentrations by 6 hours. In the exercise trial 
insulin concentrations were lower than in the control trial at the end of the brisk walking 
bout and had returned to below fasting concentrations by the end of the observation 
period. There was no difference in the change in estimated plasma volume over the 6-
hour period between the trials (Control: - 3.2±2.6%, Exercise: -S.7±2.6%, compared 
with initial values). 
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Serum apolipoprotein AI and B concentrations before and after 
ingestion of the high fat meal in the control and exercise trials. 
Mean±SEM. * significantly different than control trial, p<O.05. 
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5.4 Discussion 
The major finding of this study was that 90 minutes of low intensity exercise following 
ingestion of a high fat meal reduces postprandial lipaemia during the recovery period. 
All the subjects completed the bout of brisk walking, at a mean exercise intensity of 
40.l±1.1 % V02max, with correspondingly low heart rate and blood lactate 
concentrations throughout the exercise. 
1n accordance with the findings of others, the postprandial model of examining TAG 
metabolic capacity revealed inter-individual differences not apparent in the fasted state 
(patsch et al. 1987, Mattock et al. 1981), even in this group of normolipidaemic young. 
adults. Of the indices of postprandial lipaemia examined, the totallipaemic response 
showed both the inter-individual and between-trial differences most clearly. 
The changes in lipid and lipoprotein metabolism that occur as a result of a bout of 
exercise have the potential to influence postprandial lipaemia. Blood borne free fatty 
acids are a primary energy source for endurance exercise (Thompson 1990), 
particularly during low intensity exercise as employed in the present study (Romjin et 
al. 1993). Moreover, much of this fat is derived from intra-muscular TAG stores 
(Hurley et al. 1986). A depletion of intra-muscular TAG stores by exercise may 
stimulate secretion or synthesis of LPL, the rate limiting ernzyme in the catabolism of 
TAG-rich lipoproteins, in muscle capillaries, particularly during the recovery from 
exercise. This may enable the tissue to take up circulating TAG and thus replenish the 
muscle TAG stores. Indeed, increases in muscle LPL activity have been reported after 
single bouts of exercise (Taskinen et al. 1980, Lithell et al. 1981, Sady et al. 1986, 
Kantor et al. 1987), although these studies have all involved vigorous bouts of 
exercise. The effect of a single bout of low intensity exercise as employed in the present 
study on LPL activity is however unknown. 
Although the LPL activity of skeletal muscle is lower (per unit tissue weight) than that 
of adipose tissue (Borensztajn 1987), Lithell and co-workers (1978) found a correlation 
between muscle LPL activity and the removal rate of chylomicrons, but no correlation 
between this and adipose tissue LPL activity. They conclude that it is increased LPL 
activity in skeletal muscle that is most important in determining the increased removal of 
TAG from the circulation. Thus, the lower postprandial lipaemia (24%) seen in the 
exercise trial of the present study, attributable mainly (85%) to a lower response during 
the recovery period, could be a consequence of increased LPL activity in skeletal 
muscle to restore depleted muscle TAG stores. 
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Several previous investigations have examined the effect of single bout of exercise on 
postprandial lipaemia, although the total number of subjects studied is small. The early 
studies by Cohen and Goldberg (1960) and Nikkila and Konttinen (1962) both 
demonstrated a lower plasma turbidity after consumption of a high fat meal in 
combination with exercise rather than the meal alone. Since these earlier studies, to the 
author's knowledge, four other such studies have been conducted (Maruhama et al. 
1977. Welle 1984, Schlierf et al. 1987, Klein et al. 1992). Two of these (Maruhama et 
al. 1977, Welle 1984) report no change in postprandial lipaemia with exercise, 
conflicting with the results of the present study. Differences in experimental design 
however may account for these results as Maruhama and colleagues (1977) utilised 
intermittent exercise (2 minutes of exercise each hour during the 6 hour postprandial 
observation period) and in the study by Welle (1984) postprandial TAG concentrations 
were only followed until 3 hours after ingestion of a test meal. 
In the remaining two studies (Schlierf et al. 1987, Klein et al. 1992), which both 
employed continuous bouts of postprandial exercise, a lower lipaemic response was 
found in the exercise as compared to control condition, in agreement with the findings 
of the present study. However, in the study by Klein and co-workers (1992) the 
lipaemic response was lower during the recovery from exercise whereas in that by. 
Schlierf and colleagues (1987) lipaemia was lower immediately following exercise but 
not Significantly lower during the recovery period. 
TAG from chylomicrons and VLDL has not traditionally been regarded as a substrate or 
direct fuel source for exercising muscle (Nikkila 1987), but recent observations suggest 
that this view may not be correct Plasma TAG itself represents a potentially rich source 
of circulating energy substrates, particularly in the postprandial state when TAG-rich 
chylomicrons are present (Teljung et al. 1983). Measuring arterio-venous fluxes across 
the forearm during isometric exercise, Ruys and colleagues (1989) found that HDL was 
produced by muscle and that production was greatly increased after a high fat meal. 
Their assumption that this represented intra-vascular generation of HDL in the course of 
lipolysis of TAG-rich lipoproteins by LPL in the muscle capillary bed is supported by 
the fact that they found no net production of HDL in patients with LPL deficiency. 
Moreover, Kiens and Lithell (1989), using a one-leg dynamic exercise model, found a 
strong relationship between VLDL degradation and HDL formation across the 
exercising leg over a two-hour period. Thus increased muscle blood flow during 
exercise probably enhances uptake of TAG from chylomicrons and VLDL by 
increasing the exposure of LPL to substrate (Ruys et al. 1989). 
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Potts and co-workers (1991) found that there was a significant uptake of chylomicron 
TAG by the foreann muscle postprandially. However, VLDL-TAG was unaffected by 
passage through the foreann at any time. This suggestion that chylomicron TAG may 
be a better direct fuel source than VLDL-TAG may partially explain why the 
concentration of serum TAG does not appear to decrease when these studies are 
conducted in the fasted state, even during vigorous exercise (Cullinane et al. 1982, 
Thompson et al. 1980). The use of chylomicron TAG as a fuel source during exercise 
of the foreann has further been demonstrated by Griffiths and colleagues (1994b) after 
ingestion of a high fat meal. 
If chylomicron TAG was used directly as a fuel source during the bout of low exercise 
in the present study then we may expect to see lower plasma TAG concentrations 
during this time compared to the control condition. This was not the case however. 
Indeed, estimation of fat utilisation by indirect calorimetry shows that a mean of only 
8.8±2.5 g of fat were utilised during the 90 minute exercise bout (compared to the 84 g 
of fat ingested in the test meal). Recently, Griffiths and co-workers (1994a) have 
reported that after ingestion of fat and carbohydrate together there is direct release of 
fatty acids into the plasma, as a consequence of hydrolysis of TAG with incomplete 
uptake of free fatty acids arising, and thus increased fat oxidation. If this were the case 
then we may expect that such free fatty acids would be available for oxidation during 
the low intensity employed in the present study. However, fat oxidation during the 90 
minutes of exercise was small, and lower indeed than that expected in the fasted state. 
However, it is possible that chylomicron TAG may become available as a fuel source 
during the later stages of postprandial lipaemia (after 3 hours following ingestion of a 
meal) when there is an influx of larger chylomicron particles (i.e. when peak TAG 
concentration occurs) entering the circulation, which may act as a better substrate for 
LPL. If the exercise had been performed at such a time (for example, 3 hours after the 
meal) it is possible that there may have been increased fat oxidation. 
The brisk walking in this study, performed 1.5 hours after consumption of the test 
meal, may possibly have interfered with with either the gastric emptying or the 
intestinal absorption of the test meal. Few studies have been conducted on the influence 
of low intensity exercise on gastric emptying rates (Maughan and Rehrer 1993). 
Additionally, there is a particular paucity ofinformation concerning the gastric 
emptying of solid meals, as this cannot be measured using aspiration techniques. 
However, Maughan and Rehrer (1993) conclude in a review concerning gastric 
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empyting and exercise that, based on results from studies of glucose solution ingestion, 
exercise at intensities of less than about 70% V02max has little or no effect on the rate 
of gastric empyting, in agreement with the earlier work of Costill and Saltin (1974). 
An increase in gastric emptying rates during the brisk walking may be expected to result 
in higher TAG concentrations during the exercise period compared to the same time in 
the control trial. Alternatively, if walking actually slowed gastic emtpying rates or 
intestinal absorption, higher TAG concentrations may have been observed during the 
recovery from exercise when intestinal blood flow was restored, and lower TAG 
concentrations during the exercise bout itself compared to the control condition. Neither 
of these scenarios was the case in the present study. The data from this study, based on 
TAG concentrations, suggests therefore that the exercise employed in this study did not 
affect gastric emptying rates. 
In contrast to other studies (O'Meara et al. 1992, Annuzzi et al. 1989) and to those 
reported in Chapters 6 and 7 of this thesis, there was no relationship between fasting 
TAG concentrations and the extent of alimentary lipaemia in either trial of the present 
study. This may reflect the narrow range of fasting TAG concentrations in this study 
and the small number of subjects. The same two subjects that had the highest fasting 
TAG concentrations in both trials (Exercise: 1.48 mmol.1-1 and 1.49mmol.1-1, Control: 
1.25 mmol.1-1 and 1.59 mmol.1-1) also exhibited the highest lipaemic responses in both 
trials (Exercise: 6.19 mmol.1-1.h and 5.00 mmol.1-1.h, Control: 8.07 mmol.l-1.h and 
8.22 mmol.l-1.h). Given the reported close relationship between fasting TAG 
concentrations and the extent of alimentary lipaemia it was satisfying to note from the 
experimental point of view (linked to the dietary control imposed) that there was no 
difference in fasting TAG concentrations before ingestion of the test meal between the 
two trials in the present study. 
It is of interest to note that those subjects who, without exercise, had the highest 
postprandial TAG response tended to show the greatest change in postprandial lipaemia 
after exercise (p<O.05), demonstrated in Figure 5.11. The data for the one male subject 
who showed a greater lipaemic reponse with exercise is also shown and identified. 
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Figure 5.11 The relationship between the extent of alimentary lipaemia after the high 
fat meal in the control trial and the change with postprandial exercise 
(n=12), with the linear regression line shown. * indicates the one 
subject who showed a greater lipaemic response with exercise. 
The male subjects in this study tended to have a higher lipaemic response to the high fat 
meal than the females in both trials of this study. This observation has been made in 
several studies (Kashyap et al. 1983, Baggio et al. 1980) and is discussed more fully in 
Chapter 7. 
One intriguing aspect is that no relationship was observed between indices of 
alimentary lipaemia and fasting HDL or HD~ cholesterol concentrations in either trial. 
This is in contrast to the earlier data of Patsch and co-workers (1983) who 
demonstrated an inverse relationship between fasting HDL and HD~ cholesterol levels 
and the magnitude of postprandial lipaemia in 28 healthy subjects aged 28-42 years. 
However, Cohen and colleagues (1991) found no relationship between postprandial 
lipaemia and HDL cholesterol in a group of endurance trained young men, a group 
similar to our own physically active individuals. These workers suggest that the lack of 
relationship might have resulted partly from the narrow range of postprandial responses· 
they observed. This suggestion is not sufficient to explain our results, as the total 
lipaemic response varied considerably (range 1.62 - 8.22 mmo!.l-I.h control, 1.05 -
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6.19 mmol.l-1.h exercise) and fasting HDL cholesterol concentration varied twofold 
(0.66 - 1.44 mmol.l-1). The lack of relationship may, therefore, simply be a reflection 
of the relatively small number of individuals studied in the present investigation. 
Alternatively, it may be due to the age of the subjects as such a relationship may 
become more evident with advancing age. The results of a study by Weintraub and 
colleagues (1989) support this hypothesis, as they found lower postprandial lipaemia 
after a period of training but no concomitant increase in HDL-C in physically active 
young adults. Collectively these results indicate that postprandial lipaemia may be a less 
important determinant of HDL or HDLz cholesterol concentrations in young physically 
active adults than in older individuals. 
At the end of the 6 hours, total HDL cholesterol concentrations were increased in both 
trials although HDLz cholesterol concentrations remained unchanged. Patsch (1987) 
suggests that the metabolism of chylomicrons can affect HDLz concentrations in two 
ways. Firstly, chylomicron lipolysis, by providing phospholipids and soluble 
apolipoproteins, can lead to formation ofHDLz and, secondly, accumulation and 
prolonged circulation of chylomicrons provides a source of triacylglycerols for transfer 
into HDLz effecting loss of HDLz through the action of hepatic lipase. These 
effectively opposing mechanisms may help to partially explain the divergent findings 
with regard to HDL and HDL2 cholesterol concentrations following a high fat load. 
Indeed, several studies report no change in HDL-C concentrations during alimentary 
lipaemia (Annuzzi et al. 1989, Taskinen and Kuusi 1986, Schlierf et al. 1987). 
However, decreases in HDL-C have also been reported (O'Meara et al. 1992, Lewis et 
al. 1990), as well as increased HDLz-C (Kashyap et al. 1983). 
In agreement with the findings of others (Groot and Scheek 1984, Cohn et al. 1988b) 
serum TC concentrations were elevated after ingestion of the test meal in the present 
study and remained elevated throughout both trials, representing a possibly 
increased"atherogenic" scenario after fat ingestion. However, others have found no 
increase in TC after ingestion of a high fat load (O'Meara et al. 1992, Castro and 
Fielding 1985). The increase in TC following ingestion of a high fat meal may be 
dependent of the nature of the fat in the test meal (Norum 1992), and may thus explain 
these divergent fmdings. Apolipoprotein AI is a major constituent of newly secreted 
chy1omicrons as well as HDL-C (Patsch and Patsch 1984). The increase in apo AI after 
ingestion of the high fat meal is then in accordance with this observation and has also 
been reported in other studies (Groot and Scheek 1984). In the present study we also 
observed a significant increase in Apo B postprandially in agreement with the fmdings 
of Cohn and co-workers (1988b). This may be due either to an increase in apo B 100 
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(of hepatic origin) or apo B48 (of intestinal origin), or a combination of both. Indeed, it 
has been shown that the preferential clearance of chylomicron TAG (Apo B48) by LPL 
leads to an accumulation of very low density lipoproteins (Apo B 1 00) during 
alimentary lipaemia (Schneeman et al. 1993). 
Following ingestion of the test meal, concentrations of serum free fatty acids (FF A) and 
glycerol followed similar patterns falling immediately after ingestion, as also observed 
by other authors (O'Meara et al. 1992, Lewis et al. 1990, Schlierf et al. 1987), 
reflecting inhibited lipolysis. During the walking in the exercise trial increased lipolysis 
was reflected by marked elevation of free glycerol and FFA concentrations. 
After ingestion of the test meal there was a fall in serum glucose concentrations, despite 
the carbohydrate content of the meal (94 g), indicating rapid liberation of insulin. 
Thereafter, glucose homeostasis was well maintained, regardless of exercise. Richter 
and co-workers (1992) report that the maintenance of euglycaemia during exercise is 
achieved by feedback sensors from glucosensors that sense a minute fall in glycaemia 
elicited by the increase in peripheral glucose utilization. 
Fasting insulin concentrations may have an effect on the extent of postprandial lipaemia 
following a high fat meal. Insulin resistance may render postprandial insulin levels 
insufficient for suppression ofVLDL secretion by the liver, and thus hepatic TAG-rich 
particles superimposed on chylomicrons will augment postprandial lipaemia. There 
was, however, no difference in fasting insulin concentrations between the two trials in 
this study. At the onset of exercise insulin concentrations decreased, as found by 
Taskinen and co-workers (1980), probably due to elevated catecholamine 
concentrations (Koivisto et al. 1986). The decrease in insulin concentrations and the 
elevated catecholamine response to exercise may contribute to an increase in adipose 
tissue lipolysis and augment the flow ofFFA to the muscle. Additionally, this probably 
acts as a restraint on glucose utilization by non-exercising tissues (Richter and Galbo 
1986). The decrease in plasma insulin concentration may also attenuate the increase in 
glucose transport in exercising muscle. In the exercise trial of this study serum insulin 
concentrations remained lower during the recovery period, compared to the control 
conditon, as reflected by the higher FFA concentrations during the recovery from 
exercise compared to the control trial, indicative of increased lipolysis. 
The results of this study show that a single bout of low intensity exercise reduces the 
lipaemic response to a high fat meal in physically active, normolipidaemic young 
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adults. The attenuation of postprandial lipaemia seen in this study was attributable to a 
decrease in lipaemia during the 3-hours immediately following the brisk walk. 
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6 POSTPRANDIAL LIPAEMIA IN RECOVERY FOLLOWING A 
SINGLE BOUT OF BRISK WALKING IN NORMOLIPIDAEMIC 
YOUNG ADULTS. 
6.1 Introduction 
The previous chapter of this thesis demonstrated a reduction in postprandial lipaemia 
during the recovery period immediately following a single bout of brisk walking at 40% 
V02max. It is possible. therefore. that mitigation of postprandial lipaemia by walking 
may be revealed most clearly during recovery from exercise rather than during the 
exercise bout itself. Indeed. both the decrease in fasting TAG concentrations (Freyet 
al. 1993. Sady et al. 1986) and the increase in LPL activity (Lithell et al. 1979. Annuzzi 
et al. 1987) associated with a single bout of exercise have been frequently observed 
during recovery from exercise. There is information. however. suggesting that there 
may be a delay in this exercise induced elevation in LPL activity and that this may not 
be evident until 4-18 hours after the completion of an exercise bout (Kantor et al. 1987. 
Kiens et al. 1989). Thus. in the present study. postprandial lipaemia was examined 15 
hours after completion of the brisk walk. Examining postprandial lipaemia during the 
recovery period alone rather than during the exercise bout itself also eliminates the 
possibly confusing effects of exercise on gastric emptying rates and the catabolism of 
chylomicron TAG as a fuel source during exercise (Ruys et al. 1989). 
Previous studies have shown that the removal rate of intravenously introduced TAG is 
increased during the recovery from prolonged vigorous exercise (Sady et al. 1986. 
Annuzzi et al. 1987). compared to removal rates before the exercise bout The purpose 
of this study was to examine the effect of a single bout of brisk walking. a form of 
exercise which is socially acceptable. on the magnitude of postprandial lipaemia in the 
recovery from exercise. 
6.2 Methods 
6.2.1 Subjects 
Twelve (6 male. 6 female) normolipidaemic young adults volunteered to participate in 
the study. The physical characteristics and fasting lipid concentrations of the subjects 
are shown in Tables 6.1 and 6.2. V02max was determined during an incremental uphill 
walking test for each subject. as described previously in Chapter 3 (3.3.1). 
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Age Body Mass Height Body fat VOzmax 
(years) (kg) (m) (%) (ml.k~-I.min-l) 
Females 25.2±1.3 62.0±1.8* 1.62±O.OI* 24.0±1.l* 41.5±2.7* 
(n=6) 
Males 26.5±2.1 75.9±4.2 1.79±O.O3 15.2±1.6 55.8±3.5 
(n=6) 
All 25.8±1.2 69.0±3.0 1.70±O.O3 19.6±1.6 48.6±3.0 
(n=12) 
* significantly different from males, p<O.05 
Table 6.1 Physical characteristics of female and male subjects. Mean±SEM. 
Triacylglycerol Total cholesterol HDL-C HDL2-C 
(mmo1.I-1) (mmo1.1·1) (mmo1.1-1) (mmo1.1-1) 
Females O.86±O.O3 4.13±o.21 * 1.02±o.09 O.33±o.04 
(n=6) 
Males O.88±O.O9 4.82±O.22 1.04±o.08 O.32±o.05 
(n=6) 
All O.87±O.O5 4.48±O.18 1.03±o.06 O.32±o.03 
(n=12) 
* significantly different from males, p<O.05 
Table 6.2 Fasting serum lipid and lipoprotein concentrations of female and male 
subjects. Mean±SEM. 
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Percentage body fat was estimated by skinfold measurements at 4 sites; triceps, biceps, 
subscapular and suprailiac. All subjects took part in regular physical activity, were non-
smokers and not taking any drugs known to affect lipoprotein metabolism. 
6.2.2 Study Design 
Each subject undertook two separate trials, an exercise trial and a control trial, 7 days 
apart, in a balanced cross over design. Each trial was conducted over two days, as 
shown in Figure 6.1. 
Day 1 Control Trial - Rest 
Exercise Trial - 2 hours brisk walking 2-4pm 
Day 2 High Fat Meal Test on both Trials 
Breakfast 
t "-<111-- Resting 
S.OOam 2.00pm 
o 1 2 3 4 5 6 
t t t Time +hoUrS) t t t 
vs vs vs vs vs vs vs 
vs = venous blood sample by cannulation 
Figure 6.1 Experimental protocol for exercise and control trial 
Subjects performed no physical exercise for the 2 days prior to each trial and consumed 
no alcohol for the 24 hours prior to each trial. Food intake was weighed and recorded 
for the 2 days prior to the first trial and replicated for the two days prior to the second 
trial Additionally, the evening meal on day I of each trial was controlled using a 
system offood exchanges (Walker 1987), providing each subject with approximately 
48% of energy intake from carbohydrate. 
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Exercise trial: On the afternoon of day 1 subjects perfonned 2 hours of brisk 
walking on a motorised treadmill and ingested a high fat test meal on the morning of 
day 2 (15 hours after completion of the exercise bout). 
The speed of walking during the 2-hour exercise bout was either 1.57, 1.79 or 2.02 
m.s-1 (3.5,4.0 or 4.5 mile.hr-1), depending on the magnitude of V02max for each 
individual Expired air samples were collected into Douglas bags every 15 minutes for 
measurement of oxygen uptake and carbon dioxide production. Heart rate was recorded 
at the same intervals from three chest leads. Immediately prior to the exercise bout and 
every 30 minutes throughout the test duplicate 20 III capillary blood samples were taken 
from the thumb. 
Control trial: Subjects rested on day 1 and ingested the high fat meal on the morning 
of day 2. 
6.2.3 Oral fat tolerance test 
On the second day of each trial subjects reported to the laboratory after an overnight fast 
and a cannula was introduced to a foreann vein. A fasting blood sample was obtained 
and the test meal then ingested. Subjects rested quietly for the following 6 hours with 
further blood samples obtained at hourly intervals after the ingestion of the meal. All 
blood samples were taken with subjects seated. No food or drink other than water was 
consumed during this period. 
Test meal 
The high fat test meal was prescribed according to body mass (1.2 g fat/kg body mass) 
and consisted of cereal, fruit, nuts, chocolate and cream as described in Chapter 3 
(3.11.2). The test meal provided a mean of 16.3±o.7 g protein, 93.4±4.1 g 
carbohydrate, 84.0±3.7 g fat and 4.88±o.22 MJ of energy. The meal was well 
tolerated by all subjects, none showing any signs of nausea. 
6.2.4 Analysis 
Capillary blood samples taken from the thumb during the exercise bout were 
immediately deproteinised and stored at -70°C prior to assaying for lactate by a 
fluorimetric enzyrnatic method, as described in Appendix 6. During each fat tolerance 
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trial aliquots of blood were removed at 0 and 6 hours after ingestion to measure 
haemoglobin concentration and hematocrit for estimation of changes in plasma volume 
(Appendix 5). The remaining blood was separated and the serum stored at -70°C. 
Serum was analysed for TAG, TC, HDL-C and HDL2-C, FFA, free glycerol, glucose 
and Apo AI and B in blood samples obtained every hour. Serum insulin concentration 
was measured in samples taken at 0, 1,2,4 and 6 hours after ingestion. The phenotype 
of apolipoprotein E was determined from serum for each individual. The method of 
analysis for each assay is briefly described in Chapter 3 (3.8). 
6.2.5 Statistics 
Serum TAG values were corrected for free glycerol. Two indices of postprandial 
lipaemia were adopted; 
(i) the peak TAG concentration observed. 
(ii) the total lipaemic response, as described by the area under the TAG/time curve, 
normalised to the 0 hour level and calculated using the trapezoidal rule. 
The significance of differences between and within trials was evaluated by the 
Wilcoxon matched pairs test. Spearman rank correlation coefficients were calculated to 
examine the relationships between variables. 
6.3 Results 
All subjects completed the 2 hours of brisk walking. The relative exercise intensity of 
the walk was 30.9±1.6% V02max and the average heart rate 111±2 beat.min-I. Figure 
6.2 shows the mean heart rate of the 12 subjects during the 2-hour walk. The change in 
the respiratory exchange ratio during the walk is also shown in Figure 6.2 and fell from 
0.91±0.03 after 15 minutes of walking to 0.80±0.01 after 120 minutes of walking 
(p<O.O 1). Substrate contribution to energy provision was estimated by indirect 
calorirnetry as 30.1±8.2% of energy provision from fat at the start of exercise 
compared to 66.3±4.6% at the end of the 2 hours. Changes in blood lactate 
concentration during the walk are presented in Figure 6.3, with an increase above the 
pre-exercise value of 0.73±O.08 mmo1.l-1 to 1.66±O.21 mmol.r-t (p<0.05) after 30 
minutes of exercise with no significant increases thereafter. Where no standard error is 
shown on Figure 6.3 this falls within the boundary of the symbol. 
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Heart rate and the respiratory exchange ratio (R) during the 2-hour brisk 
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Blood lactate concentration during the 2-hour brisk walk. Mean±SEM. 
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Prior to ingestion of the test meal the fasting serum TAG concentration was 15±2% 
lower (p<O.05) in the morning after the exercise bout than in the control trial 
(0.74±o.03 v 0.92±O.08), as shown in Figure 6.4. The TAG concentrations 
throughout the postprandial observation phase in both the control and exercise trial is 
shown in Figure 6.5. Serum TAG concentration was significantly elevated (p<O.OI) I 
hour after ingestion of the meal in both trials, returning towards fasting values by the 
end of the 6 hours. In both trials peak TAG concentration was attained 3 or 4 hours 
after ingestion of the test meal, there being no difference in the time to peak between 
trials. Peak TAG concentration was lower (p<0.05) during the exercise trial than in the 
control trial (1.98±O.18 v 2.59±o.32), as is shown in Figure 6.6. 
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Figure 6.5 Serum TAG concentrations before and after the high fat meal. Mean±SEM. 
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There was considerable interindividual variation in the total lipaemic response (area 
under the TAG/time curve), which was 31±7% lower in the exercise trial as compared 
to the control. These results are shown in Table 6.3. 
Total lipaemic response (mmol.l-1.h) 
Exercise Control 
Mean (n=12) 4.28±0.66* 6.46±1.08 
2.59 - 14.12 Range 1.56 - 8.06 
* significantly different from control trial (p<O.Ol) 
Table 6.3 The total lipaemic response (area under the TAG/time curve) in the 
exercise and control trials (n=12). Mean±SEM and range. 
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For 11 of the 12 subjects the totallipaemic response was lower in the exercise than in 
the control trial. In the control trial there was a relationship between the totallipaemic 
response and fasting TAG concentrations (rho = 0.77, p<O.OI). No such relationship 
was evident in the exercise trial. 
The effect of exercise on the totailipaemic response was not significantly different 
between males and females with a 26.2±13.7% and 3S.4±4.1 % decrease respectively. 
Table 6.4 shows the distribution of apolipoprotein E phenotypes in the study. There 
was no difference between males and females in this distribution. 
Apo E phenotype 
Males 
Females 
E3-3 
3 
4 
E4-3 
2 
2 
Table 6.4 The distribution of apolipoprotein E phenotypes 
E3-2 
1 
o 
Table 6.S shows the cholesterol, lipoprotein and apolipoprotein responses to the high 
fat meal. There was no difference between trials in the response of total cholesterol with 
concentrations increased above fasting values from I hour after consumption of the test 
meal until the end of the period of observation in both trials (p<O.OI). 
By the end of both trials, 6 hours after ingestion of the test meal, HDL-C concentration 
was elevated (p<O.OS) compared to fasting concentrations. During the exercise trial 
HDL-C concentration was higher (p<O.OS) than the control trial 3, 4 and S hours after 
ingestion of the meal. No relationship was found between fasting HDL-C 
concentrations and the totallipaemic response (control trial rho = 0.29, exercise trial 
rho = -0.01). In the control trial HDLZ-C concentration remained unchanged but in the 
exercise trial there was a small but significant elevation (p<O.OI) 2 hours after 
consumption of the test meal as compared to fasting concentrations. No relationship 
was found between fasting HDLz-C concentrations and the totailipaemic response in 
either trial. 
The apo AI and apo B response to the meal did not differ between trials but 
concentrations were elevated (p<O.OS) 1 hour after ingestion and remained elevated 
throughout the postprandial period (p<0.05). 
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Time (h) 0 I 2 3 4 S 6 
TC Control 4.S4±O.20 4.71±O.19 4.69±O.20 4.66±O.19 4.67±O.20 4.70±O.20 4.77±O.19 
(mmol.l-1) Exercise 4.4I±O.18 4.61±O.19 4.S6±O.18 4.61±O.18 4.S8±O.18 4.6S±O.20 4.70±O.19 
HDL-C Control 1.01±O.O6 1.03±O.O6 I.OO±O.06 O.99±O.O6 O.99±O.O6 1.01±O.O6 1.0S±O.06 
(mmo1.J-l) Exercise 1.0S±O.OS 1.07±O.OS I.03±O.OS 1.07±O.OS* 1.06±O.OS* 1.06±O.OS* 1.11±O.OS 
HDLi-C Control O.29±O.O6 O.32±O.O6 O.33±O.O6 O.30±O.OS O.30±O.OS O.29±O.OS O.3l±O.O6 
(mmol.l-l) Exercise O.36±O.O3 O.3S±O.04 O.39±O.O3 O.37±O.O4* O.34±O.O4 O.34±O.O4 O.36±O.O3 
-
ApoAI Control 1.33±O.O6 1.38±O.O6 l.38±O.O6 1.36±O.O6 1.37±O.O6 1.36±O.O6 1.39±O.O6 IV 
.j>. (g.I-1) Exercise 1.32±O.OS 1.36±O.OS 1.36±O.O7 1.37±O.O6 1.37±O.O6 1.37±O.O6 1.38±O.O6 
ApoB Control O.93±O.OS O.96±O.OS O.98±O.OS O.97±O.OS O.98±O.OS O.96±O.OS O.97±O.OS 
(g.I-1) Exercise O.90±O.OS O.94±O.OS O.94±O.OS* O.94±O.O4* O.93±O.OS* O.9S±O.OS O.9S±O.OS 
* significantly different from control trial, p<O.OS 
Table 6.S Serum cholesterol, lipoprotein and apolipoprotein concentrations before and after the high fat meal in the control and 
exercise trials. Mean±SEM. 
Serum insulin concentration was elevated 1 hour after consumption of the meal, 
significantly only in the control trial. Figure 6.7 shows the insulin concentration 
throughout the postprandial period in both trials and Table 6.6 shows the fasting and 
peak serum insulin concentration and area under the insulin/time curve. Although there 
were no significant differences between the two trials in either of these indices of the 
magnitude of the insulin response to the high fat meal, both the peak insulin 
concentration and the area under the insulin/time curve were higher in the control trial 
by 14% and 22% respectively. 
Control 
Exercise 
Table 6.6 
Fasting insulin Peak insulin Insulin area 
(fLU.ml-I ) (IlU.ml-I ) (J1U.mI-1.h) 
4.01±1.32 20.8±2.7 24.5±11.3 
3.85+1.55 18.0+3.5 19.2+13.0 
Fasting and peak serum insulin concentrations and the area under the 
insulin/time curve in the control and exercise trials. Mean±SEM 
Figure 6.8 shows the serum glucose concentration throughout the 6-hour postprandial 
observation phase, with concentrations increased after ingestion of the meal in both 
trials, remaining elevated at 2 hours and falling gradually throughout the 6 hours. 
Figure 6.9 shows the FFA concentrations following the high fat meal which fell 
(p<O.OI) after consumption ofthe test meal in both trials and were restored to fasting 
values by 4 hours after ingestion. There was no change in estimated plasma volume 
over the 6-hour period in either trial (Control: -1.7±1.3%, Exercise: -0.1±1.2%, 
compared with initial values) and therefore no changes were made to the concentrations 
of lipids and lipoproteins to correct for this. 
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Figure 6.7 Serum insulin concentrations before and after the high fat meal. Mean±SEM 
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6.4 Discussion 
The major finding of this study was that brisk walking prior to ingestion of a high fat 
meal reduces postprandial lipaemia. The low intensity of the exercise employed in this 
study (30.1±1.6% V02max) is clearly demonstrated by the low heart rate, blood lactate 
concentration and respiratory exchange ratio throughout the brisk walk. This study was 
designed to examine the influence of a single bout of brisk walking as it may be 
performed in "real-life" outside of the laboratory, rather than exercise at a given 
intensity, on postprandial lipaemia. There was no relationship between the relative 
exercise intensity during the brisk walking (range 24.2 - 43.7% V02max) and the 
change in the lipaemic response in this study. 
In accordance with the observation of Patsch (1987) that the magnitude of postprandial 
lipaemia shows by far the greatest interindividual variability among all parameters of 
lipid transport in normolipidaemic individuals, there was a 5-fold variation in the total 
lipaemic response in both the control and exercise trials of the present study (range 2.59 
- 14.13 mmol.1-1.h control, 1.56 - 8.06 mmo1.l-l.h exercise). The totallipaemic 
response was attenuated by 31 % in the exercise trial as compared to the control trial. 
This is most likely due to some improvement of the TAG clearance system caused by 
the exercise bout and probably involves the activity of lipoprotein lipase (LPL), the 
rate-limiting enzyme for catabolism of TAG-rich lipoproteins, which is located at the 
endothelial surface of capillaries in muscle and adipose tissue (EckeI1989). 
This hypothesis is consistent with the fmdings of several previous studies (Taskinen et 
al. 1980, Lithell et al. 1984) which have shown increased activity of LPL persisting up 
to 18 hours (Kantor et al. 1984) after the performance of a single bout of exercise. 
Further, a study conducted by Lithell and co-workers (1978) found a correlation 
between muscle LPL activity and the removal rate of chylomicrons, but no correlation 
between this and LPL activity in adipose tissue. They conclude that it is increased LPL 
activity in the large mass of skeletal muscle that is most important in determining the 
increased removal of TAG from the circulation, despite the higher activity of LPL in 
adipose tissue (Borensztajn 1987). 
The mechanism by which muscular work leads to an increase in the LPL activity of 
skeletal muscle and adipose tissue is not clear. Since both glucagon and catecholamines 
are known to increase during exercise and, also, to stimulate muscle LPL activity they 
could afford one possible explanation. The activity of LPL in both adipose tissue and 
skeletal muScle appears to be insulin dependent (Farese et al. 1991) with an increase in 
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insulin concentration resulting in lower LPL activity in adipose tissue and higher 
activity of this enzyme in skeletal muscle. The lower postprandial insulin concentrations 
in the exercise trial of the present study than the control trial, do indeed suggest 
improved insulin sensitivity in the recovery from the bout of walking than in the non-
exercised state. This increase in insulin sensitivity accompanying the exercise could be 
a possible mechanism resulting in an increase in LPL activity in skeletal muscle. 
These studies are, however, exclusively of high intensity exercise and it is not known 
whether LPL activity is increased by a single bout of brisk walking, the more modest 
form of exercise effective in attenuating postprandial lipaemia in the present study. 
During low intensity exercise the muscle derives energy mainly from circulating free 
fatty acids and from its own TAG store (Romijn et al. 1993). Indeed, this recent study 
shows that the total lipid oxidation during exercise at 85% V02max is the same as that 
during exercise at 25% V02max. In the present study the net estimated utilisation of fat 
during the 2 hour bout of brisk walking was calculated as 31±5 g, using indirect 
calorimetry. 
Oscai and colleagues (1990) has suggested that as a result of the net utilisation of fat 
during low intensity exercise the TAG muscle store is depleted and is restored during 
recovery by an increase in LPL activity in muscle cells that enables the tissue to take up 
circulating TAG more readily than in the non-exercised state. The fmding that exercise 
increases the capacity to clear TAG from the circulation provides suggestive evidence 
that LPL is involved in the restoration of muscle TAG stores reduced by exercise. 
A contributing factor to the decreased lipaemic response in the exercise trial'may be the 
fasting TAG concentration, which was 15% lower the morning after the exercise than 
in the non-exercise day. The magnitude of postprandial lipaemia has been shown to be 
directly related to the fasting serum TAG concentration (NesteI1964) and this 
relationship is believed to reflect direct competition for a common clearance pathway 
between hepatic and intestinally derived TAG-rich lipoproteins (Brunzell et al. 1973). 
However, the lower fasting TAG concentration found in the exercise trial does not 
contribute to the between trial difference in the totallipaemic response, as this area 
under the TAG curve was nonna1ised to the fasting concentration. This adjustment 
assumes a fixed relationship between fasting TAG concentrations and those determined 
at each individual time point, but testing this further using a regression approach is 
difficult to justify given that the data is not normally distributed. 
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Sady and colleagues (1986) reported increased removal of intravenous TAG after 
performance of a marathon, measured 18 hours after completion of the race. The 76% 
increase in the removal rate of TAG was associated with a 46% increase in lipoprotein 
lipase activity. Annuzzi and co-workers (1987) also examined the removal rate of 
intravenous TAG, immediately after exercise and one day after the exercise bout. They 
report no increase in TAG removal rate immediately following exercise but the day after 
exercise found a 66% increase. They conclude that prolonged exercise (3 hours) 
produces an increase in the removal rate of intravenously introduced TAG from the 
bloodstream, but that some time is required following the exercise before it is manifest. 
The mechanism for this delayed increase in lipoprotein lipase activity is unknown at the 
present time. 
Prior to this investigation, a study in our laboratory examined the effect of 2 hours of 
moderate exercise (1 hour cycling, 1 hour jogging) on the magnitude of postprandial 
lipaemia in the recovery from exercise, 12-15 hours after completion of the exercise 
bout in 8 normolipidaemic young physically active adults (Aldred et al. 1993). The total 
lipaemic response was 30% lower the day after the exercise had taken place compared 
to when subjects had rested, similar results to those of the present study. However, 
Cohen and colleagues (1989) investigated the influence of a single bout of exercise 
(intensity not stated) lasting 1 hour and performed 12 hours before oral fat tolerance 
testing in 10 sedentary men. They report that postprandial lipaemia was slightly, but not 
significantly, reduced by exercise. A possible reason for the different finding in the 
present study could be greater muscle TAG utilization (Hurley et al. 1986) and free 
fatty acid oxidation (Turcotte et al. 1992) in our physically active subjects than in the 
sedentary individuals studied by Cohen. 
In accordance with the findings in Chapter 5 of this thesis, but in contrast to the earlier 
data of Pats ch and co-workers (1983), we did not observe an inverse relationship 
between indices of alimentary lipaemia and fasting HDL or HDL2 cholesterol 
concentrations in either trial. This lack of relationship may be a reflection of the 
relatively small numbers of individuals studied in the present investigation. 
Alternatively, it may be due to the age of the subjects, as a relationship may not be 
readily evident in such young individuals, as discussed in Chapter 5. 
At the end of the 6 hours, total HDL cholesterol concentrations were increased in both . 
trials although HDL2 cholesterol concentrations remained unchanged. In the literature 
there have been divergent findings with regard to HDL subfractions after a fat load: 
increased HDL2 and decreased HDL3 (Schlierf et al. 1987, Baggio et al. 1980), 
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increases in both HDL2 and HDL3 (Patsch et al. 1987) and increased HDL2 (Kashyap 
et al. 1983) have all been reported. This lack of consensus may be explained by the fact 
that the major alterations are reported to be observed 5 -10 hours after ingestion (Tall 
1986), beyond the duration of this study and many of those referred to above. Indeed, 
the half-life of HDL particles in plasma is approximately 5 days (Durstine and HaskeII 
1994), supporting this suggestion. 
Another source of variation in TAG metabolic capacity may be the hormonal fine tuning 
achieved when approaching the postprandial state (Miesenbock and Patsch 1992). In 
the present study there was no difference in fasting insulin concentrations between the 
control and exercise trials (4.0±1.3 IlV.ml-1 vs 3.9±1.6IlV. ml-l, respectively). After 
having consumed the test meal, however, the insulin concentration I hour after 
ingestion was 22.1±16.5% greater in the control trial than in the exercise trial 
(l6.9±3.6IlV. ml-l vs 13.2±4.0 IlV. ml-I, respectively). This reduced insulin 
concentration in response to ingestion after having performed 2 hours of brisk walking 
is in accordance with the fmdings of Heath and co-workers (1983) who found a 
blunted insulin response in subjects who underwent an oral glucose tolerance test after 
a single bout of exercise as compared to a similar test after 10 days of detraining. 
Insulin has a central role in the regulation and co-ordination of postprandial lipaemia 
(prayn 1993). Indeed, when insulin resistance renders postprandial insulin levels 
insufficient for suppression of VLDL secretion by the liver, hepatic TAG-rich particles 
superimposed on chylomicrons will augment postprandial lipaemia. Thus the lower 
insulin concentrations in the exercise trial of the present study may have contributed to 
the lower Iipaemic response seen in this trial, possibly due to the suppression of VLDL 
particles from the liver, as it is known that VLDL-TAG contributes significantly to 
alimentary lipaemia (Schneeman et al. 1993). 
In conclusion, the results of this study show that in physically active, normolipidaemic . 
young adults, one bout of brisk walking reduces the lipaemic response to a high fat 
meal consumed 15 hours into recovery. 
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7 THE MAGNITUDE OF POSTPRANDIAL LIPAEMIA IN YOUNG, 
NORMOLIPIDAEMIC MALES AND FEMALES. 
7.1 Introduction 
In the previous two chapters (5 and 6) of this thesis it appeared that the lipaemic 
response of the females to the high fat meal tended to be lower than that of the males. 
Given the small number of subjects in each of these studies, this chapter examines the 
data from both of these studies to compare and examine postprandial lipaemia in males 
and females with a larger group. More than 30 years ago it was observed that females, 
after a standard oral fat load, show lower postprandial lipaemia than males (Ackennan 
and Zilversmit 1953, Shah et al. 1963). Since then other researchers have made similar 
observations (Baggio et al. 1980, Cohn et al. 1988a). 
A rationale for a lower lipaemic response in women may be advanced as it is reported 
that women have higher HDL-C concentrations than men, probably influenced by 
honnonal status (Bush 1991). If, as postulated by Patsch and colleagues (1992), the 
concentration of HDL-C is dependent on the metabolism of TAG-rich lipoproteins, the 
higher HDL-C concentrations observed in women may result from an increased 
catabolism of TAG-rich lipoproteins and hence females may display lower postprandial 
TAG concentrations following a fat containing meal than males. Indeed, Zilversmit 
(1976) suggested that "a greater intensity of postprandial hypertriglyceridemia in males 
should be considered as a possible atherogenic mechanism". 
The purpose of this study was therefore to examine any differences in postprandial 
lipaemia between young normolipidaemic males and females. 
7.2 Methods 
The data obtained from the twenty (10 male, 10 female) different subjects who 
participated in the studies in Chapters 5 and 6 (control trials) of this thesis are used 
here. All subjects were nonnolipidaemic, took part in regular physical activity, were 
non-smokers and not taking any drugs known to affect lipoprotein metabolism. When 
subjects were involved in both studies in Chapter 5 and 6, the data obtained from the 
first oral fat tolerance test performed was used. The physical characteristics and fasting 
lipid and lipoprotein variables of the subjects are shown in Table 7.1 and 7.2. 
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Age Body mass Height BM! V~max 
(~ears) (k/l) (m) (k/l.m-2) (ml.k/l-1.min·1) 
Males (n=1O) 26.7±1.4 76.6±3.1 1.78±0.02 24.1±0.7 56.2±2.5 
Range 22.8 - 35.2 64.8 - 91.3 1.68 - 1.85 21.7 - 28.5 41.3 - 66.5 
Females (n=lO) 24.8±L1 62.2±2.3* 1.63±O.01 * 23.5±0.7 42.8±2.5* 
Range 21.6 - 31.7 57.1 - 77.4 1.59 - 1.65 19.5 - 25.4 35.1 - 57.8 
*significantly different from males, p<O.Ol. 
Table 7.1 Physical characteristics of the male and female subjects. Mean±SEM. 
TAG TC HDL-C HDLz.C Insulin 
(mmol.l·1) (mmol.l-1) (mmol.l-1) (mmol.l·1) 
Males (n=lO) 0.81±0.06 4.32±0.30 L11±0.06 0.37±0.05 L88±0.68 
Range 0.59 - 1.11 2.26 - 5.50 0.82 - 1.39 0.20 - 0.62 0.50 - 6.98 
Females (n=lO) 0.86±0.06 4.12±0.20 1.07±0.06 0.38±0.05 3.73±0.91 
Range 0.58 - 1.25 3.61 - 5.36 0.70 - 1.27 0.17 - 0.68 0.50 - 8.18 
Table 7.2 Fasting concentrations of serum lipid, lipoprotein parameters and insulin 
in male and female subjects. Mean±SEM. 
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As described in Chapter 5 (5.2.2) and 6 (6.2.3) of this thesis, subjects ingested the test 
meal and then rested for 6 hours with venous blood samples obtained hourly for 6 
hours. The test meal was prescribed according to body mass (1.2g fatlkg body mass), 
as described in Chapter 3 (3.11.2). Table 7.3 shows the amount offat, carbohydrate, 
protein and energy provided by the test meal for males and females. 
Fat (g) Carbohydrate (g) Protein (g) Energy (MJ) 
Males (n=lO) 93.4±3.8 103.6±4.2 l8.l±O.7 5.46±O.23 
Females (n=lO) 76.l±2.9* 84.5±3.3* l4.7±O.6* 4.42±O.17* 
* significantly different from males, p<O.01. 
Table 7.3 The amount of fat, carbohydrate, protein and energy provided by the 
test meal. Mean±SEM. 
Serum was analysed for TAG, TC, HDL and HDL3 cholesterol and insulin, as 
described in the methods section of the previous two chapters (5.2.4 and 6.2.4). 
Differences between males and females were examined using the Mann-Whitney U test. 
Spearman rank correlation coefficients were calculated to examine the relationships 
between variables. 
7_3 Results 
The serum TAG concentrations before and following ingestion of the high fat meal in 
males and females are shown in Figure 7.1. The totallipaemic response was 26% 
lower in the females than in the males and the peak TAG concentration was also lower 
in the females (11 %) than in the males, as shown in Table 7.4. These differences were 
however not significant. 
There were no major differences in the distribution of apolipoprotein E phenotypes 
between genders. Of the ten male subjects 6 were E3-3, two were E4-3 and two E3-2. 
Of the female subjects 8 were E3-3 and two E4-3. 
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Serum TAG concentrations before and following ingestion of a high fat meal in male 
and female subjects. Mean±SEM. 
• 
Males 
Females 
Peak TAG TAG Area 
(mmol.l-1) (mmol.l-1.h) 
Males (n=lO) 2.46±O.38 6.39±1.19 
range 0.96 - 4.64 2.33 - 14.12 
Females (n=lO) 2.20±O.26 4.73±O.88 
range 1.35 - 3.62 1.62 - 10.48 
Table 7.4 Peak TAG concentration and area under the TAG/time curve of male and 
female subjects. Mean±SEM. 
There was a relationship between the fasting TAG concentration and the totallipaemic 
response (rho = 0.39, p<0.05) and peak TAG concentration (rho = 0.59, p<O.Ol). 
There was also an inverse relationship between the peak TAG concentration attained 
and the fasting concentration of HDL-C (rho = -0.40, p<0.05). 
7.4 Discussion 
The female subjects in this study tended to have a lower lipaemic response to the high 
fat meal than the males. However, these differences did not reach statistical 
significance. This observation has been previously reported in several studies (Mattock 
et al. 1981, Kashyap et al. 1983, Weintraub et al. 1987b, Cohn et al. 1988a). Small 
subject numbers, as in the present study, have however limited the conclusions of these 
interesting observations. 
Postprandial TAG concentrations are dependent on both the rate of appearance of TAG 
in the circulation (absorption) and the rate of disappearance of TAG (clearance). There 
is no evidence to suggest that rates of TAG-absorption are different in men and women 
and therefore it is more likely that the difference in postprandial lipaemia be due to a 
difference in the TAG-clearance system. 
One possible explanation could be the higher adipose tissue LPL activity reported in 
women compared to men (Nikkila et al. 1978b, Taskinen and Kuusi 1986), when this 
is measured directly in biopsied human fat In the study by Nikkila and co-workers 
(1978b) adipose tissue LPL activity was elevated in the female subjects compared to the 
males irrespective of whether the values were expressed per tissue weight (7.8±1.1 v 
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3.0±0.4 ).tmol FFA.h-1g-1), per fat cell (5.4±{).9 v 1.7±{).2 ).tmol FFA.h-l per cell x 
106) or per total body fat (108±17 v 55±8 ).tmol FFA.h-l per total body fat). These 
researchers further suggest that the excess removal capacity of women is located in the 
adipose tissue, as no differences were found in the activity of LPL in skeletal muscle of 
men and women. However, in contrast, another researcher found that although females 
had a faster clearance of chylomicrons than men during an intavenous fat tolerance test 
they did not have higher skeletal muscle or adipose tissue LPL activity (Lithell et al. 
1978). 
However, it is possible that a combination of the larger total mass of fatty tissue 
generally found in women and/or an increased LPL activity in that tissue compared to 
men may account for some of the difference in lipaemia seen between genders in the 
present study. In this study estimations of body fatness were not assessed which may 
have provided ·usefu1 information regarding any relationhip between fatty tissue mass 
and the extent of alimentary lipaemia. It is not known whether the difference in lipaemia 
following a high fat meal between men and women is wholly or partly partly 
attributable to differences in body fatness. 
It is also possible that postprandial lipaemia may be influenced by the stage of the 
menstrual cycle in women, although to the author's knowledge there is no direct 
experimental evidence confmning this. There is however limited evidence in humans 
that LPL may be affected by oestrogen and progesterone (Cryer 1987). However, 
when LPL activity was measured in normal weight women during the follicular (day 
10-12) and luteal (day 24-25) phases of their menstrual cycle, LPL activity was 
unchanged (Rebuffe-Scrive et al. 1985). Preliminary cross-sectional evaluation of 
normal weight women also revealed no differences in gluteal adipose tissue LPL 
activity between menstrual cycle phases (Eckel1987). In this study we did not attempt 
to control for the stage of the menstrual cyle in determining postprandial lipaemia in the 
female subjects. The available information does not allow us to answer whether the 
possible variation in postprandial lipaemia due to the stage of the menstrual cycle is less 
than the difference shown between men and women. 
Given the close metabolic relationship between HDL-C and TAG-rich lipoproteins it is 
possible that higher HDL-C and HD~-C concentrations in women may be a 
consequence of a lower alimentary lipaemia as compared to males. Indeed, Nikkila and 
colleagues (1978b) suggest that this increased activity of LPL in adipose tissue and 
hence increased rate of TAG-rich lipoprotein catabolism might be one of the factors that 
determine the concentration of HDL-C in the plasma and account at least in part for the 
sex difference usually reported in HDL concentrations (Bush 1991). However, it can 
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be seen from Table 7.2 that there was no difference in fasting serum HDL-C or HD~­
C concentrations between men and women in the present study. It is also possible that a 
difference in fasting TAG concentrations between males and females could account for 
a difference in the magnitude of postprandial lipaemia, given the relationship between 
the fasting TAG concentration and the extent of alimentary lipaemia. However, there 
were no differences in fasting TAG concentrations between the males and females in 
the present study. 
The distribution of apo E phenotypes in this study was comparable with that found in a 
general Caucasian population (Ehnholm et al. 1986, Dallongeville et al. 1992). When 
small numbers of subjects are utilised in studies examining postprandial lipaemia it is 
possible that any differences in apo E phenotype distribution between groups may 
influence results. In the present study however there was no difference in this 
distribution between males and females. 
The magnitude of postprandial lipaemia has been reported to be lower in athletes as 
compared to sedentary controls (Merrill et al. 1989, Cohen et al. 1989), thus a 
difference in the training status of the female and male group could be responsible for 
the lower lipaemia in the female group, particularly as the well-trained utilize muscle 
TAG to a greater extent during exercise than the sedentary (Hurley et al. 1986). In the 
present study no information conceming the current training status of subjects was 
obtained. 
It can be seen from Table 7.3 that the mean fat content of the test meal for the female 
subjects was lower than that of the males, due to the lower body mass of the females. It 
is thus plausible that the lower lipaemic response of the females in this study may have 
resulted from the lower amount of fat in the meal of these subjects. The amount of fat in 
the test meal was prescribed according to body mass in this study, as performed by 
others examining postprandial Jipaemia (Cohn et al. 1988a, Mattock et al. 1981). Other 
researchers have prescribed test meals in relation to body surface area, as are many 
drugs, to adjust for variations in blood volume (patsch et al. 1983). In the present 
study prescription of the test meal by either of these methods would have resulted in the 
females ingesting a smaller amount of fat than the males, as females have a lower body 
mass and are shorter than the males. 
The aim of administering an oral fat tolerance test is to provide each subject with an 
amount of food which is both manageable and yet provides a large physiological 
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challenge. If the range of body mass of the subjects in one study is small then meeting 
these demands of an oral fat tolerance test can be met However, if there is a large range 
of body mass in a group the heaviest individual may not be able to consume all of the 
meal and for the lightest person the meal may not provide a sufficient challenge. Yet 
another possibility may be to adminster the test meal in relation to estimated fat free 
mass. Indeed, the method of prescription of a test meal is particularly important when 
examining postprandial lipaemia in cross-sectional studies rather than in studies 
involving 2 trials where the differences between trials in one subject is examined. 
Although some researchers (Cohen 1989) have recommended prescription of a standard 
test meal to all subjects regardless of mass or body surface area, it would seem that 
some method of prescription is necessary to account for the obvious difference in body 
size between individuals. 
The postprandial TAG concentrations in the present study were similar in men and 
women until 3 hours after ingestion of the test meal (Figure 7.1), with the difference 
between men and women becoming more apparent during the later phase of 
postprandial lipaemia. It is of interest to note that it was the late phase (8 hours after 
ingestion of a test meal) that Patsch and co-workers (1992) found to be most 
discriminating in defming the presence of CHD. 
To be able to answer these questions, studies investigating postprandial lipaemia in 
larger numbers of men and women need to be conducted, particularly given the large 
inter-individual variation in the lipaemic response to a high fat meal. This finding of a 
possible difference in the extent of lipaemia following a fat meal in men and women 
does however strengthen the argument for conducting more research on postprandial 
lipaemia in women (Taylor and Ward 1993) as well as in men. 
The results of this study showed that postprandial lipaemia tended to be lower in 
females than in males, although the difference was not statistically significant 
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8 THE INFLUENCE OF 12 WEEKS OF BRISK WALKING ON 
POSTPRANDIAL LIPAEMIA IN PREVIOUSLY SEDENTARY 
WOMEN AGED 40-55 YEARS. 
8.1 Introduction 
The previous two studies reported in this thesis have shown that a single bout of 
walking attenuates the lipaemic response to a high fat meal in the recovery from 
exercise. There may, however, be more long lasting effects of regular exercise on 
postprandial lipaemia. Adaptations of skeletal muscle to endurance training provide two 
main sources of evidence that there may be chronic adaptations by which exercise 
contributes to the lower postprandial lipaemia seen in athletes as compared to sedentary 
controls (Cohen et al. 1989, Merrill et al. 1989). Firstly, there is evidence that 
endurance training results in an increased capillary network in skeletal muscle (lngjer 
1979) and this may be responsible for the increased LPL activity seen after training 
(Svedenhag et al. 1983). Secondly, endurance training enhances the contribution of 
free fatty acids to energy metabolism during exercise attributable largely to increased 
lipolysis of skeletal muscle TAG (Hurley et al. 1986). 
In order to distinguish the influence of the last exercise session from any possible 
chronic effects of training on postprandial lipaemia, an interval of 48 hours was 
selected between the last exercise session and the oral fat tolerance test in this 
investigation. Therefore, this randomised control study will help to define if the 
attenuation of postprandial lipaemia following exercise is transient, resulting acutely 
from each exercise bout alone or whether there are also contributing chronic adaptations 
to exercise. 
Few longitudinal studies have examined the influence of exercise training on 
postprandial lipaemia (Altekruse and Wilmore 1973, Zauner and Benson 1977, Wirth et 
al. 1985, Weintraub et al. 1989, Yanes et al. 1989) and three of these were in patient 
groups. Exercise progammes have been rather intense, the total number of subjects 
small and fIndings have been conflicting. The effects of a training programme of brisk 
walking on postprandial TAG metabolism have not been previously reported. 
Additionally, all such studies have been of men, despite the paucity of information 
concerning the influence of exercise on risk factors for coronary heart disease in 
women. The case for a study in women is strengthened by a recent report that raised 
non-fasting TAG concentrations are an independent risk factor for mortality from this 
disease in women (Stensvold et al. 1993). 
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The purpose of this study, therefore, was to examine the influence of a programme of 
brisk walking on postprandial lipaemia in normolipidaemic middle-aged women, a 
group with very low levels of physical activity (National Fitness Survey 1992) and in 
whom this form of exercise is known to improve endurance fitness (Hardman et al. 
1992). 
8.2 Methods 
8.2.1 Study Design 
The study was a randomly controlled exercise intervention trial, conducted with the 
approval of the University's Ethical Advisory Committee. All measurements were made 
at baseline and, with the exception of preliminary tests, repeated after 12 weeks. 
Randomisation to either the brisk walking group (n=13) or the control group (n=13) 
took place after baseline tests were completed. Groups were stratified by age because 
the magnitude of postprandial lipaemia following ingestion of a high fat meal is greater 
in older people (Cohn et al. 1988b, Kransinski et al. 1990b). Women allocated to the 
control group were offered the opportunity to take part in a similar exercise programme 
following completion of the study. 
8.2.2 Subject recruitment 
Subjects were recruited for this stUdy by advertising locally in the library, community 
centre and newspapers. Subjects were accepted to participate in the study on a first 
come :first served basis providing that the following criteria were met; 
(1) Female, aged 40-55 years. 
(2) Non-smokers. 
(3) Not currently involved in a programme of regular exercise. This was assessed 
via a questionnaire (Appendix 21). 
(4) A blood pressure of less than 160 mm Hg systolic and 95 mm Hg diastolic. 
(5) Free from a history of hypercholesterolaemia (total cholesterol < 7.8 mmo1.1·1). 
(6) Free from a history of hypertriglyceridaemia (fasting TAG < 2.3 mmo1.1-1). 
(7) A body mass index of less than 30 kg.m·2. 
(8) Free from a history of diabetes. 
(9) Free from a clinical history of bleeding or coagulation disorders or any other 
physician-diagnosed cardiovascular disease. 
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These criteria were assessed by administration of a medical history questionnaire 
(Appendix 19). In tota126 subjects were recruited to participate in the study after 
careful explanation of all the procedures involved and obtaining informed consent 
(Appendix I). 
Confidential interviews prior to the study revealed that 11 subjects were pre-
menopausal (5 walkers, 6 controls), 5 peri-menopausal (3 walkers, 2 controls) and 10 
post-menopausal (5 walkers, 5 controls). Assessment of physical activity status was 
made using a questionnaire (maximum score 100), as shown in Appendix 21. 
8.2.3 Test battery 
All 26 subjects undertook the following series of tests at the beginning of the study: 
(1) Height. 
(2) Body mass. 
(3) Skinfold thickness at 4 sites: triceps, biceps, subscapular and suprailiac, for 
subsequent estimation of body fatness by the method described by Dumin 
and Womersley (1974). 
(4) Circumferences at the waist and hip. 
(5) Submaximal-incremental treadmill walking test. 
(6) Grade lactate treadmill walking test. 
(7) Oral fat tolerance test. 
All of these tests were repeated at the end of the 12 weeks, except the submaximal-
incremental treadmill walking test, as this was simply used as a means of determining 
the protocol for each individual grade lactate treadmill walking test. 
8.2.4 Brisk walking programme 
Subjects randomly allocated to the control group (n=13) undertook to maintain their 
habitual sedentary lifestyle whilst the subjects in the waJking group (n=13) followed the 
exercise programme. Both groups were asked not to make any planned dietary changes 
during the study. The walkers were given an exercise programme to follow which 
involved providing targets for the number of minutes of walking per week. The 
programme was as follows: 
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Week 1 = 60 min 
Week 2 = 80 min 
Week 3 = 100 min 
Week 4 = 100min 
Week 5 = 120 min 
Week 6 = 120 min 
Week 7 = 140 min 
Week 8 = 140 min 
Week 9 = 160 min 
Week 10= 160min 
Week 11 = 180 min 
Week 12 = 180 min 
The duration of the brisk walking programme was 12 weeks. Results from other brisk 
walking training studies in our laboratory (Hardman et al. 1992, Stensel et al. 1994) 
have shown 12 weeks to be a sufficient time period over which one might expect to see 
improvements in endurance fitness in previously sedentary middle-aged adults. 
Subjects were free to organise the walking to suit them. However, there were certain 
requirements, and these included the following: 
(1) Subjects were provided with the opportunity to attend organised walking 
sessions and were asked to attend twice per week if possible, but attendance 
was not compUlsory. 
(2) The minimum length of anyone walking session was 20 minutes and the 
maximum 50 minutes. 
(3) The walking had to be brisk. This was defined as a pace which was faster than 
they normally walked and increased their breathing rate, but could be maintained 
for the duration of the walking session. 
(4) The walking had to be additional to any walking which was normally 
performed. 
Subjects were warned about the dangers of overtraining and were asked to gradually 
increase the number of minutes performed per week and not do too much in the first 
few weeks. Walkers were also advised on footwear and the benefits of walking as 
much as possible on soft surfaces. 
8.2.5 Monitoring of brisk walking programme 
Subjects were asked to attend 2 out of 4 organised group walking sessions per week if 
possible. At attendance heart rate was monitored by short-range telemetry throughout 
the training session. The remaining walking was unsupervised but recorded in diaries 
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which were returned every 2 weeks. A timed "brisk" walk around an athletics track was 
undertaken at the start of the training programme and again after 12 weeks, to provide 
an estimate of each individual's training pace. 
8.2.6 Submaximal-incremental treadmill walking test 
The information from this initial submaximal treadmill test was used to predict each 
subject's V02max (rnl.kg-l.min-l) via a method outlined by Maritz and colleagues 
(1961). For reasons of subject safety V02max was not directly assessed. The 
submaximal exercise test was conducted using tb.e same protocol outlined in Chapter 3 
(3.3.2). Firstly, the average heart rate during the last minute of each of the four stages 
of the test were used as independent variables and matched against the corresponding 
oxygen uptakes to create a simple linear regression equation. The maximum heart rate 
was predicted via Astrand's (1960) equation 210 - (0.65 x age) and used as an 
independent variable to predict the oxygen uptake at maximal heart rate. This value was 
taken to be predicted V02ffiax. 
There are inherent problems in estimating V02max from submaximal exercise data and 
predictions of maximal heart rate. Astrand and Rodahl (1986) note that the standard 
deviation for maximal heart rate within an age group is ±1O beats.min-l, thus V02max 
will be underestimated in some individuals and overestimated in others (for discussion 
see Astrand and Rodahl, 1986: p372-380). Also, emotional factors, nervousness and 
apprehension may affect heart rate during light and moderate intensity exercise resulting 
in erroneous predictions. The sole purpose of prediction of V02max in this study was 
to ensure that the subsequent submaximal exercise test was set at a level which 
represented a similar proportion of functional capacity for each individual. 
In this study the speed of the treadmill was 2.5 or 3 mph and the inclines used were 
0%,2.5%,5% and 7.5% for the four stages of the test. 
8.2.7 Grade-lactate treadmill walking test 
This treadmill test is similar to that reported in Chapter 3 ( 3.3.2) involving walking for 
16 minutes with treadmill inclines selected to elicit 50, 60, 70 and 80% of individual 
predicted V02max for the four stages of the test Each subject walked at approximately 
50% V02rnax for the fIrst four minutes of the test; at 60% V02rnax in the second; 70% 
for the next 4 minutes, and at 80% V02rnax for the fInal four minutes of the test 
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Subjects walked at the same speed as they had in the submaximal treadmill walk. Heart 
rate and RPE were recorded during the last minute of each stage of the test, while 
collections of expired air were taking place. In addition, duplicate 20 ~ thumb prick 
samples of capillary blood were collected at the end of each stage of the test and later 
analysed for lactate. 
From this test the oxygen uptake attained by each subject at a reference blood lactate 
concentration of 3 mmol.1-1 was derived and adopted as a measure of endurance fitness 
which could be directly determined without the need for maximal exercise. This was 
accomplished by plotting oxygen uptake (rnl.kg-1.min-1) against blood lactate 
concentration and interpolating across from the 3 mmol.1-1 point on the blood lactate 
axis. A reference blood lactate concentration of 3 mmol.1·1, as opposed to 2 mmol.1-1, 
was selected, as this concentration was achieved by all the women during last three 
stages of the treadmill test. 
At the end of the 12 weeks, subjects repeated exactly the same test they had completed 
at the beginning. Calibration of the dry gas meter was perfomed, using a Tissot 
spirometer, at the beginning of this study and at the end to ensure consistent 
measurement of gas volumes by this apparatus. This treadmill walking test allowed 
assessment of the physiological and metabolic responses to steady state exercise at four 
different exercise intensities. 
8.2.8 Oral fat tolerance test 
For each of the oral fat tolerance tests, subjects reported to the laboratory after an 
overnight fast and a cannula was introduced to a foreann or antecubital fossa vein. A 
fasted 10 rnl blood sample was then obtained. Subjects ingested the test meal within 15 
minutes and then rested quietly for the following 6 hours. Further 10 rnl blood samples 
were obtained hourly after ingestion for 6 hours. No food or drink except water was 
allowed during this time. Subjects were asked to perform no exercise for 2 days before 
the test. Food intake was weighed and recorded for the 2 days prior to the oral fat 
tolerance trial at the beginning of the study and replicated for the 2 days prior to the 
same test at the end of the study. Subjects also abstained from alcohol for 24 hours 
before each trial. 
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Test meal 
The test meal consisted of cereal, fruit, chocolate, nuts and whipping cream (see 
Chapter 3 for ingredients) and provided 73.0±1.3 g of fat, 81.8±1,4 g of carbohydrate, 
14.3±O.3 g of protein and 4255±75 kJ of energy. The meal was prescribed according 
to fat free mass (1.8g fat/kg fat free mass), as opposed to body mass, in this study. 
This was done in order to provide all the women in this study with an amount of food 
which would be manageable and yet would contain a sufficient amount of dietary fat to 
provide a physiological challenge, given the large range of body mass in this group of 
previously inactive women (51.7 - 87.6 kg). 
8.2.9 Analysis 
Capillary blood samples obtained during the exercise tests were immediately 
deproteinsed and stored at -70' C until assayed for lactate (Appendix 6). Serum was 
separated and an a1iquot was removed and stored at 4' C:::; 3 days prior to analysis for 
HDL-C and HDL:3-C. The remaining serum was stored at -70' C. Serum was analysed 
for TAG, TC, FFA, glucose and insulin in blood samples obtained every hour. Serum 
concentrations of apolipoproteins AI and B were analysed in serum at 0, 2, 4 and 6 
hours following ingestion. The phenotype of apolipoprotein E was determined from 
serum for each individual. The method of analysis for each assay is described briefly in 
Chapter 3 (3.8). 
8.2.10 Statistics 
Changes over the 12 weeks were compared between walkers and controls using the 
Mann Whitney U test The Wilcoxon matched pairs test was employed to examine 
changes over time within one group. Relationships between variables were examined 
using the Spearrnan rank order correlation coefficient 
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8.3 Results 
8.3.1 Adherence to the walking programme 
Of the 13 subjects randomly assigned to the walking group, 11 successfully completed 
all the training and testing. Of the 2 subjects who did not complete training, one 
dropped out because of illness and the other due to work commitments. All control 
subjects returned for testing at the end of the study. The physical characteristics of the 
24 subjects who completed the study are shown in Table 8.1 below. There were no 
significant differences in these parameters between the groups at the beginning of the 
study. The mean score from the physical activity questionnaire was 24±2 in the 
walking group and 22±2 in the control group, out of a possible score of 100. 
Walkers 
(n=l1) 
Controls 
(n=13) 
Table 8.1 
Age Height Body mass BM! V02max 
(years) (m) (kg) (kg.m-2) (m1.kg-l.min -I) 
49.6±1.3 1.61±0.02 64.4±3.0 24.8±1.0 26.4±1.l 
41.5 - 55.1 1.54 - 1.69 51.7 - 77.9 20.3 - 29.2 19.9 - 33.6 
49.l±1.3 1.61±O.01 69.8±2.1 26.8±O.8 24.9±1.1 
41.3 - 55.2 1.55 - 1.68 58.8 - 87.6 23.6 - 33.4 19.7 - 32.5 
Physical characteristics of the walkers (n=ll) and controls (n=13) who 
completed the brisk walking study. Mean±SEM and range. 
Actual adherence to the walking programme is shown in Figure 8.1. This shows the 
mean number of minutes walked each week during the study compared with the targets 
set. For the group as a whole, the average number of minutes of walking performed 
each day over the 12-week period was 21±I minutes (range 17 - 27 minutes). This 
amounted to a mean distance walked per week of 16.3±0.8 km (range 12.7 - 21.7 km) 
or IO.I±O.5 miles (range 7.9-13.5 miles), calculated using a mean walking pace of 
1.79±O.02 ms-} (4.03±O.04 mph) assessed by the I-mile timed walk. 
The results of the I-mile timed walk showed subjects to be walking at a speed of 
1.75±O.02 ms-} (3.93±O.04 mph) at the beginning of the study and 1.84±O.03 ms-I 
(4.14±0.06 mph) at the end of the 12 weeks. 
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Minutes of walking per week perfonned throughout the 12-week 
training programme. Mean±SEM. 
Walkers attended the supervised training sessions an average of 1.5±O.2 times per 
week. During these organised walking sessions a mean heart rate of 132±3 (range 115-
152) b.min-l was recorded. This relate.s to an exercise intensity of 74.3±2. 1 % (range 
62.9-85.7) of predicted maximal heart rate. 
8.3.2 Apolipoprotein E phenotypes 
The frequency of each apolipoprotein E phenotype in each group is shown in Table 8.2 
below. There were no major differences in the distribution of apoIipoprotein E 
phenotypes between the groups. 
Group 3-3 3-2 4-4 4-2 4-3 2-2 
Walkers 9 0 0 1 1 0 
Controls 12 0 0 0 1 0 
Table 8.2 The frequency of phenotypes ofapoIipoprotein E in walkers (n=l1) and 
controls (n=13). 
8.3.3 Changes in body composition measurements 
The results in Table 8.3 show the body mass, fat mass, body composition and 
distribution of body fat as described by the ratio of the circumference at the waist and 
hip (waist:hip) at the beginning and end of the study_ Body mass decreased in the 
walkers by U±O.7 kg and increased in the controls by l.o±O.5 kg. This change in 
body mass was significantly different between walkers ahd controls. The change in 
body fatness as measured by the sum of four skinfolds was also significantly different 
between the two groups. This decreased in the walkers by 7.0±3.5% and increased in 
the controls by 3.2±3.4 %. No changes were found in the waist:hip ratio. 
Figure 8.2 shows the changes in body mass and fat mass for each individual in the 
control and walking groups over the period of the study. In the walking group 7 out of 
11 decreased in body mass and fat mass, whereas 10 of the control group increased 
The changes in fat mass and body mass were significantly different between walkers 
and controls. 
149 
Variable Grou2 Pre-training Post-training 
Bodymass* Walkers 64.4±3.0 63.4±3.0 
(kg) Controls 69.8±2.1 70.8±2.4 
SSF* Walkers 83.2±9.7 76.4±9.0 
(mm) Controls 100.3±6.4 104.6±6.7 
Body fat'" Walkers 38.0±1.9 36.9±1.8 
(%) Controls 40.9±0.8 41.4±1.0 
Fat mass'" Walkers 2S.0±2.3 23.9±2.2 
(kg) Controls 28.7±1.4 29.S±l.S 
W:Hratio Walkers 0.77±0.01 0.79±0.01 
Controls O.77±O.OI 0.78+0.01 
'" change over time significantly different between walkers and controls, (p<O.OS) 
Table 8.3 Body mass and indices of amount and distribution of body fat in walkers 
(n=ll) and controls (n=13). Mean±SEM. 
ISO 
..... 
VI 
..... 
Il Body mass 
(kg) 
Il Fat mass 
(kg) 
5 
4 
3 
2 
I 
0 
-I 
-2 
-3 
-4 
-5 
-6 
-7 
5 
4 
1:1 Walkers 
2 3 4 5 6 7 8 9 10 11 
1 2 3 4 5 6 7 8 9 10 11 
Subject number 
Il Body mass 
(kg) 
<l Fat mass 
(kg) 
5 
4 
3 
2 
I 
0 
-1 
-2 
-3 
-4 
-5 
-6 
-7 
5 
4 
3 
2 
1 
o 
-1 
-2 
-3 
-4 
-5 
-6 
1 2 
I!I Controls 
3 4 5 6 7 8 9 10 11 12 13 
-7~-------------------------1 2 3 4 5 6 7 8 9 1,0 11 12 13 
Subject number 
Figure 8.2 Changes in body mass and fat mass for each individual in the walking (n=ll) and control groups (n=13) during the study. 
8.3.4 Cardiovascular and metabolic adaptations to brisk walking 
The heart rate attained during the treadmill walking test is shown in Table 8.4 and 
Figure 8.3. Heart rate was markedly lower in the walkers and slightly lower in the 
controls post-training. The reduction in heart rate during the fmal stage of the test was 
9±3 beat.min-1 (6.1±2.0%) in the walkers and only 1±2 beat.min-1 (O.7±l.O%) in the 
controls. The changes in heart rate in the last stage of the test were significantly 
different in walkers and controls. 
Stage: 1 2 3 4 
WalkersPre 114±3 121±3 132±3 I 47±3 
Walkers Post I05±3 113±3 I 25±3 138±3 
* 
Controls Pre 113±3 124±2 137±2 153±2 
Controls Post 109+3 120±3 135±2 152±2 
* change over time significantly different between walkers and controls. (p<O.05). 
Table 8.4 Heart rate (b.min-1) for walkers and controls during the last minute of 
each stage of an incremental treadmill walking test. Mean±SEM. 
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Figure 8.3 Heart rate at the end of each stage of an incremental treadmill walking 
test pre- and post-training for walkers and controls. Mean±SEM. 
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There was no change in oxygen uptake (mLkg-l_min-l) in ei!her group during the four 
stages of !he grade lactate treadmill test over !he study (Table 8.5). Data for oxygen 
uptake is shown in mLkg-1.min-1 ra!her than l.min-1 due to the changes in body mass 
in !he study (Table 8.2)_ 
Stage 
WalkersPre 
Walkers Post 
Controls Pre 
Controls Post 
Table 8.5 
1 2 3 4 
12.7±O.4 14.6±O.6 16.8±O.7 19.7±O.7 
12.3±O.4 14.D±O.5 16.9±O.7 19.6±O.7 
12.7±O.6 14.7±O.7 17.1±O.9 19.6±O.9 
11.9±O.4 14.1±O.6 16.5±O.8 19.1±O.8 
Oxygen uptake (m1.kg-l.min-l) for walkers and controls during the last 
minute of each stage of an incremental treadmill walking test. 
Mean±SEM. 
The differences between the two groups become more apparent when examining bo!h 
heart rate and oxygen uptake. Figure 8.4 shows the heart rate/oxygen uptake 
relationship from !he grade lactate treadmill test. In !he case of !he controls this 
relationship remained unchanged, whereas the walkers experienced a lower heart rate 
for a given oxygen uptake after !he 12-week walking programme. 
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Figure 8.4 The oxygen uptakelheart rate relationship during a four staged treadmill 
walking test pre- and post-training for walkers (n=ll) and controls 
(n=13). Mean±SEM. 
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The respiratory exchange ratio (R) during the incremental treadmill test is shown in 
Table 8.6. There were no significant changes in the R value obtained in the walkers or 
controls. 
Stage 
WalkersPre 
Walkers Post 
Controls Pre 
Controls Post 
Table 8.6 
1 2 3 4 
0.89±0.04 0.90±0.02 0.95±0.02 1.01±0.02 
0.92±0.05 0.94±0.03 0.94±0.02 0.99±o.02 
0.89±0.03 0.93±0.02 0.97±0.02 1.05±o.03 
0.88+0.03 0.91+0.02 0.96+0.02 1.04±o.03 
The respiratory exchange ratio for walkers and controls during the last 
minute of each stage of an incremental treadmill walking test. 
Mean±SEM. 
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Blood lactate concentration during the grade lactate treadmill test is presented in Table 
8.7 and Figure 8.S. There was a reduction in blood lactate concentration in the walkers 
but not in the control group and these changes in lactate were significantly different 
between walkers and controls at stages 2, 3 and 4 of the test Blood lactate 
concentration during the last stage of the test was reduced by 17.5±6.3% in the walkers 
after training, whereas in the control subjects blood lactate increased by 8.9±4.0% in 
the last stage of the test 
Stage 1 2 3 4 
WalkersPre 2.S±O.3 2.8±OA 3.S±O.3 4.7±O.S 
Walkers Post 2.2±O.3 2.2±O.3 2.6±O.3 3.7±O.3 
* * * 
Controls Pre 2.S±O.3 2.7±O.3 3.7±O.S SA±O.8 
Controls Post 2.S±O.2 3.0±O.3 3.8±OA S.8±O.7 
* change over time significantly different between walkers and controls, p<O.OS 
Table 8.7 Blood lactate concentration (mmol.l·1) for walkers and controls at the 
end of each stage of an incremental treadmill walking test. Mean±SEM. 
Figure 8.6 shows that the relationship between blood lactate concentration and oxygen 
uptake during the grade lactate treadmill test changed in opposite directions for the two 
groups. For the walkers blood lactate concentration was decreased for any given 
oxygen uptake after the 12 weeks of walking. In the control group blood lactate 
concentration was higher for any given oxygen uptake at the end of the study .. 
Therefore, the change in the oxygen uptake attained at a blood lactate concentration of 3 
mmol.1-1 during the study was significantly different between walkers and controls 
(Table 8.8). 
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Figure 8.5 Blood lactate concentration at the end of each stage of an incremental 
treadmill walking test pre- and post-training for walkers (n=ll) and 
controls (n=13). Mean±SEM. 
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Figure 8.6 The oxygen uptake/blood lactate relationship during a four staged 
treadmill walking test pre- and post-training for walkers (n=ll) and 
controls (n=13). Mean±SEM. 
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Pre-training Post-training 
Walkers 
Controls 
16.4±1.l 
16.7±1.0 
18.8±1.0 
14.9±0.6 
Table 8.8 Oxygen uptake (ml.kg-l.min-l) at a blood lactate concentration of 3 
mmoI.1-1 for walkers (n=ll) and controls (n=13) during the grade 
lactate treadmill test. Mean±SEM. Change over time significantly 
different between walkers and controls. (p<O.Ol). 
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8.3.5 Fasting serum lipid, lipoprotein and apolipoprotein concentrations 
Table 8.9 shows the fasting serum concentrations for walkers and controls at the 
beginning and end of the study. There were no significant differences between the two 
groups for any of these parameters at the beginning of the study. Changes over the 
study were significantly different between groups for the TC:HDL-C ratio and LDL-C, 
both of which decreased in the walkers and increased in the controls. 
Fasting serum insulin, glucose and free fatty acid concentrations are shown for both 
groups at the start and finish of the study in Table 8.10. No significant differences were 
apparent at the beginning of the study and no significant changes over the study 
between groups were found for these parameters. 
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Variable GrouE Pre-trainins Post-trainins 
TAG Walkers O.S7±O.12 O.SO±O.ll 
(mmol.l-1) Controls 1.03±O.13 1.09±O.lS 
TC Walkers S.25±O.25 4.99±O.2S 
(mmol.l-1) Controls 5.46±O.16 S.49±O.11 
HDL-C Walkers l.59±O.1O l.56±O.O7 
(mmol.1-1) Controls l.59±O.OS l.51±O.OS 
HDL2-C Walkers O.54±O.OS O.Sl±O.06 
(mmol.l-1) Controls O.S5±O.04 O.47±O.O6 
TC:HDL* Walkers 3.49±O.34 3.32±O.29 
Controls 3.S2±O.19 3.73±O.20 
VLDL-C Walkers O.40±O.O6 O.36±O.OS 
(mmol.l-1) Controls O.47±O.O6 O.49±O.O6 
LDL-C* Walkers 3.25±O.25 3.07±O.26 
(mmol.1-1) Controls 3.40±O.13 3.49±O.14 
ApoAl Walkers 1.33±O.O6 1.29±O.O4 
(g.l-l) Controls 1.2S±O.04 1.32±O.O4 
ApoB Walkers O.S9±O.06 O.S6±O.06 
(g.l-l) Controls O.91±O.O5 O.92±O.O3 
* change over time significantly different between walkers and controls, (p<O.05). 
TableS.9 Fasting serum lipid, lipoprotein and apolipoprotein concentrations in 
walkers (n=11) and controls (n=12) at the beginning and end of the 
study. Mean±SEM. 
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Variable Group Pre-training Post-training 
Insulin Walkers 7.2±O.7 6.2±O.6 
(I1U.ml-1) Controls 6.4±O.8 5.6±O.4 
Glucose Walkers 5.6±O.1 5.4±O.1 
(mmol.l·1) Controls 5.5±O.1 5.4±O.1 
Free fatty acids Walkers O.7l±O.1O O.6l±O.O7 
(mmol.l·1) Controls O.75±O.O7 O.78±O.O6 
Table 8.10 Fasting serum insulin, glucose and free fatty acid concentrations in 
walkers (n=ll) and controls (n=12) at the beginning and end of the 
study. Mean±SEM. 
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8.3.6 Oral fat tolerance 
All of the 11 subjects in the walking group completed the two oral fat tolerance trials. 
Eleven of the 13 control subjects completed the oral fat tolerance trials. Of the two 
controls who did not complete the second test, one could not tolerate the meal and the 
other was ill at the time of scheduled testing. Thus, all data in this section is reported 
for 11 walkers and 11 controls. 
The test meal was well tolerated by these 22 subjects, none experiencing any nausea. 
The mean time taken to eat the test meal during testing at the beginning of the study was 
13.4±O.S minutes (walkers, 13.0±O.7 minutes, controls, 13.9±0.6 minutes) and at the 
end of the study was I1.S±OA minutes (walkers, 11.1±0.7 minutes, controls, 
11.9±O.5 minutes). There was no difference in the time taken to consume the meal 
between walkers and controls in either trial. 
. Figure 8.7 shows the postprandial TAG concentrations over the 6-hour observation 
period during the oral fat tolerance test for the controls and walkers at the beginning of 
the study and at the end. The changes over time were not significantly different between 
the groups at any time point 
Table 8.11 shows the TAG data expressed as area under the TAG/time curve, 
normalised to the zero hour concentration, and peak TAG concentration for each group 
at the beginning and end of the study. No significant changes during the study between 
walkers and controls were found. There was a large inter-individual variation in the 
response to the high fat meal as indicated by the range of values for the area under the 
TAG/time curve and peak concentration attained shown on the table. 
There was a relationship between fasting TAG concentration and the extent of 
postprandial lipaemia as measured by the area under the TAG/time curve at the 
beginning and end of the study (pre-training rho = 0.S3, post-training rho = 0.84, both 
p<O.Ol). There was also a modest inverse relationship between the magnitude of 
postprandial lipaemia and the fasting HDL2-C concentration (pre-training rho = -0.39, 
post-training rho = -0.37, both p<O.OS). 
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Figure 8.7 Serum TAG concentrations during the postprandial period pre- and post-
training in walkers (n=ll) and controls (n=11). Mean±SEM. 
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Group TAG Area (mmol.l·1.h) TAG Peak (mmoU·l) 
Pre Post Pre Post 
Walkers (n=ll) 2A±o.5 2.6±oA 1.6±o.2 1.6±O.2 
range ·0.1 - 4.6 004 - 5.8 0.5·2.9 0.5 - 2.5 
Controls (n=ll) 3.5±o.6 3.6±o.6 1.9±o.3 2.1±O.3 
range 0.9 -7.1 1.1 - 604 0.8·3.6 0.9 - 3.6 
Table 8.11 Area under the TAG/time curve and peak TAG concentration for walkers 
and controls at the beginning and end of the study. Mean±SEM and 
range. 
The serum insulin concentrations throughout the postprandial observation period for 
walkers and controls pre· and post·training are shown in Figure 8.8. Significant 
changes in insulin concentration between walkers and controls were found at all time 
points except 0 and 6 hours. 
The results in table 8.12 show the area under the insulin/time curve, normalised to the 
fasting concentration, and the peak insulin concentration attained during the observation 
period. There was no significant difference between the two groups in either index at 
the beginning of the study. However, changes in both these indices of the insulin 
response during the postprandial period were significantly different between walkers 
and controls. The area under the insulin/time curve decreased by 35.3±15.0 % in the 
walkers and increased by 23.1±9.8 % in the controls when comparing the oral fat 
tolerance test at the beginning of the study and that at the end. Similarly, the peak 
insulin concentration decreased by 16.1±7.6 % in the walkers and increased in the 
controls by 18.8±5A %. 
There was a relationship between the change in the area under the insulin/time curve 
and the change in body mass (rho = 0048, p<0.05), but no relationship between the 
change in the measurement of body fatness (sum of the four skinfold measurements) 
and the change in the insulin area, rho = 0.19. Use of the partial correlation technique 
revealed that there was still a relationship between the change in mass and the change in 
insulin area (rho = 0047, p<0.03) when controlling for the independent variable of 
body fatness (sum of the four skinfolds). 
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Figure 8.8 Serum insulin concentrations during the postprandial observation period 
pre- and post-training for walkers (n=ll) and controls (n=ll). 
Mean±SEM. 
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Group Insulin Area (J.lU.ml-1.h) Peak Insulin (J.lu.ml-1) 
Pre Post Pre Post 
Walkers (n=l1) 80.0±23.5 56.6±13.0 43.o±8.6 34. 8±6. 6 
range 5.0 - 295.2 -3.1 - 138.5 13.0 - 114.5 10.6 - 80.2 
* * 
Controls (n=ll) 57.7±8.3 80.9±12.7 33.4±3.1 42.6±4.7 
range 20.4 - 101.9 37.8 - 161.8 14.3 - 48.8 23.7 - 68.2 
* change over time significantly different between walkers and controls, (p<0.05). 
Table 8.12 Area under the insulin/time curve and peak insulin concentration for 
walkers and controls. Mean±SEM and range. 
Further, use of the analysis of covariance technique revealed similar relationships. 
When mass was used as the covariant there was no difference between the insulin area 
pre- and post-training (p<0.06). However, if the sum of the skinfold measurements 
was used as a covariant there was still a difference in the insulin area (p<0.02). 
Controlling for body fatness does not account for the change in the insulin area between 
walkers and controls. 
A negative relationship was found between the change in oxygen uptake at 3 mmol.l-1 
lactate, an index of change in endurance fitness, and the change in the area under the 
insulin/time curve, rho = -0.48, p<0.05. 
The glucose concentrations during the oral fat tolerance trials are shown on Figure 8.9. 
There was a significant difference in the change over the study in serum glucose 
concentration 2 hours after ingestion of the meal between the two groups. This 
increased by 6.o±2.6 % in the controls and decreased by 6.2±5.0 % in the walkers 
when comparing results from the two oral fat tolerance trials. Table 8.13 shows the 
area under the glucose/time curve, nonnalised to the fasting concentration, as well as 
the peak glucose concentration attained. There was no difference in the change in the 
area under the glucose/time curve between walkers and controls. The change in peak 
glucose concentration during the study was, however, significantly different between 
walkers and controls. 
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Figure 8.9 Serum glucose concentrations during the postprandial observation period 
pre- and post-training in walkers (n=ll) and controls (n=II). 
Mean±SEM. 
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Group Glucose Area (mmoU-1_h) Peak Glucose (mmoU-l) 
Pre Post Pre Post 
Walkers (n=l1) 0.3±O.1 -Oo4±O_6 6.7±Oo4 6.2±0.3 
range -3.5 - 6.6 -2.5 - 4.3 5.0 - 8.6 5.3 - 7.8 
* 
Controls (n= 11) 0.7±O.7 0.7±O.8 6.3±O.2 6.3±O.3 
range -304 - 5.7 -2.7 - 4.9 5.2 -7.6 5.2 - 7.5 
* change over time significantly different between walkers and controls, p<0.05. 
Table 8.13 Area under the glucose/time curve and peak glucose concentration in 
walkers and controls. Mean±SEM and range. 
Tables 8.14 - 8.16 show the serum free fatty acid, total cholesterol, HDL-C and HD~­
C and Apo AI and B concentrations during the 6-hour observation period of the oral fat 
tolerance trials. 
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Variable Group Time after ingestion 
o hour 1 hour 2 hour 3 hour 4 hour 5 hour 6 hour 
FFA Walkers Pre 0.71±0.1O 0.47±0.09 0.43±0.OS 0.49±0.06 0.71±0.OS 0.S5±0.11 0.97±0.OS 
(mmol.l- I) Post 0.61±0.07 0.42±0.06 0.42±0.05 0.42±0.05 0.59±0.04 0.74±0.07 0.S7±0.07 
Controls Pre 0.75±0.07 0.45±0.07 0.49±0.07 0.51±0.06 0,71±0.06 1.01±0.05 1.10±0.OS 
Post 0.78±0.06 0.37±0.06 0.44±0.06 0.51±0.OS 0.63±0.07 0.91±0.OS 1.09±0.OS 
...... 
-..J TC Walkers Pre 5.25±0.25 5.39±0.26 5.27±0.25 5.2S±0.25 5.30±0.25 5.35±0.25 5.50±0.25 ...... 
(mmol.l-I) Post 4.99±0.25 .5.16±0.24 5.06±0.25 5.00±0.27 4.99±0.26 5.05±0.26 5.07±0.26 
* * * 
Controls Pre 5.46±0.16 5.52±0.13 5.41±0.13 5.36±0.13 5.41±0.14 5.4S±0.12 5.44±0.15 
Post 5.49+0.11 5.65+0.11 5.49+0.11 5.43+0.11 5.50±0.11 5.52+0.11 5.61+0.11 
* change over time significantly different between walkers and controls, (p<0.05) 
Table S.14 Serum free fatty acid and total cholesterol concentration throughout the 6 hour postprandial observation period for 
walkers and controls pre and post training. Mean±SEM. 
Time after ingestion 
o hour 1 hour 2 hour 3 hour 4 hour S hour 6 hour 
HDL-C Walkers Pre l.S9±O.10 1.63±O.11 L5S±O.lO l.59±O.10 l.SS±O.lO 1.61±O.1O 1.60±o.10 
(mmol.1-1) Post l.56±o.07 1.62±O.O7 l.S7±O.07 l.S6±O.07 l.S6±O.OS l.5S±O.07 l.S7±O.OS 
Controls Pre· l.S9±O.OS 1.61±O.O9 l.5S±O.OS l.54±O.OS l.S4±O.09 l.S6±O.1O l.5S±O.OS 
Post l.S3±o.08 1.61±O.O9 l.S4±O.08 l.SI±O.OS l.53±O.OS I.S4±O.09 l.S7±O.OS 
HDL2-C Walkers Pre O.S4±O.08 O.S8±O.OS O.S8±O.08 O.66±O.12 O.S4±O.09 O.S9±O.08 O.S6±O.OS 
...... (mmol.1·1) -.J Post O.5I±O.06 O.57±O.O6 O.S7±O.06 O.S8±O.06 O.S7±O.07 O.S4±O.06 O.S4±O.06 N 
* 
.* 
Controls Pre O.SS±O.04 O.SS±O.04 O.60±O.O4 O.S7±O.OS O.S9±O.OS O.S6±O.OS O.SS±O.OS 
Post O.47±O.O6 O.S3±O.07 O.Sl±O.06 O.Sl±O.06 O.SO±O.06 O.51±O.O6 O.4S±O.07 
* change over time significantly different between walkers and controls. (p<O.OS) 
Table S.IS HDL and HDL2-C concentration during the postprandial observation period. Mean±SEM. 
Time after ingestion 
o hour 2 hour 4 hour 6 hour 
ApoAI Walkers Pre l.33±O.O6 l.33±O.O6 l.34±O.O6 l.36±O.O7 
(g.1-l) Post 1.29±O.O4 l.33±O.O5 l.29±O.O4 1.31±O.O4 
Controls Pre 1.28±O.O4 1.32±O.O4 l.30±O.O4 1.29±O.O3 
Post l.32±O.O4 1.35±O.O4 l.33±O.O4 1.36±O.O5 
ApoB Walkers Pre O.89±O.O6 O.89±O.O6 O.89±O.O6 O.94±O.O5 
(g.1.l) Post O.86±O.O6 O.89±O.47 O.87±O.O5 O.87±O.O6 
* 
Controls Pre O.9l±O.O5 O.91±O.O4 O.91±O.O5 O.92±O.O5 
Post O.92±O.O3 O.93±O.O3 O.93±O.O3 O.96±O.O3 
* changover time significantly different between walkers and controls, (p<O.05) 
Table 8.16 . Serum concentrations of apolipoproteins AI and B during the 
postprandial period. Mean±SEM. 
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8.4 Discussion 
Random allocation of subjects into walking and control groups resulted in two groups 
which were similar with regard to age, indices of body composition and endurance 
fitness. Of the 11 subjects in the walking group 7 (64%) would be classified as 
overweight (body mass index 25-30 kg.m-2), according to the guidelines of the Royal 
College of Physicians report on obesity (1983) at the beginning of this study, similar to 
the 55% of women aged 45-54 years in England reported to have a body mass index of 
greater than 25 kg.m-2 (OPCS 1993). Additionally, the mean predicted V02max of the 
walking group (26.4 ml.kg-l.min-l) was considerably lower than values obtained for 
similar aged women in the National Fitness Survey, i.e. 34.8 ml.kg-1.min-1 and 31.9 
ml.kg-1.min-1 for women aged 35-44 and 45-55 years respectively (National Fitness 
Survey 1992). Therefore, the levels of physical fitness and body fatness of the women 
in this study suggest that they had considerable potential to benefit from an exercise 
programme. 
The main finding of this study was that, in these sedentary women, there was no 
change in the lipaemic response to a high fat test meal as a result of training by brisk 
walking, when this response was determined 48 hours after the last training session.· In 
contrast the postprandial serum insulin response to the meal was clearly blunted, even 
after two days of inactivity. 
Compliance of the women in the walking group to the training programme was good. 
The total number of minutes the walkers were asked to complete over the 12 weeks was 
1540 minutes. The mean actually attained by the women was 1772±83 minutes over the 
12-week period, above that required. Of the 11 walkers, 2 did not quite achieve this 
target with total num bers of minutes of 1400 and 1454 each, but these were not far 
from the target set for them. Walkers completed more than 20 minutes of brisk walking 
per day at a pace of about 15 minutes per mile, equivalent to approximately 2.4 km (1.5 
miles)_ No exercise-related injuries were sustained by any of the walkers and a low 
drop-out rate was experienced (15%). 
The average training intensity of the subjects, as monitored by recording heart rate at 
supervised training sessions, was 74.3±2.1 % of predicted maximal heart rate. The 
range of individual training intensities was 62.9 - 85.7% of predicted maximal heart 
rate. Thus, all of the walkers were within the guidelines of the American College of 
Sports Medicine (1991) suggested as being optimal in terms of improving 
cardiorespiratory endurance (i.e. 55% to 90% maximum heart rate). 
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Evaluation of changes in endurance fitness were monitored using the heart rate and 
blood lactate response to submaximal treadmill walking exercise. The changes in heart 
rate in the walkers during the last stage of the grade lactate treadmill test were 
significantly different from that of the control group, but were not significant during the 
earlier stages of the test On the fourth stage of the test, heart rate had decreased by 9 
beats.min-l in the walkers by the end of the study compared to baseline measurements. 
This training induced bradycardia has been observed in other walking studies (Seals et 
al. 1984b, Jette et al. 1988). However, the changes in heart rate observed for walkers 
during the last stage of the test did range from -34 to +8 beats.min-l. This variability 
was not related to either the volume or intensity of training, showing that the heart rate 
response to exercise is variable and indicates that the effects of brisk walking on the 
heart rate response to exercise in a given individual are unpredictable. Similar results 
concerning the variability of the changes in heart rate response to submaximal exercise 
have been found in other studies involving brisk walking training. After I-year 
programmes of brisk walking both Hardman and colleagues (1992) and Stensel and co-
workers (1994) found changes in heart rate varying from -29 to +12 and -27 to +19 
beats.min-l respectively in response to submaximal exercise. 
There is little information regarding changes in submaximal oxygen consumption over a 
period of walking training. However, the results of this study are in accordance with 
the findings of others. For example, Seals and co-workers (1984b) reported that 
oxygen uptake at the same absolute work rate was unaffected by 6 months of walking 
training and similarly, Hardman and colleagues (1991) found no differences in the 
submaximal oxygen consumption of female walkers and controls during a I-year 
training study. 
Within the walking group the changes in blood lactate concentration during submaxirnal 
treadmill walking were marked and provide evidence for peripheral skeletal muscle 
adaptations to exercise. As a result of these changes, oxygen uptake at a reference 
blood lactate concentration of 3 mmol.l-l, selected as a index of endurance fitness, 
increased in the walking group by 12.9±4.0% during the study. These results are 
consistent with previous findings of a reduced blood lactate response to treadmill 
exercise after walking programmes. For example, Hardman and co-workers (1992) and 
Stensel and associates (1994) both reported increased V02 at 2 mmol.l-l lactate 
concentration of 16% and 15% respectively after I-year training programmes of brisk 
walking. In contrast, there was a reduction in the oxygen uptake at 3 mmol.1-l lactate 
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concentration of 9.3±3.1 % in the control group indicating a decrease in endurance 
fitness over the period of the study in these subjects. 
It has been proposed that a decreased blood lactate response to exercise after training is 
an indication of reduction in the production of lactate due to an improvement in the 
ability of the mitochondria to compete with lactate dehydrogenase for pyruvate and 
NADH (Holloszy 1988). However, other evidence suggests that training results in an 
increased rate of lactate removal (Brooks et al. 1991, Macrae et al. 1992). It is also 
possible that some of the decrease seen in blood lactate concentration after training is 
due to an elevation in the contribution of fat metabolism to energy provision during 
exercise (Holloszy 1988, Matoba and Gollnick 1984). However, this seems an unlikely 
explanation in the present study as there were no reductions in the respiratory exchange 
ratio during submaximal treadmill walking in the walking group at the end of the study 
(Table 8.6). 
Endurance fitness was clearly improved by this brisk walking programme, with the 
changes in blood lactate concentration during submaximal treadmill walking being 
particularly marked. These results are in agreement with those of Porcari and colleagues 
(1987) who found brisk walking to offer an adequate endurance training stimulus in 
adults. In contrast, the endurance fitness of the control group seemed to decrease 
somewhat, suggesting that this group became less active. If the physical activity 
questionnaire had been administered the end of the study this may have helped to 
quantify if this was in fact the case. If this questionnaire had also been answered by the 
walkers at the end of the study, the score obtained by this group would have 
approximately doubled (using the mean amount of walking done and rescoring the 
questionnaire), similar to the score obtained by the recreational exercisers in Chapter 4 
of this thesis, where the same questionnaire was used. It is unknown, however, if the 
brisk walking undertaken in this programme represents activity which was all additional 
to that being done at the start of the study, or whether to some extent the brisk walking 
replaced other activities. 
Along with changes in endurance fitness, the brisk walking programme also resulted in 
in a modest decrease in body mass and body fatness in these women. These results are 
consistent with some previous studies of walking training in women (Frey et al. 1982, 
Bergman and Boyungs 1991, Whitehurst and Menendez 1991) but not with others 
(Santiago et al. 1987, Hardman et al. 1992). BaIlor and Keesey (1991) state that 
exercise energy expenditure is one of the main predictors of change in body mass and 
percentage body fat with endurance training. Walking at a speed of 6.4 krn.hr 1 (4.0 
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mph) on a fInn level surface requires an energy expenditure of 16.7 kJ.kg-1hour1 
(Ainsworth et al. 1993). Adopting these values in the present study, the walkers energy 
expenditure while training would have been about 17.9 kJ.min-1 (using mean body 
mass of walkers as 64.4 kg). These estimations suggest that the amount of energy 
expended in planned brisk walking exercise each week would have been about 2.6 MJ. 
This very modest increase in energy expenditure approximates to the energy value of 
the average loss of body fat. However, no attempts were made to quantify energy 
intake in the present study and subjects may have altered their energy intake over the 
period of the study, despite initial instructions to the contrary. 
Despite the improvements in endurance fItness, brisk walking resulted in only subtle 
changes in serum lipids and lipoproteins determined in the fasted state. At baseline, the 
mean serum total cholesterol concentrations (S.4 mmo1.1-1) were lower than values 
reported for asymptomatic British women of comparable age, i.e. S.6 - 6.4 mmo1.1-1 
(Mann et al. 1988). Serum HDL-C concentrations, measured with the same 
precipitation technique, were similar to those reported for a more representative sample 
(1.6 mmo1.1-1) than the present group, but the mean triacylglycerol concentration (1.0 
mmo1.1-1) was also lower than values reported for those in a similar age group, i.e. 1.2-
1.S mmo1.1-1 (Mann et al. 1988). This may be explained by the fact that a criterion for 
entering the study was that all subjects were non-smokers and nonnotensive and not 
obese. Random allocation of subjects into either group was successful in showing no 
differences in fasting serum lipid and lipoprotein concentrations between the groups at 
the beginning of the study. 
The lack of change in total cholesterol in this study is not surprising as this does not 
differ consistently between trained and sedentary individuals, demonstrated in Chapter 
4 of this thesis, and would seem to confmn Haskell's (1986) conclusion that exercise 
does not independently influence total cholesterol concentration. However, the lack of 
change in HDL-C or HDL2-C concentrations in the walking group was more suprising, 
especially in the light of the changes in body mass and body fatness. Consistent with 
these results, there was also no change in apolipoprotein AI, the major apolipoprotein 
ofHDL. The effectiveness of exercise programmes based on walking in modifying 
HDL-C in fonnerly sedentary middle-aged women is unclear. Several studies (Boyden 
et al. 1987, Cauley et al. 1987, Juneau et al. 1987) involving walking/slow jogging are 
in agreement with the present study, fInding no increase in HDL-C concentrations. 
Indeed, in a meta-analysis of longitudinal exercise training studies in women by Lokey 
and Tran (1989) no effect of exercise on HDL levels in women could be demonstrated. 
However, these results conflict with the fmdings of other studies of brisk walking 
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training in women reporting an increase in this variable (Hardman et al. 1989, 
Whitehurst and Menendez 1991, Hinke1man and Nieman 1993). 
Several explanations may be advanced for the lack of change in HDL-C in the present 
study. These include the possibility that hypoestrogenic women may be insensitive to 
the stimulating effects of exercise on HDL-C and, secondly, that such moderate 
exercise does not reach the "threshold" level of exercise needed to be effective in this 
regard. 
In the present study the 5 women in the walking group that were post-menopausal did 
not experience changes in HDL-C concentrations that were quantitatively different from 
those who were either peri-menopausal (n=3) or pre-menopausal (n=5). In addition, 
this first explanation is not supported by the increases in HDL-C reported for 68-year-
old women following an 8-week walking programme (Whitehurst and Menendez 
1991). 
The low energy expenditure of the exercise in the present study is a possible reason for 
the lack of change in HDL-C concentrations. It has been suggested that there is a . 
threshold of energy expenditure below which HDL-C does not increase (Haskell 
1986). Eight to ten miles of running per week (Wood et al. 1983) and the expenditure 
of more than 5 MJ energy in exercise per week (HaskellI986) have been proposed as 
minimum "doses" of exercise likely to influence lipoprotein metabolism. This 
explanation, however, is not supported by the findings of a 6-month randomised dose-
response trial (Duncan et al. 1991) involving three different intensities of walking, i.e. 
4.8 km.hr-l (3 mph), 6.4 km.hr-l (4 mph) and 8.0 km.hr-l (5 mph) in women. HDL-C 
increased by a similar amount, relative to controls, in both the fastest and slowest 
walking group, despite the greater improvements in fitness with the faster walking 
speed. Interestingly, the increase in HDL-C in the group walking at 4 mph, similar to 
the walking speed adopted in the present study, was small (0.06 mmol.l-l). Thus, the 
low energy expenditure of the walking in the present study seems an unlikely 
explanation for the lack of change in HDL-C. Additionally, no relationships were found 
between changes in HDL-C and the total amount of walking performed, the intensity of 
the exercise or the change in oxygen uptake at a reference lactate concentration, an 
index of change in endurance fitness in this study. 
It has been suggested that exercise influences HDL-C via an effect on body fatness 
(Wood et al. 1983) and that changes in HDL-C may be enhanced when an exercise 
programme is accompanied by decreases in body fatness (Tran and Weltman 1985). In 
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the present study, despite 7 of the 11 walkers decreasing in body fat mass (Figure 7.4), 
HDL-C concentrations remained unchanged. There was no relationship between 
changes in body mass or body fatness and any change in HDL-C concentrations in 
either the walking or control group. 
In a recent review article regarding the influence of exercise on HDL-C in women 
Taylor and Ward (1993) conclude that at the present time there is insufficient data to 
demonstrate that exercise training has an important independent effect on HDL-C 
levels. The results of this study are in agreement with this conclusion, a 12-week brisk 
walking programme showing no change in HDL-C concentrations in this group of 
previously sedentary middle-aged women. 
Examination of the ratio of total cholesterol to HDL-C, which it has been suggested 
may be a more sensitive index of CHD risk than either TC or HDL-C separately 
(Durrington 1989), shows the walking and control group behaving differently. A 
reduction in this ratio of 4.0±1.5% was seen in the walkers and an increase of 
5.5±2.1 % in the control group. This change is suggestive of some alterations in the 
dynamic exchange of lipid and cholesterol between lipoproteins as a result of brisk 
walking. In a previous study of brisk walking by Hardman and co-workers (1989), a 
significant decrease in this ratio was seen, in agreement with the findings of the present 
study. 
The walkers also behaved differently than the control group with regard to LDL 
cholesterol, which decreased by 5.8±3.2% in the walkers and increased by 2.7±2.3% 
in the controls. Although this was calculated LDL-C and not directly determined, the 
cumulative changes in TAG, HDL-C and TC presented the walkers with a more 
favourable lipid profile than before training and the controls with a less favourable 
profile with regard to CHD risk based on fasting lipid profiles. 
Complementary to the lack of change in HDL-C in this study, there was also no change 
in fasting TAG concentrations, supporting the postulation of a close metabolic 
relationship between these variables (patsch et al. 1992). Other studies involving 
training programmes of brisk walking have also failed to show changes in fasting TAG 
concentrations, even when increases in HDL-C have occurred (Hardman et al. 1993, 
Duncan et al. 1991). However, changes in TAG metabolism may not be evident in the 
fasted state, an insensitive method of examining the metabolic capacity for TAG 
compared to the postprandial state. The relationship found between fasting TAG 
concentrations and the extent of postprandial lipaemia at the beginning and end of the 
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study is similar to results reported previously in this thesis and probably reflects the 
direct competition for a common pathway between hepatic and intestinally derived 
TAG- rich lipoproteins (Brunzell et al. 1973). Indeed, the preferential clearance of 
chylomicron TAG by LPL leads to an accumulation ofVLDL TAG (Schneeman et al. 
1993), suggesting that the size of the endogenous pool will influence postprandial 
lipaemia. 
Also in accordance with the findings of the studies reported earlier in this thesis, there 
was a great variation among this group of norrnolipidaemic subjects in the metabolic 
capacity for TAG, measured as the magnitude of lipaemia occurring after the test meal. 
The inverse relationship between the extent of postprandial lipaemia and fasting HDL2-
C concentrations before and after the training period is in agreement with the findings 
of Patsch and colleagues (1983) reported for a group of middle-aged subjects and 
supports the hypothesis that the concentration of HDL2-C is dependent on the 
metabolism of TAG-rich lipoproteins (Miesenbock and Patsch 1992). The influence of 
the apolipoprotein E phenotype on postprandial lipaemia and insulin resistance has been 
previously discussed in Chapter 2. The distribution of apo E phenotypes found in this 
study is comparable with that found in a general Caucasian population (Ehnholm et al. 
1986, Mastana 1993, personal communication) and did not differ between walkers and 
control subjects. As such, it is unlikely that this phenotype could account for any 
differences in changes in postprandial lipaemia and postprandial insulin concentrations 
between the two groups. 
The adaptive responses to training have the potential to influence postprandial lipaemia. 
Endurance training stimulates an increased activity of LPL in heparin eluates of skeletal 
muscle samples (Svedenhag et al. 1983), probably because it improves the 
microcirculation in skeletal muscle (Kiens and LitheIl1989). Animal studies show that 
LPL activity reflects chylomicron free fatty acid uptake (Linder et al. 1976) and so this 
may be the reason why endurance athletes show a low lipaemic response (Cohen et al. 
1989, Merrill et al. 1989). Such changes may represent a mechanism for directed 
storage of TAG, replenishing muscle TAG stores used during an exercise bout. 
Skeletal muscle's contribution to removal of circulating TAG is probably quantitatively 
important, despite the fact that muscle LPL activity is lower than in adipose tissue 
(Borensztajn 1987), because of the considerable mass of muscle - of the order of 18 kg 
in the women in this study (Snyder et al. 1975). Changes in muscle LPL activity 
associated with training the major muscle groups of the lower limbs might therefore be 
expected to have a discernable influence on postprandial lipaemia. 
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However, brisk walking had no long-lasting effect on the totallipaemic response to the 
mixed meal, suggesting that improved endurance fitness does not necessarily result in 
changes in the lipaemic response, above those attributable to the residual effects of the 
last bout of exercise. This finding is not distorted by atypical responses and there was 
no relationship between changes in endurance fitness and changes in the indices of 
lipaemia. Further, changes in postprandial lipaemia were not related to changes in body 
mass, fat mass or estimations of body fatness. 
The decreased. blood lactate responses during the laboratory exercise tests provides 
suggestive evidence of increases in the oxidative capacity of muscle with brisk walking 
but these could reflect an improved ability of mitochondria to compete with lactate 
dehydrogenase for pyruvate and NADH (Holloszy 1988) rather than enhanced 
capillarisation. Training may have to provoke improvements in the microcirculation 
before a long-lasting ("chronic") effect on postprandial lipaemia is evident It is not 
known whether a 3-month period of training by brisk walking - at just over 60% 
V02max - is sufficient to do this, either in respect of intensity or duration. 
Previous work is not all inconsistent with our fmding. To our knowledge, five other 
studies have examined the influence of exercise training on postprandial lipaemia, two 
of which found no change (Zauner and Benson 1977, Yanes et al. 1989). However, 
the three other studies report a decreased lipaemic response after training (Wirth et al. 
1985, Weintraub et al. 1989, AItekruse and Wilmore 1973). All these workers 
attempted to remove the effect of the last exercise session with intervals of between 36 
hours and 3 days separating training from measurements of lipaemia. In two of these 
studies subjects were trained by running, either an average of over 50 miles a week for 
10 weeks (AItekruse and Wilmore 1973), or 15 miles per week of "intense" running, 
eliciting 80% of maximal heart rate for 7 weeks (Weintraub et al. 1989). The third 
study (Wirth et al. 1985) trained patients with primary hypertriglyceridaemia using 
three hour-long sessions per week of "jogging, ball games, callisthenics and short 
periods of relaxation". High levels of endogenous TAG in these patients were probably 
associated with profound postprandia1lipaemia (Cohn et al. 1988a), perhaps leading to 
a greater potential to demonstrate an influence of exercise training. Thus, where 
postprandia1lipaemia has been attenuated by training, either the exercise has been more 
intense than the walking programme in this study or postprandia1lipaemia would have 
been high at baseline. 
The lack of change in postprandial lipaemia in this study suggests that brisk walking 
training did not result in an increase in the amount or activity of LPL. Regular exercise 
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has been shown to increase LPL activity in skeletal muscle (Peltonen et al. 1981, 
Svedenhag et al. 1983, Kiens and LitheII 1989). The study by Peltonen and co-workers 
(1981) did not account for the residual effects of the last exercise bout on LPL activity 
but, where LPL activity has been measured at least 48 hours after the last exercise bout, 
an elevation in LPL is still reported (Svedenhag et al. 1983, Kiens and LitheII 1989). 
Both of these studies, however, employed more vigorous exercise regimens than in the 
present study. Subjects in the study by Svedenhag and co-workers (1983) trained for 8 
weeks at 70% of V02max and the study by Kiens and LitheII (1989) involved I-legged 
cycling training at 65% of peak V02 for 8 weeks. These two studies also report an 
associated increase in skeletal muscle capiIlarization with exercise training. A possible 
reason no change in the Iipaemic response to the high fat meal was found in the walkers 
in this study may be because waIking was not sufficiently intense exercise to result in 
increased capiIlarization of skeletal muscle and thus no subsequent increase in the 
amount or activity ofLPL occurred. Certainly, studies reporting increased 
capiIlarization after exercise training have involved more strenuous exercise (70% 
V02max) than the present regimen (Ingjer 1979, Andersen et al. 1977). Indeed, 
Henriksson (1992) reports that skeletal muscle capillarization is rapidly enhanced after 
endurance training but that there is a lack of information as to what extent increased 
capiIlarization is dependent on training intensity and duration. In addition, this 
researcher comments that less intense training regimens often seem to result in oxidative 
enzyme increase without any change in capiIlarization. 
The changes in HDL and its subfractions, total cholesterol and FFA and 
apoIipoproteins AI and B in response to the high fat meal are not discussed in detail 
here as these results are similar to those reported in the preceding chapter of this thesis, 
with little change observed during the postprandial period. 
Intriguingly, although it had no influence on postprandial lipaemia, brisk waIking was 
associated with a 35% decrease in the serum insulin response to the test meal compared 
with a 23% increase in controls. As this was not accompanied by an increase in blood 
i 
glucose concentrations it is suggestive of improved insulin sensitivity. 
A contributory factor may have been that brisk walking resulted in modest decreases 
Gust over a kg on average) in body mass and subcutaneous fat in these women, 
probably associated with the increased energy expenditure. Changes in insulin response 
were related to changes in body mass (rho=O,48), in agreement with many other 
studies reporting such a relationship (Reaven et al. 1988, Bazelmans et al. 1983, Wing 
et at 1992). The change in the insulin response was not however related to changes in 
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the sum of the skinfolds (rho=O.19), suggesting that alterations in internal, rather than 
subcutaneous, fat were the more important determinant of the altered insulin response. 
This would tie in with the proposal that insulin resistance is particularly associated with 
central adiposity or an accumulation of intra-abdominal fat (Frayn and Coppack 1992). 
Changes in the waist:hip ratio, the index of central adiposity used in this study, were 
unrelated to changes in the insulin response. This ratio may not, however, reflect the 
amount of central internal visceral fat which is, arguably, the more important indicator 
of diabetic risk (HaskellI993, personal communication). 
The decrement in the insulin response with the brisk walking programme appears 
somewhat greater than would be expected from the rather small weight loss (Wing et al. 
1992) per se and adaptive changes in skeletal muscle may have been an additional 
factor. Changes in endurance fitness (V02 at blood lactate concentration of 3 mmo1.1-1) 
were related to changes in the insulin response, in support of this view. Moreover, 
other workers have confmned that training can influence insulin sensitivity without 
changes in body composition (Rosenthal et al. 1983, Lamarche et al. 1993). 
The fall in the insulin response with brisk walking in the present study confmns the 
view of Young and co-workers (1989) that the residual effects of exercise on insulin 
sensitivity persists for at least 40 hours. It is possible that chronic and acute effects of 
the brisk walking in this study on the insulin response to the test meal may interact The 
increase in insulin sensitivity associated with exercise has been cited as a purely 
transient effect of a single bout of exercise (Burstein et a1. 1985). However, an increase 
in insulin sensitivity (8%) has also been reported in older men (mean age 63 years) 
following a 6-month walking programme at 60% of maximal heart rate (Seals et a1. 
1984a). Koivisto and colleagues (1986) report that a number of factors contribute to the 
improvement in muscle sensitivity to insulin following chronic physical training. These 
include an increase in muscle capillarization, an increase in the oxidative capacity of 
muscle (i.e. increase in mitochondrial enzymes) and an increase in insulin receptor 
numbers. More recently, however, it has been suggested that the increased insulin 
r-
action in muscle after exercise is probably caused by post receptor events (Richter et al. 
1992). 
The evidence for the exercise induced effects on insulin sensitivity are, however, 
observations from studies involving the use of glucose oral tolerance tests, rather than 
mixed high fat meals as in the present study, and as such we should be careful in our 
interpretation to the fmdings of the present study utilizing a mixed meal. Indeed, in 
recent observations the composition of test meals has been suggested as important in 
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detennining both the extent of postprandial lipaemia and the extent to which insulin 
resistance may be altered in response to this meal and thus the consequential hepatic 
production of VLDL during alimentary lipaemia (Chen et al. 1993. Schneeman 1993). 
In this study. utilising a test meal containing both fat and carbohydrate. serum insulin 
concentrations are raised above fasting concentrations for much of the 6-hour 
observation period. Changes in this response are of interest, not only because of the 
implications for the development of insulin resistance. but also because of the central 
role of this hormone in the regulation and co-ordination of postprandial lipid 
metabolism (Frayn 1993). Insulin controls both muscle and adipose tissue LPL activity 
and has a direct impact on postprandial lipaemia. In adipose tissue. insulin suppresses 
release ofNEFA (concentrations fall for 2-3 hours after the test meal) and stimulates 
LPL activity. enhancing the hydrolysis of circulating TAG. In contrast, insulin inhibits 
LPL in skeletal muscle. decreasing uptake of NEFA from TAG. It has even been 
suggested that basal muscle LPL could be regarded as an indicator of muscle insulin 
sensitivity (Kiens et al. 1989). Additionally. when insulin resistance renders 
postprandial insulin levels insufficient for the suppression of VLDL secretion by the 
liver. hepatic TAG-rich particles superimposed on chylomicrons will augment 
postprandial lipaemia. As such. it may be expected that the increased sensitivity to 
insulin be accompanied by a fall in postprandial lipaemia. In this regard. the lack of any 
indication of a change in lipaemia in the walkers in this study is surprising. In fact. no 
relationship was found between the change in insulin and lipaemic responses (pre. 
rho=O.32. post. rho= 0.25). 
As none of the walking training sessions in this study were prolonged and exhaustive. 
this data suggests that exercise does not have to be glycogen-depleting in order to 
stimulate improvement in glycaemic control. Moreover. as the effect on the insulin 
response was clearly evident so long (48 hours) after the last training session. brisk 
walking 3 to 4 times a week might be sufficient to oppose the development of insulin 
resistance. The finding that brisk walking can mitigate the postprandial rise in serum 
insulin concentration therefore strengthens the case for promoting this activity in 
middle-aged women. It also goes some way to allaying fears that exercise may have to 
be intense in order to improve glycaemic control and therefore contraindicated in 
patients with non-insulin-dependent diabetes. many of whom exhibit a constellation of 
cardiovascular risk factors. 
In conclusion. this 12-week programme of brisk walking proved a sufficient stimulus 
to elicit improvements in endurance fitness in previously sedentary middle-aged 
women. Although the brisk walking resulted in a decrease in body mass and body 
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fatness of the walkers there were no changes in fasting lipid concentrations. Brisk 
walking training did not influence postprandial lipaemia, when this was detemined 48 
hours after the last exercise session. However, walkers did experience a decreased 
insulin response to the high fat test meal, associated with both a decrease in body mass 
and an improvement in endurance fitness. 
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9 GENERAL DISCUSSION 
The purpose of the studies conducted in this thesis was to examine the effect of 
moderate exercise on fasting and postprandiallipoproteins. Overall, the fmdings in this 
thesis demonstrate that moderate exercise, in the form of brisk walking, results in 
attenuation of postprandial lipaemia during the recovery from a single bout of such 
exercise. Further, these data suggest that this influence may be relatively short-lived 
and thus infers that moderate exercise needs to be conducted regularly in order to obtain 
the benefit from exercise in this regard. 
The results of the cross-sectional study (Chapter 4) demonstrate that men and women who 
participate in recreational exercise have a more favourable lipoprotein profile than their 
sedentary counterparts. These results suggest therefore that moderate exercise, as well as 
more vigorous activity, has the potential to modify lipoprotein metabolism, particularly the 
HDL-C and HDLz-C concentration. If, as it has been proposed, the HDL-C concentration 
is dependent on the metabolism of TAG-rich lipoproteins (Patsch and Patsch 1984) the 
elevated HDL-C concentrations observed in the endurance runners and recreationally active 
men and women in this study may reflect an enhanced ability of such individuals to degrade 
TAG-rich lipoproteins. 
The influence of TAG-rich lipoproteins on HDL is particularly pronounced in the 
postprandial state with the entry of chylomicrons into the circulation. Thus, the clearest 
way to describe the TAG metabolic capacity may be not to use a single fasting TAG 
measurement but a measure of the TAG-rich lipoprotein transport system under strain: 
postprandial lipaemia. Indeed, the magnitude of postprandial lipaemia differed substantially 
(18-fold) amongst the subjects studied in this thesis (integrated area under TAG/time curve, 
range 0.9 mmol.1-1.h to 16.1 mmol.l-1.h), in agreement with the findings of other 
researchers (Patsch et al. 1987, Mattock et a1. 1981), despite the fact that all subjects were 
considered normolipidaemic on the basis of fasted lipid values. This suggests that 
examination of postprandial TAG concentrations may reveal individual differences in the 
TAG metabolic capacity not apparent from observations of fasting TAG concentrations. 
Previous research has however demonstrated (NesteI1964, O'Meara et al. 1992) that there 
is a relationship between the fasting TAG concentration and the magnitude of the lipaemic 
response following a high fat meal. Figure 9.1 shows this relationship (rho = 0.53, 
p<O.OI) for the 54 different subjects who undertook an oral fat tolerance test in the various 
studies in this thesis. 
186 
3.0 rho = 0.53 ...... 2.5 
.... ...... 
rho = -0.41 
• ... 
-: • 
- 2.5 • -: 0 
-
2.0 e 0 0 e e 2.0 e ....., 
....., 1.5 
0 0 • 
-< 1.5 0 o .0 • ...:I Eo< • 0 \ .. Cl 
=: 1.0 • • • 
e.o 1.0 o~. • • I: 
. ~ er. ••• ... III 0.5 .0 <Il 0 r.-
0.0 
-5 0 5 10 
TAG area 
(mmol.I-1.h) 
e.o 
I: 0.5 .~ 
... 
III 
<Il 
r.- 0.0 
15 20 -5 o 
• 
• 
5 10 
TAG area 
(mmol.l·1.h) 
Note: the open circles represent the subjects in Chapter 8 for whom the meal was 
prescribed according to fat free mass. 
Figures 9.1 and 9.2 The relationship between the area under the TAG/time curve and 
fasting TAG concentrations (n=54) and fasting HDL-C 
concentrations (n=46). 
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lfthe rate of catabolism of TAG-rich lipoproteins serves as a detennimint of plasma HDL-C 
concentrations such that a high lipolysis rate would lead to high HDL-C concentrations, 
then individuals with high HDL-C levels should be associated with good fat tolerance, or in 
other words a lower lipaemic reponse. This is demonstrated by the inverse relationship (rho 
= -0041, p<0.05) between the magnitude of postprandial lipaemia and the fasting HDL-C 
concentration (Figure 9.2) in the subjects who ingested the high fat meal. 
The strong association of HDL-C concentrations with reduced risk of CHD (and the lack of 
such an association for TAG) has lead researchers to emphasize the protective effect of 
HDL against atherosclerosis. The model by which HDL is thought to play a direct anti-
atherogenic role has been called "reverse cholesterol transport", with the movement of 
cholesterol away from peripheral cells to the liver. Not mutually exclusive, the catabolism 
of TAG-rich lipoproteins may present an alternative anti-atherogenic mechanism placing 
HDL in a more indirect role. Rapid clearance of TAG-rich lipoproteins promotes the 
formation of HD~·C and low levels of TAG-rich lipoproteins do not allow excessive 
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transfer of the HDL cholesteryl esters into TAG-rich lipoproteins. This keeps the 
cholesterol carrying capacity of HDL high and the net effect is anti-atherogenic. In recent 
years the role of the process termed "reverse cholesterol transport" has been emphasized, 
although there is little direct experimental evidence to support this theory (Barter 1993). 
Maybe it is time for a shift in emphasis to include the role of the metabolism of TAG-rich 
lipoproteins of both hepatic and intestinal origin in the atherogenic process. 
The studies in Chapter 5 and 6 of this thesis demonstrate that a single bout of prolonged 
walking results in attenuation of postprandial lipaemia in the recovery period immediately 
following exercise (24%) and 15 hours after the exercise bout is completed (31 %). The 
study conducted in Chapter 8 demonstrates that a programme of brisk walking is a 
sufficient stimulus to induce an improvement in endurance fitness in middle-aged women. 
However, the training regimen did not provoke any change in postprandial lipaemia, when 
this was detemined 48 hours after the last training session. The results of this study 
suggest, therefore, that brisk walking training does not influence the magnitude of the 
lipaemic response to a high fat meal over and above the effects of the last exercise session, 
demonstrated in Chapters 5 and 6. 
This conclusion assumes that sedentary, middle-aged individuals would behave in a similar 
manner as the younger more active subjects employed in the studies in Chapters 5 and 6, 
demonstrating a reduced alimentary lipaemia during the recovery from a single bout of 
brisk walking. This mayor may not be the case as this has yet to be determined. On the one 
hand it is possible that the larger muscle mass and intra-muscular TAG store of the younger 
physically active subjects may enable such individuals to utilise muscle TAG stores during 
exercise more readily than the untrained person (Lithell et al. 1979), who may rely more 
heavily on glycogen as a fuel source (Costill et al. 1979). However, it is also possible that 
the older individuals who, on average have higher fasting (O'Meara et al. 1992) and 
postprandial TAG concentrations (Kransinski et al. 1990) may show a similar or greater 
attenuation of alimentary lipaemia than the younger subjects, as those with a high lipaemic 
response in the rested state tend to show the greatest decrease with a bout of walking 
(section 5.4). 
From the results of the studies conducted in this thesis it appears that the influence of 
walking on postprandial lipaemia is short-lived. The study in Chapter 6 demonstrates that 
there is an attenuation of postprandial lipaemia 15 hours after the last exercise bout 
However, beyond this, these studies do not help to detemine how long lasting is the 
influence of a single bout of walking on alimentary lipaemia. Studies examining the 
influence of a period of detraining may help to identify the time period over which exercise 
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results in attenuation of postprandial lipaemia. A couple of such studies have recently been 
reported (Mankowitz et al. 1992, Verstraete et al. 1994). Both of these studies however 
have examined the long-term effects of detraining rather the short-term effects of cessation 
of exercise on postprandial lipaemia 
In the study by Mankowitz and co-workers (1992) 8 male runners ingested a vitamin A oral 
fat tolerance test in the trained state (20 hours after the last exercise bout) and after 14 days 
of detraining. No change in fasting TAG concentration or the area under the TAG/time 
curve was found. Verstraete and colleagues (1994) examined the magnitude of postprandial 
lipaemia in 11 marathon runners who ingested a high fat meal following a period of training 
and after 12-14 days of detraining. There was no change in fasting or postprandial TAG 
concentrations. The timing of the last exercise bout, however, was not controlled in this 
study, although it was likely that this occurred 24-48 hours before the initial test (Verstraete 
1994, personal communication). The results of these two studies suggest that if exercise 
does influence postprandial TAG concentrations that this is no longer apparent 20 hours 
(Mankowitz et al. 1992) or 24-48 hours (Verstraete et aI. 1994) after the last exercise bout 
A preliminary study examining the effect of short-term cessation of exercise on 
postprandial lipaemia has recently been conducted in our laboratories (Nelson et al. In 
Press). In this study 7 male subjects ingested a high fat meal12 hours, 2 days and 7 days 
after the last training session. The mean area under the TAG/time curve was 40% lower 12 
hours after the last exercise bout than after 2 days without exercise (4.5 v 2.7 mmol.I-1.h, 
p<0.05). After 7 days without exercise the TAG area was 3.2 mmol.I-l.h. These results 
demonstrate that attenuation of postprandial lipaemia is apparent 12 hours after the last 
exercise session but is no longer apparent after 2 days without exercise. This suggests that 
the influence of exercise on alimentary lipaemia is short-lived. In this study there was no 
difference in fasting TAG concentrations after detraining, demonstrating once again that 
fasting TAG concentrations are not necessarily a sensitive indicator of changes in the 
metabolic capacity for TAG. In the future it would be of interest to determine the effect of 
short-term cessation of training on postprandial lipaemia in a larger group of subjects, in 
the presence of a control group. 
The lower lipaemic response, which represents an integrated measure of the metabolic 
capacity for TAG-rich lipoproteins, following a single bout ofwa1king could theoretically 
be a result of a decreaSe in the rate ofappearance of chylomicrons and/or VLDL or 
alternatively a consequence of increased removal rates of both these TAG-rich lipoproteins. 
Indeed, the methodology employed in this thesis of measuring postprandial TAG 
concentrations does not distinguish between lipoproteins of exogenous and endogenous 
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origin. The recent development of biochemical techniques allowing identification of apo B-
48 and apo B-I00 should help future research to determine the relative contribution of 
TAG-rich lipoproteins of intestinal or hepatic origin to postprandial lipaemia. The results of 
several recent studies utilising such techniques have suggested that the accumulation of 
VLDL particles and chylomicron remnants (Schneeman et al. 1993, Karpe et al. 1993) 
contribute significantly to lipaemia after the ingestion of dietary fat. 
It is most likely that the attenuation of the lipaemic reponse during the recovery from the 
single bouts of walking in Chapter 5 and 6 involves an increase in the activity of LPL, as 
discussed in the appropriate sections (5.4 and 6.4) of these individual chapters. Although, 
all the studies that have previously examined the influence of a single session of exercise on 
LPL activity have utilised vigorous prolonged exercise. Measures of both plasma and tissue 
(skeletal muscle and adipose tissue) LPL activity in future studies similar to those 
conducted in this thesis would help to elucidate this possible mechanism by which exercise 
results in attenuation of postprandial lipaemia. Physiological measurement of LPL activity 
is, however, difficult. The enzyme activity measured in tissue biopsies does not necessarily 
reflect that in the capillary lumen. Additionally, post-heparin plasma LPL activity may not 
reflect tissue activity and serial measurements cannot be made. 
The data from the studies conducted in this thesis do not shed any light on the fate or final 
destination of the TAG cleared from the vascular system. It is possible that the destination 
of circulating TAG may be different in the rested state than when recovering from a bout of 
exercise due to the metabolic perturbations induced by exercise. Blood borne free fatty 
acids are a primary energy source for endurance exercise, particularly during low intensity 
exercise and it has been suggested that much of this fat is derived from intra-muscular TAG 
stores (Hurley at al. 1986, Oscai et al. 1990). Therefore, in the recovery from such 
exercise, free fatty acids from circulating TAG could be directed to muscle tissue in order to 
replenish muscle TAG stores degraded during exercise. Results from stable isotope tracer 
studies have recently shown, however, that there is little lipolysis of muscle TAG during 
low intensity exercise and that free fatty acids from adipose tissue are the substrate utilized 
(25% V02max) (Romijn et al. 1993). 
The factors regulating the transport of TAG to different tissues are the distribution of blood 
and the activity of LPL in a specific tissue (LithellI986). It is possible that an increase of 
LPL activity in a specific tissue may be indicative of the destination of free fatty acids from 
exogenous or endogenous TAG-rich lipoproteins (Le. ~irected storage). An increase in the 
activity ofLPL in muscle (Lithell et al. 1981, Taskinen et al. 1980) and adipose tissue 
(Taskinen et al. 1980, Lithell et al. 1979) has been reported following a bout of vigorous 
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exercise. However, Nikkila (1987) reports that the increase in adipose tissue LPL activity 
following a single bout of exercise is quantitatively much less remarkable than that 
occurring in muscle. In support of this view the results of a study by Lithell and colleagues 
(1978) found a correlation between muscle LPL activity and the removal rate of 
chylornicrons, but no correlation between this and adipose tissue LPL activity. They 
conclude therefore that it is increased skeletal muscle LPL activity that is most important in 
determining the increased removal rate of TAG from the circulation. 
The activity of LPL in muscle, and particularly adipose tissue, is under the hormonal 
control of insulin. Thus, it is possible that further insight regarding the directed storage of 
TAG may be obtained by examination of postprandial plasma insulin concentrations. 
Insulin concentrations were lower both in the recovery from a single bout of walking 
(Chapter 5 and 6) and after a training programme of brisk walking (Chapter 8). These 
results would then seem to suggest a reduced LPL activity in adipose tissue and an 
increased activity of the enzyme in muscle following exercise (either after a single bout or 
training) when compared to the non-exercised state. This might then favour a shift in the 
transport of postprandial TAG towards muscle as opposed to adipose tissue. At the present 
time it is not clear which deposition site is quantitatively more important, but it is possible 
that this may depend on the relative mass or amount of each tissue in a given individual. 
In terms of the risk of atherosclerotic plaque formation the fmal destination of the TAG-rich 
lipoproteins of dietary or hepatic origin may not be as important as the time for which the 
potentially atherogenic particles are in contact with the arterial wall. The results from 
studies in this thesis are consistent with a reduced transit time of TAG-rich lipoproteins in 
the circulation following a bout of walking, possibly reducing the risk of development of 
atherosclerosis. Indeed, recently Patsch and coworkers (1992) demonstrated in a case-
control study that elevated postprandial TAG concentrations were one of the most powerful 
predictors of the presence of CHD. Data from other case-control studies also suggest that 
the presence (Groot et al. 1991, Simons et al. 1987, Simpson et al. 1991) and progression 
(Karpe et al. 1994) of CHD is associated with an elevated postprandial lipaemia. Indeed, 
Karpe and colleagues report that "alimentary lipaemia is likely to represent an important 
atherogenic mechanism". Postprandial Jipaemia has also been found to be more pronouned 
in non-insulin dependent diabetics, than non-diabetic subjects (Lewis et al. 1991), who 
have a markedly increased risk of cardiovascular disease. 
Despite the fact that potentially beneficial changes in postprandial Jipaemia can be achieved 
with drug therapy (fibrates) designed to target the synthesis or catabolism of TAG 
(Simpson et al. 1990, Syvanne et al. 1993), there is growing evidence to suggest that 
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natural intervention in the fonn of physical exercise can contribute to the correction of this 
underlying metabolic disorder. Indeed, "exercise appears to enhance the catabolism of 
postprandial TAG concentrations by increasing peripheral lipolysis and it seems to reduce 
the overproduction of endogenous TAG that occurs with insulin resistance, presumably by 
nonnalizing the insulin-dependent flux of free fatty acids to the liver" (Griffm 1993). 
Indeed, the overall positive effect of exercise and the lack of detrimental side effects make it 
a very attractive intervention. At the present time the reduction in postprandial lipaemia 
required to reduce the risk of atherosclerosis is unknown. Some insight may be gained 
from studies of CHD patients and control subjects, with the difference in the magnitude of 
postprandial lipaemia between the two groups reported as being around 15-30%. Thus, it is 
possible that the reduction in the lipaemic response seen in the studies in this thesis 
following a single bout of walking (24% and 31 %) may be large enough to be of clinical 
significance. 
It has recently been reported that there is increasing evidence that some of the major 
health-related changes produced by physical activity may be due more to "acute" 
biological responses during and for some time following each bout of activity than to a 
"training response" (Haskell1994). This idea has been referred to as the "last bout 
effect". Also, there may be an interaction betWeen these two types of responses. 
If such "last bout effects" prove to provide significant clinical benefit, it may be 
necessary to make major changes in how the potential value of various activity profiles 
is assessed. For example, two cross-sectional studies (Cohen et al. 1989, Merrill et al. 
1989) have demonstrated a lower postprandial lipaemia in athletes than in sedentary 
controls. However, in both these studies no attempt was made to control the time 
interval between the last training session conducted by the athletes and the 
administration of the oral fat tolerance test Similarly, in studies conducted by Sady and 
co-workers (1988) and Pod! and colleagues (1994), an intravenous fat tolerance test 
was administered to endurance trained runners and sedentary controls without 
determining the timing of the last bout of exercise. It is therefore possible that the 
differences found between the groups of different training status in these studies be due 
to the influence of the last bout of exercise rather than as result of chronic training. It 
would be interesting to examine the magnitude of postprandial lipaemia in groups of 
differing activity status with an interval of around 48 hours between the last exercise 
bout and the fat tolerance test This would be best conducted with relatively large 
numbers of subjects in each activity group due to the large inter- subject variation in 
postprandial TAG concentrations. 
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In Figure 9.3 three different exercise response profiles are depicted. The biological 
changes produced by each of these activity profiles may differ from one another but 
each may have a beneficial clinical outcome. Each of these response profiles will be 
discussed regarding the influence of exercise on postprandial lipaemia and the 
consequence for exercise prescription. 
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Figure 9.3 Various profiles of acute versus chronic responses to exercise sessions 
(adapted from HaskellI994). 
Response A represents an "acute" response in which the benefit occurs after a single 
bout of exercise and does not improve any further (no training effect) with continued 
exercise. Indeed the studies in this thesis suggest that a single session of walking 
attenuates postprandial lipaemia and that there is not additional benefit from training. In 
terms of exercise prescription these results suggest that benefit can be gained from each 
session of exercise in this regard, and further, indicates that exercise needs to be 
conducted regularly as these benefits may be short-lived. 
Response B shows a rapid response in which most of the benefit is derived after a 
week or two of frequent exercise sessions with a relative plateauing of the response 
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after that After a single bout of exercise postprandial TAG concentrations may be 
lower after one day, as demonstrated in this thesis. Over a 5-day period, if exercise was 
performed every day postprandial lipaemia may decrease further. Thus the acute 
response is augmented by repeated bouts of exercise. A plateauing in the response will 
be found as a lower physiologic limit is reached, which may be different for each 
individual. In this scenario regular exercise would seem to confer the greatest benefit. 
Response C demonstrates an acute response that is augmented by an increase in 
endurance fitness as a response to training. It is likely that as a person's functional 
capacity increases and the absolute intensity of exercise performed during an exercise 
session is increased (relative intensity stays the same), the acute response to various 
physiologic reactions will be enhanced. Indeed, there are adaptations to training which 
suggest that the attenuation of postprandial lipaemia as a result of a single bout of 
exercise maybe further increased by training. As well as having a larger muscle mass, 
trained individuals have been reported to uilize muscle TAG stores to a greater extent 
during a bout of exercise than non-trained subjects (Costill et al. 1979). Therefore, the 
replenishing of these intra-muscular TAG stores, along with the possible increased LPL 
activity in skeletal muscle as a result of increased capillarization of endurance trained 
muscle, may result in a further reduction in postprandial TAG concentrations with 
training. However, it also possible that such an augmented training response be due to 
the a~ditional energy expended during the exercise session. 
To the author's knowledge no studies have examined the influence of a single bout of 
exercise prior to and following a period of endurance training. Such an investigation 
would help to determine the benefits of training in this regard. 
A preliminary study in our laboratory (Burnett et al. 1993) has examined the influence 
of a 90 minute bout of jogging/running at two different relative exercise intensities 
(48% and 66% Y02max) on postprandial lipaemia in the recovery from exercise (i.e. an 
increased energy expenditure at 66% Y02max than at 48% Y02max). The exercise 
bouts resulted in a decrease in the lipaemic response to a high fat meal compared to a 
control (rest) condition. Following the exercise bout at 48% Y02max postprandial 
lipaemia was attenuated by 62% compared to the control condition and by 52% 
following the exercise at 66% V02max. Thus, in this preliminary study, an increase in 
energy expenditure did not result in an additional attenuation of postprandial lipaemia. 
An avenue for further research includes examining the influence of energy expenditure 
on postprandial lipaemia. The results of this study are however encouraging as they 
suggest that moderate intensity exercise which may be attainable by a large percentage 
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of the population, may be just a as beneficial as that of high intensity in this regard. 
This could be a consequence of the increased contribution of fat metabolism to the 
energy demands of exercise during low intensity exercise compared to that of high 
intensity (Romijn et al. 1993). 
Thus, each of these exercise response profiles may have a beneficial outcome as 
regards the influence of exercise on postprandial lipaemia. However, more infomation 
is needed about the relative importance of the type, frequency and duration of the 
exercise required to elicit this response, so that that an effective exercise prescription 
can be advanced. These results do however support the recent recommendation that 
moderate exercise needs to be taken on most days of the week if health gains are to be 
achieved (US Centers for disease control and the American College of Sports Medicine 
1993). 
In summary, the results of the studies in this thesis are encouraging from the public 
health point of view as they demonstrate that exercise does not have to be very intense 
in order to reduce the lipaemic response to a high fat meal. It appears that such exercise 
maybe both an effective and attractive intervention in lowering postprandial lipaemia. 
Indeed, "exercise represents the only effective means of lowering plasma TAG and 
increasing the activity of LPL and insulin sensitivity" (Griffm et al. 1993). 
Additionally, walking as a form of exercise has been recently promoted by the English 
pioneer of research into CHD risk and exercise, reporting that "walking is the 
commonest and most natural exercise, and the only sustained activity that is all 
prevalent" (Morris 1994). These results suggest that exercise helps to reduce the time 
for which the arterial wall is exposed to potentially atherogenic particles, and thus the 
case for encouraging increased physical activity as part of a prevention strategy against 
CHD is strengthened. Indeed, the astute advice of the Greek physician Hippocrates 
(460-377 BC) over 2000 years ago was that "Walking is man's best medicine". 
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Appendix I: Informed consent form 
STUDY TITLE: The affect of a 12-week training programme of brisk 
walking on serum Iipids and fat tolerance in women 
aged 40-55. 
PURPOSE: 
PROCEDURES: 
There is evidence to suggest that regular exercise may help to 
protect against coronary heart disease. One of the ways that this 
reduced risk may be conferred is that fat may be cleared more 
quickly from the blood after a J1.leal. The purpose of this study is 
therefore to examine whether brisk walking alters the rate at 
which fat is cleared from the blood after a meal. 
Any results from tests and information given by you during this study will be held in 
the strictest confidence. 
Participation in the study includes the following tests: 
(i) You will be asked to complete a short questionnaire regarding your level of habitual 
physical activity. 
(ii) A short questionnaire regarding menopausal status will also be completed. 
(iii) A familiarisation session will be conducted giving you an opportunity to practise 
walking on the treadmill and trying out the mouthpiece so that you feel comfortable 
with all the procedures involved in the exercise test You will need to wear loose 
comfortable trousers and supportive comfortable shoes for this practise. 
(iv) A l6-minute treadmill test will be conducted. During this test the speed of the 
treadmill will stay the same, but the slope will get slightly steeper, so that it gets a bit 
harder every four minutes. Your heart rate will be monitored continually and samples of 
the air that you breathe out will be collected at intervals. Again, you will need to wear 
loose comfortable trousers and supportive shoes. 
The following tests will be undertaken at the begining of the study and repeated after 12 
weeks. 
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(v) It will be necessary to take a few basic body measurements, i.e. weight, height, 
circumference at the waist and hips and 4 skinfold measurements (biceps, triceps, 
supraiJiac and subscapular) using a simple technique of measuring the thickness of the 
fat under the skin using a pair of calipers. You will be asked to wear only bra and pants 
during these measurements and they will be done in a private room. 
(vi) A second l6-minute treadmill test similar to the one described in test (iv) will be 
conducted. You will again be asked to walk on the treadmill at 4 different gradients 
which will be increased gradually according to your own abilities. These will represent 
50, 60, 70 and 80% of your own estimated maximum exercise capacity. During this 
test 4 small thumb prick samples of blood will be taken. You will need to wear loose 
comfortable trousers and flat supportive shoes for this test. 
(vii) You will be asked to come to the laboratory after an overnight fast. A cannula (a 
small plastic tube which will be shown and explained to you before the test) will be 
introduced to a forearm vein using local anaesthetic and a 10 ml blood sample taken. 
You will then eat the test meal which consists of cereal, fruit, nuts, chocolate and 
cream. You will rest for the following 6 hours with further blood samples taken every 
hour. During this time you may read, chat etc. at the laboratory. No food or drink other 
than water will be consumed during the 6 hours. You will also be asked to do no 
physical exercise for 2 days prior to this test and you will also be asked to weigh and 
record all your food and drink for these 2 days. 
EXERCISE AND CONTROL GROUPS: 
Each person who volunteers to take part in the study will be allocated by chance into 
either the exercise group or the control group after the baseline measurements have been 
made. 
CONTROL GROUP 
Those in the control group will be asked not to change their activity habits for the 
duration of the study (12 weeks) and will be given the opportunity to be involved in a 
similar exercise training programme at the end of the study if they wish, but there is no 
obligation to do so. 
EXERCISE GROUP 
Those in the exercise group will undertake a programme of brisk walking training. In 
summary, this will involve walking briskly a minimum of 4 times per week for at least 
30 minutes, but the walking will be increased gradually to this amount. You will be 
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asked to attend 2 organised walking sessions per week. These will be conducted at 
times to suit as many people as possible in the group. 
POSSIDLE RISKS AND DISCOMFORTS 
Blood sampling via the cannula in test (vii) may cause minor bruising and carries a risk 
(which is exceedingly small) of plastic or air embolism, as is usual with such 
procedures. All experiments will be conducted by trained staff and closely monitored. 
STATEMENT OF INFORMED CONSENT 
I understand that I will be asked to undertake the series of tests described above. I also 
understand that I will be randomly allocated to either the exercise group or the control 
group. The tests and procedures have been explained to me and I am aware that I am 
free to withdraw from the study at any time without the need for explanation. 
SIGNED _________ _ DATE _____ _ 
WITNESSED BY ______ _ 
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Appendix 2: The calculation of oxygen uptake and carbon dioxide 
production 
YESIDP = VEATPS x <BP- SWVPt) x ill 
760 273 +t 
Where: 
BP = barometric pressure in mm Hg 
SWVP 
t 
= 
= 
saturated water vapour pressure (mm Hg) at ambient temperature 
ambient temperature (degrees Celsius) 
AlPS = ambient temperature and pressure, saturated with water vapour. 
SWVPt was calculated as follows: (1.001 x t) - 4.19 
Y02 = Vo!. 02 inspired - Vol 02 expired 
Vo!. 02 inspired = VI x Er.Qt& 
100 
Vo!. D2 expired = YE x FECh% 
100 
Similarly VC02 = Vo!. C02 expired - Vo!. C02 inspired. 
VC02 = (VE x FE,.CO?%) - (VI x EICQt&l 
100 100 
It is assumed that F\02% is 20.93% and FICD2% is 0.03% as the composition of 
inspired air is very stable. 
FE02%, FEC02% and VE are measured in the expired air sample. VI is derived from 
the Haldane transformation. 
The Haldane transformation uses the concentrations of nitrogen (assumed to be 
metabolically inert) in the inspired and expired air to derive the volume of air inspired 
from direct measurements of the volume expired. 
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i.e. As concentration = mass 
volume 
mass N2 inSllin;d - FIN2% 
VI 
mass N2..exllired - FEN2% 
VB 
But mass of N2 inspired = mass of N2 expired 
therefore 
and VI = EEN2% x VE 
FIN2% 
and 
VI can therefore be derived if VE is measured and FIN2% and FEN2% are known. 
FIN2% and FEN2% are found by subtracting the concentration of carbon dioxide and 
oxygen from 100%. 
Finally, the respiratory exchange ratio (R) is calculated as: VCOz 
V~ 
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Appendix 3: Treadmill calibration 
Treadmill calibration took place at the beginning and end of each study. Calibration was 
perfonned by measuring the length of the treadmill belt and the time taken for it to 
complete 50 revolutions at a variety of speeds. The length of the belt was multiplied by 
50 to give the total distance (in metres) the belt had travelled. This distance was then 
divided by the number of seconds taken to complete the 50 revolutions in order to 
detennine the actual speed the belt was travelling. Below is an example of the 
calibration perfonned. 
Belt length = 3.78 m 
Total distance travelled by the belt = 3.78 x 50 = 189 m 
Speed dial Time taken Mean time Speed calculated % diff 
(mph) (s) (s) (mph) 
2.5 174.2/174.1 174.1 2.43 2.8 
3.5 121.0/121.0 121.0 3.49 0.2 
4.5 94.3194.2 94.2 4.49 0.3 
5.5 78.1/78.1 78.1 5.41 1.6 
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Appendix 4: Haemoglobin assay 
Haemoglobin concentration was detennined using a test kit Samples were assayed in 
duplicate. 
Kit: Test-Combination Haemoglobin 
Supplier: Boehringer Mannheim, V.K. Ltd. 
Principle 
haemoglobin + cyanide + ferricyanide -----------------.--> cyanmethemoglobin 
Solution 
Drabkin's solution: one bottle of potassium hexacyanoferrate (Ill) solution and one 
bottle of potassium cyanide solution (both supplied in kit) were diluted with distilled 
water and made up to 1 litre in a volumetric flask. 
Procedure 
(1) 20 III of whole blood was collected in glass micro-pipette tubes and immediately 
dispensed into 5 ml of Drabkin's solution. 
(2) Samples were shaken vigorously, immediately. 
(3) The absorbance of the samples was measured at a wavelength of 546 nm using 
an Eppendorf photometer (model 1101 M). Drabkins' solution was used as a 
blank. 
(4) Haemoglobin concentration (g. 1 00 ml-1 ) was detennined by multiplying the 
absorbance value of the sample by 36.77. 
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Appendix 5: Determination of haematocrit and estimation of plasma 
volume 
Haematocrit was determined by collection of blood samples into three separate 
heparinized micro-hematocrit tubes (Scientific Industries Ltd.) and subsequently 
centrifuged for 15 minutes (Hawksley micro-haematocrit centrifuge). From these tubes 
haematocrit was determined using a micro-haematocrit reader (Hawksley). 
Plasma volume was estimated by the method described by Dill and Costill (1974) 
utilizing both the haemoglobin concentration and haematocrit of given samples before 
and 6 hours after administration of the oral fat tolerance test, in this case. 
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Appendix 6 : Blood lactate assay 
Blood lactate was measured using a modification of the enzymatic method described by 
Maughan (1982). Samples were assayed in duplicate. 
Principle 
LDH 
lactate + NAD+ ------------------> pyruvate + NADH + H+ 
NAD = nicotinaminde-adenine-dinucIeotide 
LDH = lactate dehydrogenase 
Deproteinisation 
20 J.Ll of blood was deproteinised in 200 J.Ll of perchloric acid (2.5%). The sample was 
then mixed thoroughly, centrifuged and stored at -70°C until analysed. 
Solutions 
Perchloric acid (2.5%): 10.4 rn1 of 60% perchloric acid made up to 250 mI with 
distilled water gave a 2.5% perchloric acid solution. 
Hydrazine buffer (pH 9.1): 6.5 g hydrazinium sulphate; 24.26 mI hydrazine hydrate; 
and 1 g ethylenediaminetetra-acetic acid (EDTA) made up to 500 rn1 with distilled 
water. 
Lactate diluent (0.07 M hydrochloric acid): made up from a 1 molar solution of 
hydrochloric acid (86 rn1 of hydrochloric acid, specific gravity 1.18, made up to 1 litre 
with distilled water). 70 rn1 of 1 molar hydrochloric acid was made up to 1 litre with 
distilled water giving a 0.07 molar hydrochloric acid solution. 
Reaction mixture: prepared immediately before use; 2 mg of NAD and 10 III of LDH . 
per 1 mI of hydrazine buffer. 
Standards 
These were made up from 1.0 molar lactate stock and included the following 
concentrations: 0,1,2,5,10 and 15 mmol.l-l. 
227 
Procedure 
(1) Samples were allowed to thaw to room temperature for at least one hour. 
(2) Samples were mixed thoroughly. 
(3) Samples were centrifuged for 4 minutes at 12,000 rpm. 
(4) 20111 of supematent or standard was pipetted into a glass test tube. 
(5) 200 111 of reaction mixture was added to each test tube. 
(6) Tubes were mixed and left to incubate for 30 minutes. 
(7) 1 ml of lactate diluent was added to each test tube and then mixed thoroughly. 
(8) The fluorescence of the samples and standards was determind using a Locarte 
fluorimeter. 
(9) A linear regression equation was calculated using the known standard 
concentrations and their respective fluorescence values. The concentration of 
lactate in each sample was ascertained using this regression equation. 
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Appendix 7: Free glycerol assay 
Free glycerol was measured using the enzyrnatic method described by Laurell and 
Tibbling (1966). Samples were assayed in duplicate. 
Principle 
Glycerol is converted to glycerol-3-phosphate by glycerokinase and adenosine 
triphosphate. Under the influence of glycerophosphate dehydrogenase and NAD+ 
dihydroxyacetone phosphate, which is trapped by hydrazine, and NADH are then 
formed in proportion to the glycerol content of the sample. 
Solutions 
Zinc sulphate (0.087M): 6.25 g of ZnS04.7H20 were dissolved in 250 rnI of distilled 
water. 
Barium hydroxide (0.083M): 6.55 g BaOH2.8H20 were dissolved in 250 ml of 
distilled water. 
Hydrazine buffer (1.0M): 19.0 rnI ofhydrazine hydrate in 250 rnI distilled water (64% 
solution) with 1.5 mM MgCl2 (76.2 mg in 250 rnI distilled water). The pH was 
adjusted with HCl to 9.4. This is stored at 4°C. 
Diluent (O.OlM NaOH with 1.0mM EDTA): 0.4 g NaOH with 372.24 mg EDTA were 
dissolved in distilled water and made up to 1 litre in a volumetric flask. 
Cysteine (0.2M): 35.0 mg of cysteine in 1.0 rnI of O.4M NaOH. This is made up fresh, 
just prior to use. 
Reaction mixture: 12 mg of A 1P and 20 mg of NAD were dissolved in 0.2 rnI of 
distilled water, per rnI of reacton mixture needed. Added to this was 100 J.ll of the 
cysteine (0.2M), 700 III of the hydrazine buffer, 1.0 III glycerokinase and 5.0 III of 
glycerine-3-phosphate dehydrogenase. 
Standards 
These were made up from O.4mM glycerol stock solution and included the following 
concentrations: 0.25, 0.5, 1.0, 1.5 and 2.0. 
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Procedure 
(1) Serum samples were allowed to thaw at room temperature for 1 hour. 
(2) Samples were mixed thoroughly. 
(3) 0.25 ml of zinc sulphate was pipetted into plastic eppendorf tubes. 
(4) 50 J.1I of sample or standard was added to these tubes. 
(5) 0.25 ml of barium hydroxide was added to each tube and each tube mixed 
immediately. 
(6) Samples were then chilled in the freezer at -20°C for 5 minutes. 
(7) Samples were then centrifuged for 5 minutes at 12,000 rpm. 
(8) 200 J.1I of the resulting supematent was removed and placed in a glass test tube. 
(9) To each glass tube 100 J.1I of reaction mixture was added. 
(10) Samples were mixed and left to incubate for 60 minutes. 
(11) 1.0 ml of diluent was added to each tube and then mixed thoroughly. 
(12) The fluorescence of the samples and standards was determined using a Locarte 
fluorimeter. 
(13) A linear regression equation was calculated using the known standard 
concentrations and their respective fluorescence values. The concentration of 
free glycerol in each sample was ascertained using this regression equation. 
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Appendix 8: Total cholesterol assay 
Total cholesterol concentration was detennined from serum samples by an enzymatic 
colourimetric method using a commercially available kit. Samples were assayed in 
duplicate on a Cobas Bio automated analyser. All samples from the same subject were 
analysed in a single run. 
Kit: Cholesterol C-system. CHOD-PAP method. 
Standards: Preciset Cholesterol 
Quality control: Precinorm L and Lipid Control (Roche U.K. Ltd.) 
Supplier: Boehringer Mannheim. U.K. Ltd. 
Principle 
cholesterol esterase 
cholesterol ester + H20 --------------------------------> cholesterol + RCOOH 
cholesterol oxidase 
cholesterol + 02 ---------------------------------> L'J.4 - cholestenone + H202 
peroxidase 
2 H202 + 4-aminophenazone + phenol------------------> 4-(p-benzoquinone-
mono-imino)-phenazone + 4 H20 
Solution 
Bottles of reagent solution supplied were dissolved in redistilled water. 
Procedure 
(1) Samples were removed from the freezer and allowed to warm to room 
temperature. 
(2) Samples were mixed. dispensed into plastic sample cups and loaded onto the 
Cobas Bio analyser. 
(3) 5 j.1l of standard. sample or control sera was pipetted into a cuvette. 
(4) 350 III of reagent was added to each cuvette. 
(5) Samples were mixed and incubated for 5 minutes at 37°C. 
(6) The absorbance of the samples was read at a wavelength of 500 nm. 
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(7) Sample concentrations were calculated by the Cobas Bio using a regression 
equation established from a reagent blank and 3 standards of known 
concentration. 
Note: In Chapter 4 the above assay was performed manually; in this case the procedure 
varied slightly. The volumes of sample and reagent were I 0 ~I and ! ml respectively. 
The incubation period was 30 minutes at room temperature. Samples were read on an 
Eppendorf photometer (model!! O! M) at a wavelength of 546 nm. Standards were 
used to establish a linear regression for determination of sample concentrations. 
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Appendix 9: Precipitation procedures for the determination of HDL·C 
and HDL3·C 
The precipitation method used is that reported by Gidez and colleagues (1986). Serum 
samples requiring precipitation were stored at 4°C after collection. Precipitation and 
subsequent assay for cholesterol were performed within five days of sample collection. 
Principle 
An insoluble complex is formed between a polyanion-divalent cation and lipoprotein 
particles. Manganese and heparin selectively precipitate chylomicrons, VLDL and LDL, 
leaving HDL in solution. Following centrifugation, HDL-C is measured in the 
supernatant. 
Solutions 
Sodium heparin: this solution was made up fresh each day using Sigrna grade I sodium 
salt from porcine intestinal mucosa which was dissolved in 1 ml of 9 g.1-1 saline. The 
weight of sodium heparin used depended on the number of USP units as follows: 
181 USP units = 31.5 mg per rnI saline 
178 USP units = 32.0 mg per rnI saline 
176 USP units = 32.4 mg per rnI saline 
Manganese chloride (1 mmol.l-1): 4.95 g of MnC12.4H20 was dissolved in 25 rnI of 
distilled water in a volumetric flask. This was made up fresh every 7 days. 
EDTA (Ethylenediaminetetra-acetic acid) (0.4 mol.1-1): 14.88 g ofEDTA disodium 
salt, was dissolved in 100 rnI of distilled water. Solubilisation of the EDTA was 
achieved by adjusting to pH 7.7 while stirring. 
Dextran sulphate (15.4 g.l-I): 77 mg of dextran sulphate was dissolved in 5 rn1 of 9 
g.1-1 saline. 
Procedure for HDL-C determination 
(1) 40 ~l of sodium heparin solution was added to 1 mI of serum. 
(2) The sample was immediately mixed for ten seconds. 
(3) 100 ~l of manganese chloride was added to each sample. 
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(4) Sample was immediately mixed again for ten seconds. 
(5) Sample was incubated in an ice bath at 4°C for 30 minutes. 
(6) Sample was centrifuged Wc) for 25 minutes at 4,000 rpm. 
(7) The resulting supernatant was removed. 500 III of this supernatant was used for 
further precipitation of HDL3-C. If preciptate was floating, the supernatant was 
passed through a MiIlipore fIlter. 
HDL cholesterol analysis is described in Appendix 10. 
Procedure for HDL,1-C determination 
(1) 50 III of dextran sulphate was added to 500 III of the supernatant resulting from 
the precipitation procedure described above. 
(2) Samples were mixed immediately for 10 seconds. 
(3) Samples were left to stand at room temperature for 20 minutes. 
(4) Samples were centrifuged Wc) for 30 minutes at 4,000 rpm. 
(5) The resulting supernatant was removed and used for HDL3-C determination as 
described in Appendix 10. 
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Appendix 10: HDL-C and HDL3-C assay 
Procedure 
(1) Samples were assayed immediately after precipitation procedures. Supematants 
were not frozen prior to analysis. 
(2) Samples were mixed. 
(3) 250 III of supematant was added to 10 III ofEDTA. 
(4) Samples were mixed again and left to stand for five minutes. 
(5) The procedure for total cholesterol (Appendix 10) was then followed. 
(6) The concentrations ofHDL-C and HDL3-C derived from the cholesterol assay 
were multiplied by correction factors as follows: 1.1856 x HDL-C concentration 
and 1.2896 x HDL3-C concentration. These correction factors were required to 
adjust for dilution of the samples by heparin, manganese chloride, dextran 
sulphate and EDTA. 
(7) HDL2-C concentration was calculated as HDL-C - HDL3-C. 
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Appendix 11: Calculation of LDL-C and VLDL-C 
Friedewald and colleagues (1972) devised the following fonnula to calculate LDL-C 
and VLDL-C (mg.dl- I) in fasted serum: 
triacylglycerol concentration + 5 = VLDL-C 
LDL-C = total cholesterol - HDL-C - VLDL-C 
This fonnula is based on two observations. The first is that the ratio of the mass of 
triacylglycerol to that of cholesterol in VLDL-C is relatively constant at about 5: I in 
nonnal subjects. The second is that when chylomicrons are not present (as in fasted 
serum). most of the triacylglycerol in serum is contained in VLDL. 
If values are expressed in mmol.l-1 (as in this thesis) then triacylglycerol concentration 
is not divided by 5 but by 2.2 to obtain VLDL-C. 
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Appendix 12: TriacyIglyceroI assay 
Triacylglycerol concentration was detennined from serum samples by an enzymatic 
colourimetric method using a commercially available kit. Samples were assayed in 
duplicate on a Cobas Bio automated analyser. All samples from the same subject were 
analysed in a single run. 
Kit: Triglycerides GPO-PAP 
Quality control: Precinorm L and Lipid Control (Roche U.K. Ltd.) 
Supplier: Boehringer Mannheim, U.K. Ltd. 
Principle 
lipase 
triacylglycerol + 3 H20 ---------------> glycerol + 3 RCOOH 
glycerol kinase 
glycerol + A TP ---------------------> glycerol-3-phosphate + ADP 
glycerol phosphate oxidase 
glycerol-3-phosphate + 02 -------------------------> dihydroxyacetone phosphate 
+H20 2 
H20 2 + 4-aminophenazone + 4-chlorophenol-----------------------> 
4-(p-benzoquinone-mono-imino)-phenazone + 2 H202 + HCL 
Solutions 
Buffer solution 
Reagent strips 
Both of the above were supplied with the kit. A reagent strip was immersed in a bottle 
of buffer solution, stirred for ten seconds and left for five minutes. The buffer was 
again stirred with the reagent strip for ten seconds and the strip then discarded. 
Procedure 
(1) Serum samples were removed from the freezer and allowed to thaw for at least 
one hour at room temperature. 
(2) Samples were mixed, dispensed into sample cups and loaded onto the Cobas 
Bio analyser. 
(3) 5 J.1l of sample, standard or control sera was pipetted into cuvettes. 
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(4) 350 Jll of reaction mixture was added to the cuvettes. 
(5) Samples were mixed and left to incubate for 5 minutes at 37°C. 
(6) Samples were read at 500 nm. 
(7) Sample concentrations were calculated by the Cobas Bio analyser using a 
regression equation derived from a reagent blaok and a series of 3 standards of 
known concentration. 
Note: In Chapter 3 and 4 samples were analysed maoua11y using a sample volume of 10 
111 and reagent volume of I ml. Samples. control sera and standards were incubated for 
10 minutes at room temperature and their absorbance read on ao Eppendorf photometer 
(ModeIIIOIM) at a wavelength of 546nm. Sample concentrations were derived from a 
linear regression equation established from standards of known concentration. 
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Appendix 13: Glucose assay 
Glucose concentration was detennined from serum samples by an enzymatic 
colourimetric method using a commercially available kit. Samples were assayed in 
duplicate on a Cobas Bio automated analyser. All samples from the same subject were 
analysed in a single run. 
Kit: Glucose GOO-P AP 
Quality control: Precinorm L and Control serum (Roche U.K. Ltd.) 
Supplier: Boehringer Mannheim, U.K. Ltd. 
Principle 
glycerol phosphate oxidase 
glucose + 02 + H20 ----------------------------------> gluconate + H202 
peroxidase 
2 H20z + 4-aminophenazone + phenol -------------------> 4-(p-benzoquinone-mono-
imino)-phenazone + 4 H20 
Solutions 
Bottle I: Contents of bottle are dissolved in 200 ml of redistilled water. 
Bottle 2: Phenol (560 mmo1.1-1). 
" Reaction mixture: Add one bottle of the phenol to the dissolved solution (bottle 1). 
Procedure 
(1) Samples were removed from the freezer and allowed to thaw at room 
temperature for 1 hour. 
(2) Samples were mixed, dispensed into plastic sample cups and loaded onto the 
Cobas Bio analyser. 
(3) 4 III of sample, standard or control material was pipetted into cuvettes. 
(4) 300 III of reaction mixture was added to the cuvettes. 
(5) Samples were mixed and left to incubate for 1 minute. 
(6) Samples were read at 500 nm. 
(7) Sample concentrations were calculated by the Cobas Bio analyser using a 
regression equation derived from a reagent blank and a series of 3 standards of 
known concentration (2,4 and 6 mmo1.1-1). 
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Appendix 14: Free fatty acids assay 
Free fatty acid concentration was detennined from serum samples by an enzyrnatic 
colourimetric method using a commercially available kit Samples were assayed on a 
Cobas Bio automated analyser. All samples from the same subject were assayed in a 
single run. 
Kit:NEFA 
Supplier: Wako Chemicals 
Principle 
Acyl-CoA-synthase in the presence of A TP and free fatty acids catalyses the acylation 
of CoA to acyl-CoA, which is oxidised by acyl-CoA oxidase to give 2,3-trans-enoyl-
CoA with the formation of hydrogen peroxide. In the presence of peroxidase, 4-
aminoantopyrine and 3-methyl-N-ethyl-N-(13-hydroxyethyl)-aniline (MEHA) form a red 
quinone dye by oxidative condensation with hydrogen peroxide. The concentration of 
this dye is proportional to the concentration of non-esterified fatty acids. 
ACS 
RCOOH + ATP + CoA ------------> Acyl-CoA + AMP + PPi 
ACOD 
Acyl-CoA + 02 -------------> 2,3-trans-Enoyl-CoA + H202 
peroxidase 
4-Aminoantipyrine + MEHA + 2H202 ---------------> red quinoneimine dye + 4H20 
RCOOH = non-esterified fatty acids 
ATP = adenosine triphosphate 
AMP = adenosine monophosphate 
CoA = coenzymeA 
PPi = pyrophosphate 
MEHA = 3-methyl:N-ethyl-N-(B-hydroxethyl)-ani1ine 
ACS = acyl-CoA synthetase 
ACOD = acyl-CoA oxidase 
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Reagents 
Colour reagent A: Containing acyl-CoA synthetase, ascorbate oxidase, coenzyme 
A, adenosine triphosphate and 4-aminoantipyrine. 
Colour reagent B: Containing acyl-CoA oxidase, peroxidase and 3-methyl-N-ethyl-
N-(13-hydroxyethyl-aniline). 
Solvent for A: Containing phosphate buffer, magnesium chloride and Triton X-
100. 
Solvent for B: Containing maleimide, phenoxyethanol and Triton X-lOO 
Preparation of reagent solutions 
Solution A: Dissolve contents of bottle A with 10 rnl of solvent A 
Solution B: Dissolve contents of bottle B with 7.5 rnl of solvent B. 
Standard (1 mmo1.1-1): Oleic acid, ready for use 
Procedure 
(I) Samples were removed from the freezer and allowed to thaw at room 
temperature for at least 1 hour. 
(2) Samples were then mixed thoroughly, dispensed into plastic sample cups and 
loaded onto the Cobas Bio. 
(3) 10 III of sample or standard was pipetted into each cuvette. 
(4) 100 III of reagent A was then added to each cuvette. 
(5) Samples were mixed thoroughly and incubated for 10 minutes. 
(6) 75 III of reagent B was added to each cuvette. 
(7) Samples were again mixed thoroughly and read at 550 nm. 
(8) Sample concentrations were calculated by the Cobas Bio using a one point 
standard of 1.0 mmo1.1-1, supplied with the kit. 
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Appendix 15: Apolipoprotein AI and B assay 
Apolipoprotein AI and B concentrations were determined from serum samples by an 
immunoturbidimetric method using commercially available kits. Samples were assayed 
on a Cobas Bio automated analyser. 
Kits: UNI-KIT Apolipoprotein AI T Antiserum and UNI-KIT Apolipoprotein B T 
Antiserum and T Standard 
Quality control: Lipid Control 
Supplier: Roche U.K. Ltd. 
Principle 
Human apolipoprotein AI and B forms with a specific antiserum a precipitin which is 
determined turbidimetrically by a fixed time method. 
Solutions 
T Standard: The contents of one bottle are dissolved with 0.5 ml redistilled water. 
T Antiserum AI: Antiserum specific for human apolipoprotein AI in phosphate buffer 
stabilized with sodium azide. Ready for use as supplied. 
T Antiserum B: Antiserum specific for human apolipoprotein B in phosphate buffer 
stabilized with sodium azide. Ready for use as supplied. 
NaCI solution (0.9%). 
Procedure 
(1) Prior to use allow antiserum and T Standard to warm to room temperature. 
(2) Dilute the reconstituted T Standard with NaCI solution in a geometric series (as 
explained in kit). 
(3) A calibration curve using the dilutions ofT Standard is established for both 
. assays prior to running any samples. Each new batch of antiserum requires a 
new calibration curve to be established. 
(4) The calibration curve is established by placing the dilutions ofT Standard in 
ascending order in plastic sample cups and loading on to the Cobas Bio. 
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(5) The Cobas Bio is programmed according to instructions in the kit, making sure 
printout mode is on 2 or 1 as desired. A standard non-linear curve will be 
established and stored. 
(6) Samples were removed from the freezer and allowed to thaw at room 
temperature for at least I hour. 
(7) Samples and control serum are diluted with NaCI (0.9%) solution in ratio 1 :21 
(1 + 20) in plastic sample cups and loaded onto the Cobas Bio. Printout mode 
was on 0 before beginning analysis. 
(8) 5111 of diluted sample or control material was pipetted into cuvettes. 
(9) 200 III (Apo AI) or 160111 (Apo B) of antiserum was added to the cuvettes. 
(10) Samples were mixed and left to incubate for 5 minutes at 37°C. 
(11) Samples were read at 340 nrn. 
(12) Sample concentrations were calculated by the Cobas Bio analyser using the non-
linear calibration curve established. 
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Appendix 16: Insulin assay 
Insulin concentration was detennined from serum samples by a solid phase 
radioimmunoassay using a commercially available kit. All samples from one study were 
analysed in a single batch. 
Kit: Coat-A-Count Insulin 
Supplier: Diagnostics Products Corporation, USA. 
Principle 
In the coat-a-count insulin procedure, 125I-labelled insulin competes with insulin in the 
sample for sites on insulin·specific antibody immobilized to the wall of a polypropylene 
tube. Mter incubation, isolation of the antibody-bound fraction is achieved by 
decanting the supematent The tube is then counted in a gamma counter, the counts 
being inversely related to the amount of insulin present in the sample. The quantity of 
insulin in the sample is then detennined by comparing the counts to a standard curve. 
Materials supplied 
Insulin Ab-Coated Tubes: polypropylene tubes coated with antibody are supplied. 
Uncoated Tubes T: For total counts. 
Non·specific binding tubes NSB: for non-specific binding count. 
125Insulin: 100 ml distilled water is added to each vial and mixed gently. 
Insulin calibrators: In order to set up calibration curve, standards are provided in 
concentrations of 0,5, 15,50, 100,200 and 400 IlU.mH. 
Control material 
Procedure 
(1) Pipette 200 III of the zero calibrator into 4 T tubes and 4 NSB tubes, and 200 III 
of the remaining calibrators, samples and control into the antibody tubes. Pipette 
directly to the bottom. 
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(2) Add 1 ml of 125Insulin to every tube and vortex. 
(3) Incubate for 18-24 hours at room temperature. 
(4) Decant thoroughly and allow tubes to drain for 2-3 minutes. Strike tubes 
sharply on absorbant paper to shake off all residue droplets. 
(5) Count for I minute in a gamma counter. 
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Appendix 17: Apolipoprotein E phenotyping 
Phenotyping of apolipoprotein E was perfonned by Dr SJ Mastana, Department of 
Human Sciences at Loughborough University by isoelectric focussing using Westem 
blot techniques. 
(1) Preparation of plates 
6.66 ml Acrylamide stock: made up from 29.1 g Acrylamide, 0.9 g bis-acryamide and 
100 mI distilled water 
0.6 ml Pharmalyte pH 4.5 - 5.4 
1.2 ml Pharmalyte pH 5.0 - 8.0 
7.2 g Urea 
31.6 ml distilled water 
(2)~ 
1 ml of I % ammonium persulphate 
12 JllTEMED 
(3) Sample preparation 
10 III serum 
lOO 1l15mM dithiothreitol in 0.25% (v/v) Tween 20 
Incubate overnight at 4 QC 
(4) Running conditions 
ANODE: IM H3P04 
CATHODE: IM NaOH 
2000 volts, 10 W maximum current. 
Prefocus for 15 minutes. 
Apply sample on 5 x 10 mm 3MM chromatography paper close to the cathode. 
Focus for 30 minutes, remove sample wicks and focus for a further 90 minutes. 
Blotting and visuali7Jltion of apolipQProtein E 
After electrofocussing the gel was washed in TSB and the electrode strips removed. 
Nitrocellulose membrane, soaked in TSB, was applied to the gel. 3MM 
chromatography paper, wetted with TSB, was placed over the membrane, followed by 
paper towels, a glass plate and a weight. After 1.5 hours, the membrane was rinsed 
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with TSB and incubated for 2 hours in 5% non-fat milk to saturate the remaining 
protein binding sites. 
The filter was then exposed to goat anti-human apoE antiserum overnight, anti apoE 
diluted 25 ~l in 25 ml TBS. Antisera was reused by adding an extra 10 ~l anti-human 
apoE antiserum. 
The following morning the membrane was washed with TSB (3 x 10 minutes) and then 
exposed to rabbit anti-goat IgO anti-serum conjugated with alkaline phosphatase, 
diluted 25 ~l in 25 ml TBS. The anti-serum was reused by adding an extra 5 ~l rabbit 
anti-goat anti-serum. The membrane was then incubated for 90 minutes and then 
washed with TBS (3 x 10 minutes). 
The bands visualized histochemically using: 
25 mg beta-naphthyl phosphate 
25 mg fast blue BB 
60 mg magnesium sulphate 
50 ml developer buffer (1.8 g NaOH and 3.7 g boric acid/I) 
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Appendix 18: Within batch and between batch coefficient of variations 
Assay· Within batch precision Between batch precision 
Mean SD CV% Mean SD CV% 
Automated 
analyzer 
TAG (mmol.l-l) 1.71 0.011 0.64 1.74 0.065 3.74 
TC (mmol.l- l) 4.89 0.059 1.23 4.82 0.079 1.64 
FFA (mmol.l-l) 0.13 0.002 1.54 0.16 0.008 5.00 
Glucose (mmol.l-l ) 4.32 0.04 0.93 5.93 0.13 2.19 
Apo AI (g.!-l) 1.73 0.013 0.75 1.29 0.046 3.57 
Apo B (g.!-l) 0.88 0.009 1.02 0.94 0.034 3.62 
Insulin (IlV.ml-l) 8.77 0.43 4.90 - - -
Hand 
TAG (mmol.l-l) 0.79 0.02 2.53 1.25 0.051 4.08 
TC (mmol.l-l) 2.95 0.07 2.37 5.36 0.18 3.36 
HDL-C (mmol.l-l ) 1.51 0.03 1.99 1.09 0.05 4.59 
HDL3-C (mmol.l- l) 1.03 0.04 . 3.88 0.78 0.039 5.01 
Glycerol (mmol.l- l) 0.82 0.039 4.76 0.75 0.051 6.80 
Lactate (mmol.l-l ) 1.60 0.06 3.90 1.10 0.053 4.82 
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Appendix 19: Medical history questionnaire 
CONFIDENTIAL HEALTH HISTORY QUESTIONNAIRE 
Name ________________ ___ Date of Birth 
Address, ______________ _ Telephone (home) 
Telephone (work) 
Weight ________ __ Height 
PRESENT SYMPTOMS 
(Have you recently had?) 
yes no 
Chest pains/discomfort ( ) ( ) 
Shortness of breath ( ) ( ) 
Heart palpitations ( ) ( ) 
Frequent headaches ( ) ( ) 
Back pain ( ) ( ) 
Arthritis/swollen painful 
joints ( ) ( ) 
PAST HISTORY 
(Have you ever had ?) 
yes no 
High blood pressure ( ) ( ) 
Any heart trouble ( ) ( ) 
Disease of arteries ( ) ( ) 
Varicose veins ( ) ( ) 
Lung Disease ( ) ( ) 
Asthma ( ) ( ) 
Diabetes ( ) ( ) 
Epilepsy ( ) ( ) 
Thyroid Disease ( ) ( ) 
Heart m urrn ur ( ) ( ) 
FAMILY HISTORY 
(Have any of your immediate family or grandparents had ?) 
Heart attacks 
who age __ _ 
High blood pressure 
High cholesterol 
Stroke 
Diabetes 
Early or sudden death 
Clotting disorders 
yes no 
() () 
( ) 
( ) 
( ) 
( ) ( ) 
( ) 
( ) 
( ) 
( ) 
( ) 
() 
( ) 
Other family illnesses ________ _ 
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LIST ALL CURRENT PRESCRIPTION AND NON·PRESCRIPTION 
MEDICATIONS (include birth control pills). If none please write NONE. 
Medication Reason for taking For how long? 
Please list below any other medical problems not already indicated 
Have you ever had your cholesterol level measured? ___ _ 
If so, can you remember what it was approximately? __ _ 
Have you ever had your blood triglyceride level measured? ___ _ 
If so, can you remember what it was approximately? _____ _ 
When did you last have your blood pressure checked? _______ _ 
Can you remember what it was approximately? _____ _ 
Do you currently smoke? yes ___ _ no ____ _ 
If yes, how many? _____ _ 
Have you ever quit smoking? yes,--::____ no ___ _ 
For how many years did you smoke? _____ _ 
How much alcohol do you normally consume in 1 week? Please give your answer in 
number of units 
1 unit = I glass of wine or half pint of beer or I measure of spirits. _____ _ 
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Appendix 20: Calculation of energy expenditure (metabolic rate) by 
indirect calorimetery. 
Estimations of energy expenditure and fuel utilization during exercise were calculated 
according to the method described by Consolazio and co-workers (1963), as 
demonstrated below. 
(1) Carbohydrate (CHO) 
C6H1206 + 602 = 6C02 + 6HzO R = 6+ 6 = 1.0 
Oxidising 1 g CHO uses 0.828litre 0z, producing 0.828 litre C02 and 17 kJ 
energy. 
(2) Fat (palmitic acid) 
C16H3202 + 2302 = 16COz + 16H20 R = 16 + 23 = 0.7 
Oxidising 2 g fat uses 1.989 litre 02, producing 1.419 litre C02 and 39 kJ 
energy. 
(3) If parallel, steady state values for V02 and VC02 are known, the quantities of 
fat and CHO oxidised per minute may be calculated using simultaneous 
equations. 
Let x g of CHO and y g of Fat be oxidised per minute. 
Then V02 = 0.828x + 1.989y 
VC02 = 0.828x + 1.419 y 
Example: 
VC02 = 1.31.min-1 
1.5 = 0.828 x + 1.989 y (1) 
1.3 = 0.828 x + 1.419 y (2) 
Subtracting 0.2= 0.57 Y y = 0.35 
Substituting in equation (1) 1.5 == 0.828 x + (1.989 x 0.35) 
x = 0.97 
Energyexpenditure = [(0.35 x 39) + (0.97 x 17)] kJ.min-l 
= 30kJ.min-1 (7.2 cal.min-l) 
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Appendix 21: Physical activity questionnaire 
Name: Date: ____ _ 
1. Which of the following activities have you done in the last four weeks? 
Football Rugby Cricket Hockey 
Tennis T.Tennis Squash Badminton 
Golf Bowls. Volleyball Basketball 
Netball Athletics (track) Athletics (field) Cross-country 
Jogging Running Swimming Sailing 
Windsurfing Waterskiing Rowing Canoeing 
Skiing Ice skating Roller skating Rock climbing 
Potholing Hill walking Cycling Orienteering 
Rambling Hiking Horse riding Fishing 
Motor sports Air sports Martial arts Archery 
Fencing Skittles Snooker Darts 
Weight training Exercises Gymnastics Yoga 
Keep fit Aerobics Dance-fit Social dance 
Any Other 
(if none please go on to question 4) 
Please List: 
2. Please record below on how many separate days you did each activity and how 
long you spent doing each activity in the past four weeks. 
ACTIVIIY No.ofDays TIME 
For example: Aerobics __ 3 __ 1 hr each time - 3 hr 
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3. Please mark with a * those activites you have listed above which made you 
breathe heavily or sweat. If the activity had this effect every time put an 
equivilent number of *'s. ie. if aerobics made you sweat on each occasion mark 
Aerobics***. 
4. Have you done any heavy manual work in the garden in the last four weeks? ie. 
digging. 
(i) On how many days? 
(ii) How much time did you spend altogether? Please circle your answer. 
0-1 hrs 1-2 hrs 2-3 hrs More - please state __ _ 
5. Have you done any lighter work in the garden in the last four weeks? ie. 
weeding, mowing grass. 
(i) On how many days? __ _ 
(ii) How much time did you spend altogether? 
0-2 hrs 2-4 hrs 4-6 hrs More - please state __ _ 
6. Have you done any heavy manual work (DIY etc) in the past four weeks? 
(i) On how many days? ___ _ 
(ii) How much time did you spend altogether? 
0-1 hrs 1-2 hrs 2-3 hrs More - please state __ _ 
7. Have you done any lighter work (housework etc.) in the last four weeks? 
(i) On how many days? 
(ii) How much time did you spend altogether? 
0-4 hrs 4-8 hrs 8-12 hrs More - please state __ _ 
If you do not work please go to question 12. 
8. When at work are you mainly: Please circle you answer. 
seated standing up walking about 
9. Does your work involve much walking between floors? 
How many times on average would you do this per day? 
10. How much physical effort is involved in your job? 
None/little Moderate A lot 
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11. How do you nonnally travel to work? 
Please circle answer 
Bus 
Train 
Motorcycle 
bicycle 
Car walk 
other (please specify) ___ _ 
12. On how many occasions during the last four weeks did you walk continuously 
for more than 1 mile? 
Do not include here any walking used as an answer to questions 3&4. 
13. About how much time in the past four weeks have you spent on walking? 
0-2 hrs 2-4 hrs 4-6 hrs More (please state) 
14. Which of the following best describes your pace on these walks? 
Slow Steady Average Fairly brisk Fast 
15. Did these walks make you breathe heavily or sweat? Please circle your answer. 
Most of the time About half Not very often at all 
16. Thinking about all your local trips. which mode of transport do you use most? 
car walk cycle public transport 
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